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Methods 
One hundred and three patients were randomised to either strength or endurance 
training. Training sessions for both protocols involved twice weekly sessions for a 
period of 8-10 weeks. Sensitive and affective pain, and disability were measured by 
visual analogue scale and validated questionnaire. Secondary outcomes were machine, 
and non-machine measures of muscular strength and endurance, and range of 
movement. As the treatment therapist could not be blinded, patient's perceptions of the 
therapist's enthusiasm and commitment to the treatment were surveyed 2-3 months post 
treatment. A post-hoc analysis of the training instructions recorded at each session was 
conducted. This facilitated the development of a systematic method of ranking 
participants in order of adherence to allocated protocol. Ranked adherence lists for each 
group were correlated against traditional measures to ascertain their validity and 
sensitivity. The second analysis was conducted on the top seventeen participants in 
each group as defined by the ranked adherence lists. 
Results 
There is no significant difference for pain, disability or muscle function between the top 
seventeen participants of each group and the other participants at the pre-treatment 
measure. There is no inter-group difference for patients' perceptions of the therapist's 
attitude ( p = .60), which indicates that there are no placebo affects associated with the 
treatments. In terms of validity and sensitivity the ranked adherence system is clearly 
superior to both the blinded classification, and the ranked lists of total weight and total 
number of repetitions. The results of the Whole Group analysis for most of the measures 
are inconclusive, but the Top Adherers analysis shows a consistent trend favouring 
strength training. Significant and marginally significant inter-group differences are, (1) 
the SF-36 Role-Emotional scale indicates, both in the Whole Group and Top Adherers 
analyses that strength training is more effective in reducing the emotional distress 
associated with chronic pain (p = .076, p = .029), (2) the SF-36 Physical-Functioning 
scale indicates, both in the Whole Group and Top Adherers analyses, that regionalised 
strength training elicits clinically meaningful, greater reductions in disability (p <.05), 
and (3) the Top Adherers analysis shows that strength trained participants experience 
clinically meaningful, greater gains in muscle strength (p = .04). 
Conclusions 
In an intention to treat analysis the ranked adherence system is a useful tool for 
measuring adherence to protocol, which facilitates more valid measurement. The results 
of this double-blind trial indicate that strength training, by comparison to endurance 
training, produces significantly greater reductions in pain and disability. 
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CHAPTER ONE 
T HESIS O VERVIEW AND INTRODUCTION 
Neck pain is a common musculo-skeletal problem in the industrialised world with fifty 
to ninety percent of people experiencing one or more episodes of neck pain during their 
lifetime [1, 2]. The majority recover quickly from these episodes, but five percent of all 
cases persist for more than three months [ 1 ]. The recurrence rate is high at sixty-percent 
[1]. The cost to the individual in tem1s of reduced earning capacity and personal and 
family distress is very high. The cost to society in terms of lost productivity and 
compensation payouts is reported to be substantial [3]. Thus, there are very compelling· 
reasons for finding the most effective therapies for neck pain. 
Most whiplash injuries to the neck recover spontaneously within three months, but 
chronic symptoms develop in some 25% of individuals, where pain persists more than 
three months after the initial injury [ 4 ]1. If associated restricted mobility persists for 
more than a few weeks, joint immobility becomes progressively more complete. Disuse 
atrophy, with attendant lowered fatigue resistance, also occurs [5]. The link between 
muscular weakness and chronic low-back pain is well established [6]. Research also 
suggests a correlation between weak cervical musculature and chronic neck pain [7]. 
Further, as neck muscle strength is shown to be a controlling factor in the stability of the 
cervical spine [8, 9] it seems logical to seek safe and effective ways of strengthening it. 
However, many clinicians feel that strength-training the cervical spine, where the 
emphasis is on exercising slowly with heavy weights, is unsafe and may even aggravate 
patients ' symptoms [10]. Other clinicians maintain that muscular endurance-training, 
where the emphasis is on exercising fast with light weights, may be more suitable in the 
initial stages of training, the theory being that it facilitates maximal blood perfusion 
thereby maximising healing [ 11]. Hence, muscular endurance-training is prescribed 
more often because clinicians believe it is less likely to harm patients, but will still 
increase their muscular strength. 
1Chronic pain is defined as pain that has continued for at least three months. 
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It is also important to establish whether ·physiological changes in muscle size and 
structure resulting from different training methods impact differently on people's pain 
and disability. Therefore, the research questions of this thesis are, for patients with 
chronic neck pain, when compared with muscular endurance-training, (1) does strength-
training result in a greater increase in muscle strength? (2) Does strength-training result 
in a greater reduction in pain and disability? The underlying rationale of strength 
training the cervical muscles, therefore, is that by strengthening the weakened muscles 
of the neck the symptoms of pain and disability that accompany chronic neck pain will 
be significantly reduced. 
Candidates Role in the Trial 
The trial is my own work. In mid 1996 Dr John Corry, a rehabilitation specialist from 
Occupational Health and Rehabilitation Services (OHRS), which is a private. 
rehabilitation centre in Canberra, approached the National Centre for Epidemiology and 
Population Health. He sought an independent evaluation of the strength-training 
program that he prescribed for his patients. I was offered the chance to review the 
literature on strength-training for people with chronic neck pain. As there was so little 
literature on the subject, and Dr Corry' s preliminary data warranted more rigorous 
analysis, I became interested in designing and co-ordinating a randomised controlled 
trial to evaluate the strength-training program at OHRS. Table l ,,Table 2, and Table 3 
summarise the contributions of all collaborators. 
Chapter 2 reviews the history of therapeutic exercise and the advent of progressive 
resistance exercises. It also categorises conservative management strategies for chronic 
neck pain, quantifies those that incorporate some form of regionalised progressive 
resistance exercise and gives the reasons for its under utilisation. 
In Chapter 3, I review the evidence-based literature on exercise therapy for chronic 
neck, and low back pain for, (I) suitable placebo or alternative treatments for the control 
group, and (2) appropriate outcomes and measurement methodology. 
Chapter 4 outlines the methods and overall research design of the trial, the sample size 
calculations, the imbedded reliability study of the MedX Rotary Neck Machine and the 
muscular endurance measures that were developed for the trial. 
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Chapters 5 details the baseline group demographics and describes the development and 
validation of the systematic method of measuring adherence to protocol. It then gives 
the demographic details of the 'Top Adherers'. 
Chapter 6 presents the results for the primary and secondary analyses of sensory and 
affective pain. Chapter 7 presents the results of the primary and secondary analyses for 
disability. Chapter 8 details the results of the test-retest reliability study, and the pre and 
post-treatment measures for the machine and non-machine measures of muscular 
strength and endurance. The results of patients' perceptions of the therapist's 
enthusiasm and commitment to treatment are also discussed · in chapter 8. The 
implications of the results are discussed in chapter context. Chapter 9 is an all inclusive 
final discussion addressing the overall results. 
3 
Table 1 Contribution to the Development of the Trial * 
Task Primary Responsibility Advice 
Concept of research question JR GB 
Study design JR GB,WS 
Obtaining ethics approval JR GB,WS 
Application for grants JR 
Power Calculations JR WS,MS,RA 
Generator of random assignment JR GR 
*Key to personnel follows Table 3 
Table 2 Contributions to the Implementation of the Trial* 
'I ask Primary Advice 
Responsibility 
Provision of sample JC,GS 
Training of blinded measurer for secondary outcomes JR 
The development of the intervention JR LG, AT, JC,GS 
The development of the control JR LG,AT 
Executor of random assignment LG,M 
Administering training protocol LG,M 
*Key to personnel follows Table 3 
Table 3 Contributions to Outcome Measures* 
TasK Primary Advice 
Responsibility 
Location and decision to use Visual analogue scales to JR GB 
measure sensory and affective pain 
Location and decision to use West haven Yale Multi- JR GS 
dimensional Pain Inventory 
Location and decision to use SF-36 General Health JR GB,WS 
Questionnaire 
Development of questionnaire to measure demographics, JR WS 
physical characteristics and chronicity 
Location and decision to use Neck Disability Index JR GB, WS 
Location and decision to use Work Environment JR GB,WS 
Questionnaire 
Location and decision to use Short Form Beck Depression JR GB,WS 
Inventory 
Location and decision to use Crowne and Marlowe Social JR DB 
Desirability Scale 
Blinded measurement of primary outcomes JR 
Blinded measurement of secondary outcomes JM JR 
Entry and cleaning of all data JR 
Analysis of data JR MS,RA 
*Key to personnel follows 
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* Key to personnel 
AT Ms Anne Tiedmann, Exercise Physiologist (OHRS) 
DB Professor Don Byrne, School of Psychology, ANU 
GB Dr Gabriel Bammer, National Centre for Epidemiology and Population Health, 
(NCEPH)ANU 
GR Dr Geetha Ranmuthugula NCEPH ANU 
GS Dr Geoff Speldewinde, Occupational Health and Rehabilitation Services (OHRS) 
JC Dr John Corry, (OHRS) 
JM Mr Jim Magill, Occupational Therapist (OHRS) 
JR Ms Judy Ryan, School of Psychology, ANU 
LC Ms Liana Gathercole, Exercise Physiologist (OHRS) 
MF Ms Michele Freirnanis, Exercise Physiologist (OHRS) 
MS Dr Michael Smithson, School of Psychology, ANU 
RA Ms Robyn Attewell, Principal Statistician Covance Pty Ltd 
WS Dr Wayne Smith, (NCEPH) ANU 
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CHAPTER TWO 
THE EVOLUTION OF PROGRESSIVE RESISTANCE EXERCISE AND ITS 
PLACE IN CURRENT CONSERVATIVE MANAGEMENT OF NECK PAIN 
The Evolution of Progressive Resistance Exercise 
The first recorded instance of progressive resistance exercise (see Glossary) is said to 
have been when the Greek god Milo set himself the daily task of carrying a calf into the 
market square. He continued with this task until the calf matured into a full-grown bull 
[12]. Understandably this first form of progressive resistance exercise 'weight lifting' 
became associated with concepts of masochism, machoism and 'muscleism [ 13]. These 
connotations, unfortunately, have hindered the acceptance of the therapeutic and 
rehabilitative properties of progressive resistance exercise by the medical community_.. 
The record shows that around 1856 Dr Gustav Zander developed machines, remarkably 
reminiscent of those used today, to apply progressive resistance exercise to the limbs of 
patients [14]. These medico-mechanical machines were used in the medical 
environment for a few years before being taken over by gymnasiums and used for 
muscle strengthening exercises in healthy individuals. Therapeutic exercise came to 
have little significance in the medical environment and was considered largely 
irrelevant to post-injury rehabilitation [14]. Progressive resistance exercise came to be 
mainly the domain of weightlifters and was practised in the form of strength-training. 
However, a degree of muscular hypertrophy occurs with strength-training which limits 
functional flexibility and speed [15]. Therefore, athletes, such as runners and hurdlers, 
who needed to increase their stamina, opted for endurance-training(see Glossary) [16]. 
It was only with the Second World War and the associated urgency for maximum use of 
manpower that the medical community once again became interested in therapeutic· 
exercise. In 1942 a young orthopaedic surgeon Dr Tom DeLorme took the step of 
transfening the strength-training version of progressive resistance exercise back into 
medical practice when he used it to treat the injured limbs of soldiers. For DeLorme the 
decision, whilst it was not consistent with general medical thinking at the time, was not 
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difficult. He was a professional world-class· weightlifter; therefore, he was convinced of 
the benefits of strength-training. Further, his patients were young male soldiers who 
were psychologically receptive to the treatment. It was not until the 1960's, however, 
that progressive resistance exercise, in the form of muscular endurance-training, (see· 
Glossary) was prescribed for treating spinal pain [17]. But research conducted in 1970, 
demonstrated an increase in intra-discal pressure as a result of dynamic exercise [18]. 
Consequently it was discontinued and isometric exercise (see Glossary) became the 
favoured form of therapeutic exercise during the decade of the 70's. [19). During that 
time very little evidence-based research was conducted in the field of therapeutic 
exercise and none evaluating dynamic exercise [20]. At the close of the 70's, McKenzie 
showed that extension exercises had a beneficial effect on chronic low back pain [21]. 
Thus they were often prescribed during the 80's for low back pain. At this time 
immobilisation in a soft collar was the accepted form of treatment for neck pain. Early 
randomised controlled trials addressing acute neck pain compared passive therapies, 
such as physiotherapy or very gentle isometric exercises, to the 'Gold Standard'---collar 
and rest [22, 23). Other trials addressing neck pain compared alternate passive therapies 
such as mild isometric exercises, stretching, or proprioceptive (see Glossary) 
movements, mobilisation (see Glossary), manipulation (see Glossary) or transcutaneous· 
electrical nerve stimulation (TENS) [24-27] (See tables of excluded and included trials 
in chapter three). 
It was not until the late 80's that dynamic intensive exercises again came under 
consideration for treating spinal pain. Mayer and Gatchel applied the philosophy of the 
'sports medicine' approach from the athletic arena to the other end of the population 
spectrum- inactive chronic pain patients. They incorporated dynamic exercises into a 
multi-disciplinary package and termed it 'functional restoration' [5). Around this time 
researchers commenced evaluating exercise that included non-isolated (see Glossary) 
forms of progressive resistance exercise for treating spinal disease, firstly in the lumbar 
spine [28] and later in the cervical spine [29]. However, the muscular endurance version 
of progressive resistance exercise was the only form considered suitable for cervical 
pain, as clinicians regarded strength-training as unsafe and likely to provoke patients' 
symptoms [ 1 O]. This cautious attitude towards strength-training was supported by 
organisations such as the American College of Sports Medicine which, up until 1990, 
recommended against strength-training for the frail and elderly [30]. 
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Only in the last decade has iso-equipment (see Glossary) capable of isolating the effect 
of progressive resistance exercise to the spine become available. Initially it was 
available only for the lumbar spine, but later became available for the cervical spine 
with the advent of equipment such as MedX Cervical Extension Machine, the MedX 
Neck Rotator (see Figure 3) and Nautilus equipment [3 1]. !so-equipment is not without 
its critics. During 1993 Newton and Waddell questioned both the reliability and validity 
of iso-machine [32], but they have since been shown to be safe, reliable and valid [10, 
33-35]. However, as there is a lack of evidence for the effectiveness of regionalised 
progressive resistance exercise for the cervical spine it is rarely prescribed. 
The Place of the Regionalised Strength and Muscular Endurance-
Training in Current Conservative Management of Neck Pain 
The terminology of spinal disorder is neither standardised nor validated. Consequently it 
varies according to the setting, based sometimes, for example, on a radiological 
diagnosis and sometimes on a physiopathologic hypothesis. This partly explains the 
heterogeneity of the, sometimes contradictory and confusing, reports in the literature 
regarding the multitude of therapies advocated for the rehabilitation of patients with 
cervical pain [36]. Another problem associated with identifying and evaluating therapies. 
for cervical pain is the contextualisation of therapies within a management model that 
recognises the three chronological stages of pain being, acute pain (< 4 weeks), sub-
acute pain (4-7 weeks) and chronic pain(> 12 weeks) [36]. 
Management strategies for neck pain have been categorised into conservative and non-
conservative treatments [2, 36]. Based on the Cochrane systematic review of 
mechanical neck pain (see Glossary) conservative strategies can be further categorised 
into (1) manual therapy, which incorporates manipulation, massage and chiropractic 
treatment, (2) drug therapies, (3) patient education, and ( 4) physical medicine modalities 
(see Figure 1). Physical medicine incorporates physiotherapy, sometimes termed 
physical therapy and occupational therapy. Physiotherapy includes such therapies as 
cervical orthoses, therapeutic heat or chill, traction, biofeedback, electrotherapy, laser 
therapy, acupuncture, and exercise. 
Traditional therapeutic exercise can be categorised further into isometric or dynamic, 
both of which incorporate strengthening exercises as a common form. Dynamic exercise 
can be further broken down into aerobic training (sometimes termed endurance), work 
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hardening, aquatic, postural correction, neuromuscular control, movement awareness, 
stretching, and non regionalised forms of progressive resistance exercise2. The 
Cochrane review team found that with the possible exception of electromagnetic 
therapy, there was insufficient evidence to indicate whether any conservative 
management strategy, exercise included, was effective, or even innocuous, in treating. 
cervical pain [2]. But, these findings contradict the results of research into exercise 
therapy for chronic low back pain [37]. Moreover, the 1998 update to the Cochrane 
systematic review preceded the first published randomised controlled trial evaluating 
regionalised (see Glossary) progressive resistance exercise for cervical pain. 
As discussed in chapter one the primary reason for the under utilisation and paucity of 
research regarding regionalised progressive resistance exercise is that the technology 
has only become available within the last decade. Only since then have researchers 
turned their attention to regionalised versions of muscular endurance and strength-
training. Consequently there is very little evaluation of these new forms of progressive 
resistance exercise. The 1996 Cochrane review of conservative management strategies 
indicates that about thirty-one percent of treatment packages that have been evaluated in 
randomised controlled trials have a substantial component of one or other manual 
therapy (see Figure 1). Ten percent have patient education and fourteen percent have· 
drug therapies as their major components. About forty-five percent of treatments have 
some form physical medicine. The 1998 update of the Cochrane review and my search 
of the randomised controlled trials in the literature up until 2000, which totals 28 trials, 
indicates that the exercise component of physical medicine consists of the following 
categories: -eighty-two percent very gentle isometric or stretching type relaxation with 
exercises as a major component (see Figure 2). Thirteen percent have more intensive 
dynamic exercises that may incorporate a non regionalised (see Glossary) form of 
muscular endurance-training. Four percent have regionalised muscular endurance-
training and approximately 1 % have regionalised strength training, as a major 
component. (Figure 2). Further research into regionalised strength and muscular 
endurance versions of progressive resistance exercise is required to determine if they are 
effective treatments, and if so, whether one version is more effective than the other? 
2 With very few exceptions physiotherapists do not prescribe regionalised strength or endurance-training for the 





Figure 1 The Proportion Of Regionalised Progressive Resistance Exercise In 
Conservative Management Strategies For Chronic Neck Pain 























Figure 2 Proportion Of Regionalised Strength Training In Randomised 
Controlled Trials Evaluating Therapeutic Exercise 
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This review addresses the research into non-regionalised and regionalised progressive 
resistance exercise. It examines both the biological and methodological rationale 
supporting the choice of strength-training as the treatment and endurance-training as the 
control, or alternative treatment, in the proposed trial. It then goes on to review the 
literature regarding the design of the two training protocols for the trial. Finally it 
reviews the issue of measurement methodology for the primary and secondary 
outcomes. As there are few published randomised controlled trials evaluating exercise 
therapy for the cervical musculature, trials from various medical disciplines were 
considered (see Table 4 and Table 5 for the details of all studies considered for the 
proposed trial). 
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Table 4 Uncontrolled Studies On Neck Pain Considered For The Proposed Trial 
~ Population Purpose Pain Pain Results Physical Measure Physical Measure Measure Results 
1991 Leggett Healthy Reliability & validity n/a n/a Isometric strength in Strength increased 
M&F testing of iso-machine sagittal plane Sig. P< .05 
1991 Trinkle Healthy Reliability testing of n/a n/a Isometric strength in Highly reliable, one 
M&F iso machine rotational plane practice best for 
accurate results 
1992 Healthy Evaluating regionalised 10 pt analogue scale Significantly Isometric strength in Significant gains in 
Highland M&F strength-training Reduced sagittal plane strength 
1992 Berg Patients Evaluating regionalised Single categorical Significantly Isometric strength in Significant gains in 
M&F strength-training Question Reduced rotational & other plane strength 
1993 Pollock Healthy Evaluating regionalised n/a n/a Isometric strength in Significant gains in 
M&F strength-training sagittal plane strength 
1994 Ylinen Patients Evaluating isometric 10 pt analogue scale Significantly Non regionalised Significant gains in 
M&F strength measures Reduced Endurance strength 
1995 Priest et Patients Evaluating regionalised Undescribed NSID Isometric Strength Significant gains in 
al. M&F strength-training Rotational Plane strength 
1999 Nelson Prospective Evaluate effect of Whether or not patient No patient had Non regionalised Significant gains in 
surgical intensive non Required surgery before requi_red Endurance dynamic 




Table 5 Randomised Controlled Trials Considered for the Proposed Trail 
~ Type Population Chronic/ Acute (IT) Intervention Pain /Disability Results (AT) Alternative Treatment Measure (C) Control ( PT) Placebo Treatment 
1970 Goldie Single-blind Neck Pain Chronic (IT) Isometric exercises Sick leave NSJD 
and Landquist (AT) Traction 
(C) No intervention 
1981 Single-blind Neck Pain Acute less than (AT) Collar and manual Pain intensity Pain significantly reduced in all 
Nordemar and 3 days therapy by VAS. three groups, but NSID 
Thomer (AT) Collar and TENS Analgesic Analgesics consumption reduced 
(C) Collar only consumption in all three groups, but NSID 
1983 Brodin Double-blind Hospital Not provided (!) Manual mobilisation & DT Pain by VAS Group proportions sig different 
outpatients ( PT) Mock therapy and DT Tender spots NSID 
(C) Drug treatment 
1983 Loy Unblinded Cervical Sub (AT) Physiotherapy with short Relief of NSID 
Spondylosis acute/chronic wave diathermy and traction symptoms 
(AT) Electroacupunture 
1986 Mealy et Single-blind Patients Acute Whiplash (I) Maitland mobilisation and xPain intensity Active group sig better for pain 
al. attending (see glossary) daily exercises for cervical by VAS (p< .02) 
Emergency spine 
Clinic with (C) Collar, rest for two weeks 
Neck Injury then gradual mobilisation 
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1986 Pennie Single- blind Patients attending Acute (I) Twice weekly traction Pain intensity Pain significantly reduced in 
andAgambar Emergency Clinic Whiplash and advice on sleeping by VAS botl1groups,but1'lSID 
with 1'leck Injury posture and exercises 
(C) 2 weeks rest in collar Sick Leave Sick Leave 1'lS but sig social 
then taught active exercises class differences 
1988 Possibly two LBP patients Chronic (I) Intensive back Pain& Intervention group sig. better 
Manniche et exercise referred from GP's strengthening exercises disability by 
al. programs (AT) Same exercises, but LBP rating 
were double- I/5th intensity scale 
blind (C) Isometric and stretch 
exercises 
1989 Hurri Single-blind FemaleLBP Chronic (I) Education and exercise Pain by VAS Pain and disability sig better for 
patients (C) 1'lo trealment Disability by intervention group 
VQ 
1989 Single-blind Patients attending Acute (I) Early mobilising Pain by VAS Intervention group had 
McKinney Emergency Clinic Whiplash exercises significantly less pain at two 
with 1'leck Injury (AT) Physiotherapy year follow up. 
(AT) Initial rest with advice 
to mobilise at I 0 to 14 days 
1990 Deyo et Single-blind Respondents to ChronicLBP (I) TE1'lS Pain by VAS Exercise was more effective 
al. newspaper add (AT) TE1'lS & exercise Disability by than TE1'lS 
( PT) sham TE1'lS & SIP 
exercise 
( PT) sham TE1'lS 
1990 Pennie & Single-blind Patients referred Acute (I) Early traction and Pain by VAS NSID for pain 
Agambar from accident Whiplash Physiotherapy Time off work NSD for time off work but 
units (C) Collar and rest social class related to time off 
work 
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1991 Kamendo Single-blind Female clerical Mild episodic (I) Traditional neck school xSick Leave NSID 
et al. workers neck pain exercise plus 2 hours 
individualised counselling 
(AT) Traditional neck school 
exercise 
(C) No intervention 
1992 Koes et Single- blind Patients attending sub (AT) Manual Therapy MPI NSID 
al. GPs acute/chronic (AT) Physiotherapy SIP 
(exercise) 
(AT) Continued treatment by 
GP 
(C) Placebo, Detuned 
ultrasound and detuned short-
wave diathermy 
1992 Cassidy Single-blind Mechanical Neck pain drawing, (I) Single rotational Pain by Pain significantly reduced by 
pain patients analgesics manipulation lOINRS and lOlNRS in both groups, but 
intake and (AT) localised isometric Pain Disability NSID. Pain disability Index not 
pressure pain pressure (muscle Index reported 
threshold mobilisation technique 
1993 Levoska Single-blind Female office Mild, episodic (I) Non-regionalised Painful spots by 
workers neck pain Endurance palpation NSID 
(AT) Thermo therapy, Pressure-
massage and stretching threshold by 
(C) Healthy volunteers algometry 
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1994 Fitz- Double-blind Whiplash Chronic (I) Head eye coupling Neck Disability Intervention group improved 
Ritson Patients coordinated exercises plus Index significantly more than (AT) 
attending chiropractic treatment group, but serious confounds 
private rehab (AT) ROM, stretching, identified due to small group 
clinic isometric and isokinetic sizes of 15. 
exercises plus chiropractic 
practice 
1994 Revel et Single- blind Patients Chronic (I) Eye/head coupling Pain by VAS Intervention group significantly 
al. attending exercises plus anti Analgesics more pain reduction ( p<.004) 
rheumatology inflammatory and analgesics consumption 
clinic (C) Wait List Control 
1994 Takala et Cross-over Female light Mild episodic (I) Group gymnastics 45 Pain by VAS NSID, but significant seasonal 
al. design industry mins once weekly for ten Pressure pain by variation in pain measured by 
workers weeks algometry VAS 
WLC (cross over control 
groups) 
1994 Timm Single-blind Low back pain Chronic (I) Non regionalised high Treatment Low technology exercises 
patients technology exercises efficacy by experience a significantly 
(AT) Non regionalised low survival analysis longer pain free interval 
technology exercises on no of weeks 
(AT) Physiotherapy till return to 
(AT) joint manipulation treatment 
1995 Fitz Attempted Whiplash Sub/acute (I) Phasic exercises and Neck Disability Confounds identified 
Ritson et al. double-blind patients chiropractic Index 
( PT) Rehabilitation 
exercises and chiropractic 
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1995 Constant Single-blind Males and ChronicLBP (I) Spa therapy Pain by VAS Spa treatment more effective 
et al. females referred (C) No treatment Disability by VQ 
by GP 
1998 Randlov Single-blind Females Neck Chronic (I) Intensive non Pain by 11 point Pain and disability significantly 
pain patients regionalised endurance- box scale reduced but NSID 
referred to training 
Rheumatology (C) Same exercises, but less Disability by 
clinic intensive CNFDS 
1998 Jordan Single-blind Neck pain Chronic (I) Intensive regionalised Pain by 11 point All groups significantly reduced 
patients endurance-training box scale for pain and disability, but 
(AT) Physiotherapy Disability by NSID 
(AT) Chiropractic CNFDS 
2000Waling Single-blind Volunteers Mild episodic (AT) Non-regionalised Pain by VAS NSID for pain by VAS or 
Female workers strength pressure point algometry 
(AT) Non-regionalised Pressure point by between exercise groups, but 
endurance algometry when combined significantly 
(AT) Co-ordination training more pain reduction than 
(C) Advice on stress Pain drawing control group ( p<.05). 
management NSID pain drawing 
2000 Taimela Single-blind Working male Mild episodic, (I) Active general exercises Pain by VAS, vas score significantly lower for 
and female (AT) Lecture and home pain drawing, two exercise groups compared 
volunteers exercise program analgesics intake with control. Pain drawing, 
(C) Lecture and told to and pressure pain analgesics intake and pressure 
exercise threshold pain threshold not reported 
NSID =No significant inter-group differences, CNFDS = Copenhagen Neck Function Disability Scale, based on low back pain rating scale (38), SIP= Sickness 
Impact Profile, VAS = Visual analogue scale, DT = Drug Treatment, TENS = Transcutaneous electrical nerve stimulation 
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Research into Non Regionalised Progressive Resistance Exercise 
Before the advent of iso-technology for the cervical spine, non-regionalised forms of 
progressive resistance exercise were sometimes incorporated into general, therapeutic 
exercise based, treatments. The first randomised controlled trial compared a non-
regionalised form of endurance training, incorporated into an active physiotherapy package, 
with passive physiotherapy (29]. However, the results for muscular strength and 
endurance, whilst they appeared to favour the active group, were ambiguous, and no inter-
group differences were noted. Furthermore, there was no significant increase in pain 
threshold levels over time, or inter-group differences for mean number of tender palpation 
spots. A later, uncontrolled, study evaluated a non-regionalised endurance training program 
which was incorporated into an active physiotherapy program (39]. Ylinen et al. reported 
large clinically meaningful and significant reductions in pain, measured by a 10 category 
visual analogue scale3, and disability measured by the Oswestry Low Back Pain Disability 
Index. They also reported an approximate thirty percent increase in cervical extension 
strength (p <.05), measured in the sagittal plane by a commercially available isometric 
strain gauge system 4• 
A later randomised controlled trial compared non-regionalised endurance-training, 
incorporated into an intensive dynamic training program, to light training [41).Both groups 
increased their muscular strength and endurance, but there were no significant inter-group 
differences. There were significant reductions in pain for both groups at some of the 
follow-up measures, but again no significant inter-group differences. Further, there is sound 
experimental evidence that the ten point box scale, which was used to measure pain ir1 this 
trial, is of questionable validity [ 42) (see page 31 for more details). Therefore, these results 
possibly should not be taken at face value. A recent randomised controlled trial compared 
non-regionalised strength-training to aerobic endurance-training, co-ordination training, 
3 Not clear what this instrument is. Some scales that are termed 1 Opt visual analogue scales to in the literature arc actually 
adjectival scales with discrete categories 40. Strcincr, D.L. and G.R. Norman, Health Measurement Scales; A 
practical guide to their development and use. 1989, Hamilton Ontario: Oxford University Press .. They have I cm 
gradients marked on them, which makes them a confusing instrument to complete as respondents are not sure whether 
to place a slash through the line or circle one of the gradient marks. 
4 The Newtest Incorporated Isometric Strain Gauge system comprises of a strain gauge attached to a metal stand mounted 
on the wall. The patient is harnessed at the shoulder and knee level to restrict movement lo the cervical spine. They 
then pull against the measurement gauge while in the standing position with the strap fixed firmly around their head 
above the level of the eyebrows. 
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and no exercise (43]. Three lOOmm visual analogue scales were used to measure pre and 
post-treatment levels of pain at present, in general and at worst. However, the sample size 
of twenty-five in each group was too small to detect pain reductions of less than 20mm. 
Consequently, although participants in the strength and endurance-training groups appeared 
to experience pain reductions in the vicinity of 10-15mm they were not significant. It is 
possible that in non-regionalised trials of therapeutic exercise, patients' perceptions of their 
pain and function are influenced by the alleviation of depression, which often results from 
generalised exercise [ 44, 45]. It is also possible that the two significant inter-group 
differences for the strength and endurance groups compared to the control group could have 
occurred by chance, as a multiplicity of tests were conducted. The results of the pressure 
pain threshold and pain drawing measures were ambiguous. Muscular strength . and 
endurance were not measured. 
Research into Regionalised Strength and Endurance.-training 
Initially, uncontrolled studies evaluated regionalised strength-training in healthy individuals 
using the MedX Cervical Extension machine. Averaged increases in extension strength 
were within the range of 6-15% (46, 47]. The first uncontrolled study evaluating 
regionalised strength-training for patients also used the MedX Cervical Extension machine 
[l O]. Patients increased their average cervical strength by approximately twenty-two 
percent. They also experienced clinically meaningful and statistically significant reductions 
in pain measured by 10 point visual analogue scale. More recently two small uncontrolled 
studies evaluated progressive resistance exercise in the rotational plane for patients with 
neck pain [ 48, 49]. Rotational strength was increased by more than 30% in both stu~ies. 
Pain was not significantly reduced in Priest' s study, and it is not clear what measuring 
instrument was used. Berg et al. reported a clinically meaningful and significant reduction 
in pain, measured by a single categorical question. 
A recent uncontrolled study used MedX and Nautilus equipment to strength train thirteen 
patients with chronic neck pain, and thirty-three with chronic lumbar pain, in both the 
sagittal and rotational planes (50]. All patients were being considered for surgical 
intervention. At follow-up, which occurred from twelve to thirty months later, no patient 
had required surgery. Cervical isometric strength was not reported, but although there were 
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some differences according to gender, dynamic muscular endurance in the sagittal plane 
increased by approximately 63% and in the rotational plane by 110%. 
One single-blind randomised controlled trial compared regionalised endurance based 
intensive training with physiotherapy and manipulation using the Neck Exercise Unit, 
which trains in the sagittal plane [ 51). Patients in all three groups experienced 
approximately fifty-percent reduction in pain, measured by a ten-point box scale. But, as 
discussed previously the accuracy of the ten point box scale measure of pain is 
questionable, therefore, the results for pain in this trial should be interpreted with caution. 
(Also see inherent problems with single blind trial trials pages 11 and 12). Surprisingly, 
although the inter-group differences were not significant, the endurance group increased 
their muscular strength considerably less than the more passive physiotherapy .. and 
manipulation groups. This finding contradicts the belief held by some clinicians that 
endurance-training will increase muscular strength in chronic pain patients. The authors 
" .. .. expected that patients in the training group would increase relative strength levels more 
than the other patients ....... ... " [51 , pp 316]. However, the endurance-training group 
improved their muscular endurance by 100% compared to 50 and 57% respectively for the 
manipulation and physiotherapy groups, but the inter-group differences were not 
significant. 
One observation from the above research is that, by comparison to healthy individuals, 
patients make larger strength gains as a result of strength-training, but not from endurance-
training. This suggests that a degree of disuse atrophy (see Glossary) has occurred, which is 
reversed by the strength-training. The second observation is that training in the rotational 
plane seems to elicit larger strength gains (see chapter eight for details). Finally; the 
variation in pain reduction between studies may be attributable to either a genuine change 
over time or the questionable validity of the ten point box scale used in some studies. 
The Biological Rationale Supporting the Choice of Regionalised 
Strength-training as the Intervention and Regionalised Endurance-
training as the Alternative Treatment 
Disuse atrophy is noted after only short periods of casting in the limbs, yet, as it is not 
readily discernible in the spine, is rarely recognised as a factor in ongoing chronic disability 
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[5]. It occurs when muscles are immobilised ·or restricted for any reason [52]. It can occur 
in the cervical musculature as a result of immobilisation in a soft collar, or even protective 
restricted movement by the patient. The physiologic sequelae to disuse atrophy include loss 
of muscle weight and atrophy of type II fibres5. It is not dissimilar to the muscular atrophy 
that is present in the elderly, which has been shown to be reversed by strength-training [30, 
53]. 
It is well recognised that endurance-training is not as effective as strength-training in 
reversing disuse atrophy [ 52, 53]. Its aim is to enhance performance and aerobic power, 
through facilitating both oxygen transport and utilisation at the local level, by overloading 
specific muscle groups (54]. In patients with chronic neck pain it is aimed at increasing the 
capacity of type I muscle fibres, in the cervical musculature, to extract oxygen from the 
blood. The rationale is:- (1) it is the type I muscle fibres that are primarily involved iri low 
intensity activities such as supporting the cervical spine [7, 39], and (2) the maximal blood 
perfusion occurring as a result of the training maximises healing [51]. However, whether 
this second point is applicable to chronic pain that, by definition, has extended well past 
normal healing time is debatable. 
To summarise, theoretically there are plausible biological reasons in support of the 
effectiveness of both regionalised strength and regionalised endurance-training. However, 
if disuse atrophy accompanies chronic neck pain, and the literature suggests that it does [5-
7, 10], strength-training should be more effective in reducing the pain and disability 
associated with chronic neck pain [7]. 
The Methodological Rationale in Support of the Choice of Strength and 
Endurance-training 
From a methodological viewpoint the choice of the intervention and control treatment is 
paramount to the success and definitiveness of a trial. The control must be different from 
s Human skeletal muscle comprises of two distinct types of muscle fibre, fast twitch or type II, which is associated with 
power and speed, and slow twitch, or type I, which is characterised as possessing an aerobic endurance quality. the 
fast twitch fibres produce more force than slow twitch fibres but they fatigue more rapidly. for this reason slow twitch 
fibres are preferentially recruited during low intensity activities, but as activity and muscle tension requirement 
increase fast twitch fibres are activated 15. Ackland, T.R. and J. Bloomfield, The Anatomy and Biomechanics of 
Sports Performance. The Textbook of Science and Medicine in Sport, ed. J. Bloomfield, P.A. Fricker, and K.D. Fitch. 
1992, Carlton: Blackwell Scientific Publications. 
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the intervention otherwise there is no point to the trial. However, the extent of the 
difference is problematic as it effects the expected size of the treatment difference, 
therefore, the sample size calculations [55]. The various trial designs considered and 
rejected before selecting the double-blind research design are discussed below. 
Trials that have no Treatment for the Control Group 
The largest difference can be expected if the control group has no treatment. But, how 
realistic are the results of a trial where the control group has no treatment? Firstly, the 
participants are not blinded,6 therefore, it is possible that those in the control group will 
experience a negative placebo effect. Participants in the trial conducted by Koes et al. 
experienced a negative placebo effect. Those participants randomised to continued 
treatment by their GP actually scored worse for self reported pain and disability than those 
randomised to de-tuned diathermy, which was the true placebo group [56]. Second~y, a 
large treatment effect can be expected in these trials simply because the control group has 
no treatment. In effect, the trial is merely demonstrating that some treatment is better than 
nothing. Thirdly, usually there can be no long term follow up in such research because 
ethical considerations mandate that the control group receive the preferred treatment at or 
soon after completion of treatment, if the evidence indicates that it is more effective [55, 
57, 58]. These compromises distract from the research design of such trials to the extent 
that their results should be interpreted with caution. 
Trials that Compare to the 'Gold Standard" 
Many trials attempt to compare a new treatment to the current 'Gold Standard', which is 
physiotherapy for chronic neck pain. More often than not, when comparing a new treatment 
to the current 'Gold Standard', the treatments are not of similar nature and it is impossible 
to conduct a double-blind trial [59]. For example when comparing intensive exercise with 
physiotherapy the logistics of maintaining blinded conditions whilst also obtaining 
informed consent are impossible in a single centre trial. Consequently, when comparing a 
new treatment to the 'Gold Standard' the pragmatically simpler single centre, single-blind 
6 Blinded refers to a condition where treatment assignation, or other information is withheld from an individual, or 
individuals in the study as a means of improving the objectivity of the treatment, data collection and its interpretation. 
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trial7 is by far the most common in the literatUre (55) and due to the inadequacy of blinding 
is open to the critique of bias and other placebo effects [55). 
Trials that have Sham Treatments 
Research design incorporating sham treatments, usually double-blind trials8 overcomes the 
problem of negative placebo and Hawthome9 effects. However, for ethical reasons such 
trials usually incorporate a common background treatment into the research design. The 
results of such trials are sometimes difficult to interpret because the effectiveness of the 
common treatment may swamp, or negate possible effects of the sham or intervention. This 
was the case in Deyo's(LBP) trial comparing TENS to sham TENS with exercise as the 
common background treatment [60]. It was the case in Klein's (LBP) trial comparing laser 
and sham laser also with a common background exercise program [61). It could also have 
been the case to a certain extent in Jordan's trial, comparing endurance-training to 
physiotherapy, because the physiotherapy group was prescribed the same home ex~rcise 
program as the endurance-trained group [51]. 
Double-Blind Trials 
It is also difficult to conduct a double-blind randomised controlled trial comparing different 
exercise programs such as regionalised strength and endurance-training. However, 
depending on the amount of information given at the time of gaining informed consent it is 
possible to keep the patient naive to which is the preferred treatment [3 7). The task is to 
choose a control treatment that is medically distinguishable from the intervention yet 
administratively indistinguishable, and acceptable to the patient. It also must be ethically 
acceptable and medically justifiable to attending physicians [55]. The proposed trial to 
compare regionalised strength to regionalised endurance-training meets the criteria for a 
doubler-blind trial, as the patient is naive to which is the preferred treatment, and ~oup 
allocation is unknown to those measuring the patient's progress. 
7 In a single-blind trial one or other of the interested parties is not blinded, usually it is the patients. 
s Double-blind is characterised by (I) participants are blinded to treatment allocation (2) the observer collecting data and 
measurements is also blinded to treatment allocation. 
9 The Hawthorne effect is the positive effect on a persons behaviour when they know they arc being observed. In a 
double-blind trial it is balanced, but not eliminated. 
23 
However, to reiterate, the most compelling reason for comparing regionalised strength to 
endurance-training is that both treatments are new and have been little researched." The 
research that has been undertaken, however, indicates that both treatments, but more 
particularly regionalised strength-training, may be useful in reducing the pain and disability 
that accompanies chronic neck pain. 
In the proposed trial, if regionalised strength and endurance-training are equally effective, 
there will be no significant inter-group differences. Therefore, even if both groups make 
significant and clinically meaningful reductions in pain and disability, it will be impossible 
to disprove the notion that both groups are simply demonstrating a Hawthorne or placebo 
effect of similar magnitude. For this reason trials often include either a waitlist control, or a 
separate control group, which receives either no treatment, or what is regarded by the 
researchers, as relatively ineffective treatment. However, the introduction of a control 
group reduces that component of the trial to single-blind conditions. The results of a trial 
that incorporates a waitlist control group, which has no treatment, before receiving either 
treatment (a) or (b) are still questionable. If pain reductions are similar for both treatments, 
but significantly more than those experienced during the waitlist control period, where 
participants could not be blinded to the fact that they were having no treatment, it is still 
impossible to disprove a placebo effect. Likewise, especially in a secondary care setting, 
participants in a separate control group cannot be blinded to the fact that they are having 
either no treatment, or a treatment that is different from what they expected to receive. 
Given the above, and recognising that both waitlist, and separate control groups lengthen 
the accrual period of a trial the 'questionable' advantages are outweighed by the 
disadvantages. 
Further, if there is a significant difference between treatments, and after all the hypothesis 
is that there will be, then for the reasons discussed previously the results of double-blind 
trials will be robust. 
Designing the Strength and Endurance-training Programs 
Regarding the design of training protocols, the main considerations are safety, specificity, 
and the frequency, duration and structure of sessions. Another important consideration is 
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the therapist's attitude, in that patients shouid be encouraged to work through their pain 
[62]. 
Safety 
Progressive Resistance Exercises for the rehabilitation of patients needs to be carried out in 
a clinical setting under close supervision. Safety features such as controlled range of 
movement, regulation of difficulty and isolation of the muscles undergoing rehabilitation 
should be incorporated into the equipment [11 ]. Even the critics of iso-technology confirm 
its safety [32]. 
Specificity of Training 
When referring to exercise training 'specificity' applies to adaptations in both the metabolic 
and physiologic systems. At the metabolic level the traditional consensus has been that 
there is virtually no overlap between strength and endurance-training. Strength-training 
induces specific strength 10 and power adaptations 11 , whereas endurance exercise elicits 
endurance-training adaptations such as maximising oxygen uptake [54]. However, thls is 
not strictly correct as research shows that endurance-training can increase muscle strength 
in some deconditioned individuals [63]. 
At the physiologic level, in the rehabilitation and training of athletes it is well recognised 
that similarity should exist between the training conditions and those required for the 
specific athletic performance. Training should involve the muscle groups that cause the 
desired movement and the antagonist and stabiliser muscles that assist in the production of 
the movement [15]. When applying progressive resistance exercise to the cervical 
musculature, equipment such as MedX and Nautilus train the cervical muscles in the 
sagittal extension/flexion, and lateral flexion whilst the MedX Rotary Neck Machine trains 
in the rotational plane. Whilst the current consensus is that training in lateral flexion has a 
greater impact on the lower muscles of the cervical spine, both rotation and lateral flexion 
include elements of extension and flexion and involve many of the same muscles °[11]. 
From the patient's perspective the ability to move comfortably in the sagittal, lateral and 
10 Strength is defined as the amount of force a muscle can exert against a resistance in one maximal effort 
11 Muscular power is dependent on two interrelated factors, strength and contraction velocity 54. McArdle, W.D., F.l. 
Katch, and V.L. Katch, Exercise Physiology: Energy, Nutrition and Human Petfonnance Second Edition. 1986, 
Washington: Lea and Febiger. 
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rotational planes is equally important. However, at the time of researching for the proposed 
trial there was no equipment that could train in all three planes. 
Duration and Frequency of Treatment Sessions 
Morganti's research shows that 50% of strength gains attainable for a one year period of 
progressive resistance training are achieved within the first twelve weeks [64]. Therefore, 
the most effective duration of treatment is close to twelve weeks, with the patient being 
encouraged to continue progressive resistance training at their local gym at conclusion of 
treatment. Jordan et al. recommend that programs be designed so that they can be carried 
out within a one hour session two to three times a week over a period of 8-12 weeks [1 1]. 
However, good strength gains are possible with a frequency of 2 sessions weekly over the 
same period (47]. It is difficult to determine the optimum frequency and duration for 
regionalised progressive resistance exercise from the literature because the range of total 
hours of contact time is wide, and it is unclear what component of session time is actually 
spent on regionalised progressive resistance exercise (see Table 6). 
26 
Table 6 Frequency And Duration Of Previous Exercise Protocols For 
Regionalised Progressive Resistance Exercise 
K Subjects Session PRE1 Freq no of Total PRE Length ffilDS per weeks hours hours (mins) week 
Berg Patients x 12 2 8 x 3 25 
Highland Patients x x 2x 8 x x 
1 xx 
Jordon Patients 60 x 2 6 12 x 
Leggett Healthy volunteers x x 1 10 x x 
Pollock Healthy volunteers x x 1 12 x x 
Pollock Healthy volunteers x x 2 12 x x 
Nelson Patients 60 x 2 -10 x x 
Priest Patients x x x 8 x x 
xx_ no 
- -x = 151 first 4 weeks, - 2 4 weeks, x not stated or unclear PRE - Progressive resistance 
exercise. 
Structure of Sessions, Initial Starting Weight and Percentage Increases f or 
Training Programs 
The initial resistance provided for either strength or endurance-training is contingent 9n a 
number of factors such as the patient's gender, size, age, initial strength level and clinical 
diagnosis [11]. It is clear that the cervical musculature requires considerable resistance to 
achieve meaningful strength gains [10). In Pollock's strength-training protocol conducted 
on healthy volunteers, the initial resistance was set at 80% of measured strength, with an 
increment of 5% per session. In Leggett's strength-training protocol, also conducted on 
healthy volunteers, the initial resistance was calculated as 8-12 repetition maximal (RM) 
(see Glossary), which is the equivalent of 70-80% of lRM, and increased by 10% when 12 
repetitions were reached. In Highland's strength-training protocol, in which the patients 
made substantial strength gains, the initial resistance was set at 80% of measured isometric 
strength, and increased by 3.9 newton meters (nm) (approximately 20%), when patients 
could perform twenty repetitions. Nelson's strength-training protocol was similar to 
Highland's, but the initial starting weight was not described. In Berg's study of strength-
training in the rotational plane the initial resistance was set at approximately sey.enty 
percent of lRM. Currently the recommended protocol for strength-training the cervical 
musculature entails one to two sets of eight to twelve repetitions with the resistance set at 
70-80% of measured isometric strength. Patients should rest for two to three minutes 
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between sets (11). The recommended protocol for endurance-training is three sets of twelve 
to fourteen repetitions at 30-40% of maximal voluntary contraction, with a two minutes rest 
period between sets (1 1]. However, patients' ability to adhere to these protocols is not 
sufficiently tested as yet. The protocols represent the current consensus on progressive 
resistance training of the cervical musculature, and are not evidence based. They are 
preliminary conclusions drawn from the few published studies. 
In Jordan's trial of regionalised endurance-training the initial starting weight was set at 
thirty percent of measured strength and readjusted every fourteen days, which translates to 
two increases during the six week program. The recommended endurance-training protocol 
was prescribed for the treatment group. However, although the endurance-trained group 
made greater gains in muscular endurance there were no inter-group differences, and all 
three groups made clinically meaningful gains. 
Table 7 Initial Resistance And Increments In Published Regionalised Strength 
And Endurance Programs · 
~ Protocol Initial Sets Reps Plane Rest Incremen Resistance t 
1991 Leggett Strength 12RM 1 8-12 Sag Ext x 10%when 
(healthy 12 reps 
volunteers) reached 
1992 Berg Strength 12RM 1 12 Rotation I min x 
(semi patients) 1 12 Sag Ext 
I 12 Sag Flex 
1992 Highland Strength 80% 1 20 Sagittal x 20% 
(patients) Measured when20 
strength reps 
reached 
1993 Pollock Strength 80% 1 8-12 Sagittal x 5%per 
(Healthy Measured session 
volunteers) Strength 
1995 Priest Strength x x x Rotation x x 
(patients) 
1998 Jordan Endurance 30% I 12 Sag Flex x 14 day re 
(patients) 3 12 Sag Ext measure, 
3 12 Lat Flex to new 
30% 
RM =Repetition maximal = No of repetitions that can be performed, to full range of motion and in 
good form, with a given weight before involuntary fatigue occurs. 
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As can be seen from (see Table 7) the protocols prescribed to date vary widely and do not 
always strictly adhere to the principles underlying strength and endurance-trail}ing. 
However, while these principles are finnly established in sports medicine their scientific 
basis in spinal rehabilitative medicine is not yet clear. 
Primary Outcome Measurement 
The consensus is that pain and disability should be the primary outcomes when evaluating 
treatments for cervical musculo-skeletal disorder [36]. Health related quality of life is also 
important and should be measured by generic and specific questionnaires. There is also a 
growing recognition in medicine that patients' perceptions are essential in judging the 
results of treatment. In the past patients' perceptions of their pain and disability, measured 
by questionnaire, have been regarded as subjective, therefore, not as accurate as 'objective' 
physiologic measures such as spinal radiograph. However, the reliability of validated 
questionnaires is at least as good, and in some cases better than that for physiologic and 
anatomic measures. (65]. Other 'objective' measures such as return to work may be 
affected by any number of environmental factors such as job autonomy, closeness to 
retirement age or availability of other income (65]. Validated multi-item interval scales are 
commonly used to measure the multiple dimensions of pain and disability. However, the 
visual analogue scale is traditionally one of the most also often instrument to measure pain 
intensity. It is now sometimes used to measure some of the negative emotions that comprise 
the affective dimension of pain. However, the validation techniques used for multi-item 
interval, and visual analogue scales are very different, as discussed below. 
Validation and Reliability Assessment Techniques for Multi-Item Scales 
Multi-item interval scales may consist of several items that are adjectival scales [ 40, pg33], 
i.e. they consist of ordered categories labelled with adjectival descriptions. There is the 
untested assumption that the categories of adjectival scales are equidistant. Based on this 
assumption, and the premise that averaging or summing the responses of several items.will 
reduce the margin of error, ratio scale properties are attributed to multi-item scales. But, as 
Streiner points out they are actually based on an ordinal level of measurement. Multi-item 
scales may also consist of a series of numeric rating scales, which are interval level of 
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-measurement [ 66, pg 13]. Construct and content validation criteria used to assess the 
validity of multi-item scales were developed prior to the l 960's [67]. 
Traditional Validation 
Traditional validation consists of the following steps:--
1) Subjective assessment based on a review of the measure by one or more experts 
regarding content and face validity [40]. 
2) Empirical Validity of the subjective assessment is established by one of two 
methods. 
2a) Concurrent, or convergent validity is determined if there is a 'Gold Standard', to 
compare the instrument with. However, the status of 'Gold Standard' for validated 
questionnaires has usually been achieved through history or longevity, and close review 
suggests that they usually have less than ideal validity and reliability [ 40, pg8]. Therefore, 
even if the correlation between the new instrument and the 'Gold Standard' is acceptable 
there is no guarantee that the new instrument will be psychometrically sound. 
2b) Construct Validity is determined when there is no 'Gold Standard' for comparison 
[ 40, pp 150]. The problem with construct validity is that as the approach is very non-
specific strong relationships do not usually emerge from a single study. Many correlational 
studies are required [ 40, 68]. Another problem with construct validity is that because the 
instrument can discriminate between different populations for a given attribute, it is 
assumed that the instrument will measure intra-subject change over time for this attribute in 
a meaningful and accurate manner. However, it is sometimes the case that validated 
questionnaires attribute statistical significance to very small sometimes clinically 
meaningless changes. The problem is that it is unethical to continue a clinical trial 
comparing different treatments once a clinically meaningful difference is established 
beyond reasonable doubt [59]. Therefore the researcher should always be aware that 
statistical significance is not synonymous with clinical value [69]. 
3) Reliability is the concept that the scale is measuring something in a reproducible 
manner. It is assessed via establishing internal consistency and stability [ 40] 
A final problem with multi-item scales is that the robustness of their ratio scale properties is 
positively related to the number of items in the scale and the number of categories per item. 
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The greater the number of items and their assumedly equidistant categories the smaller the 
degree of measurement error will be [ 40]. Therefore, the more psychometrically sound 
scales tend to be long, to reduce the measurement error, and repetitive, to establish internal 
consistency. These necessities increase respondent burden, which when measuring change 
over time in a clinical trial can become an issue of compliance to post-treatment measures 
Experimental Validation 
There are well described experimental methods of testing the ratio scale properties of 
measures. Experimental validity and reliability assessment of the visual analogue and 
numeric rating scale measures of both sensory and affective pain has been conducted. The 
experiment of Price et al. [ 42) consisted of the following steps. 
1. Patients were given 28 different heat stimuli of varying intensities and asked to rate 
pain intensity on a visual analogue scale. 
2. They were then given the heat stimuli again and asked to rate on their pain intensity 
on the 11-point numeric rating scale. 
3. The results for both instruments were plotted and the line of best fit inserted. 
4. Patients were given a heat stimulus of about 47 degrees and instructed to remember 
it as a reference stimulus. 
5. During six separate trials the heat was slowly increased until the patients reported 
that the stimulus was twice as intense as the reference stimulus. 
6. The judgments of ratio intensity were compared with those predicted by the line of 
best fit established from the random stimuli applied in step 1. 
A power-function derived from the sensory visual analogue scale predicted temperatures 
shown to be twice as intense as the reference temperature accurately, which demonstrates 
its robust ratio scale characteristics. The same stimulus response function derived from the 
11-point numeric rating scale failed to accurately predict when the temperatures were twice 
as intense as the reference stimuli, which demonstrates that it does not have ratio scale 
properties. The power function for the pain unpleasantness visual analogue scale showed 
more variation. It was reliably different from the sensory visual analogue scale indicating 
the unique and separately measurable characteristics of sensory and affective pain. 
Validity was established with the triangulation procedure as follows:-
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1. Patients rated their clinical pain during the previous week both on the visual 
analogue scale and the 11-point numeric rating scale. 
2. A stimulus temperature was applied and gradually increased until the patient 
reported that it matched their clinical pain. 
3. If patients were judging pain intensity in an internally consistent manner the 
intersection of the mean scale rating of their clinical pain (on they axis) and their 
mean temperature match to their clinical pain (on the x axis) would occur on, or 
very close to their line of best fit, established in step 1 of the original experirrient. 
The validity of both scales was acceptable. 
As can be seen from the above, experimental validation is a rigorous process based on 
validating the ratio scale properties of instruments. Traditional validation techniques do not 
experimentally test the ratio scale properties of scales. They are based on subjective 
assessment, and underlying assumptions regarding equidistant adjectival descriptors, which 
are then empirically tested with various statistical techniques. As discussed above empirical 
validation of subjective assessments does not necessarily rigorously test the psychometric 
properties of the instrument under question. 
Pain 
Pain is an integral part of life. It is essential for survival and plays an important protective 
function. However, pain that extends well beyond normal healing time is no longer of any 
survival value. It results from disease and/or sometimes unidentifiable tissue pathology 
[70]. It is defined as an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, therefore, its conceptualisation must acknowledge the 
importance of emotional as well as sensory factors [70]. Furthermore, there are contextual 
and psychological factors, which can selectively and powerfully alter the cognitive 
dimension of pain and memory for pain. Consequently, the measurement of pain requires a 
wide variety of psychological and physiological methods that explicitly recognise the 
multiple dimensions of the pain experience and pain related behaviour (71]. Many 
instruments were considered for measuring pain and disability in the proposed trial (see 
Table 4, Table 5 and Table 8). 
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The two dimensional pain model was first recognised by Melzack and Casey in 1968 and 
later espoused by many other authors [72]. In this model pain is conceptualised as 
comprising both the 'sensory' or pain intensity dimension, and the affective dimension. The 
second 'affective' dimension consists of two stages. The first stage is that person's 
immediate cognitive response to the painful stimuli, i.e. 'it bothers me because it hurts'. 
The second stage is a more reflective appraisal of the implications of the pain and its 
influence on one's daily activities and quality of life. The second stage of pain is heavily 
dependent on the experienced context of the pain, its perceived origin and one's perceived 
ability to control it. 
As discussed previously experimental research has provided evidence for the empirical 
basis of the sensory and affective dimensions of pain by demonstrating that they can be 
independently measured. Therefore, it is necessary to measure both the sensory and 
affective entities when evaluating the effect of treatment. 
The Rationale Supporting the Use of Questionnaires Based On the 
Cognitive Behavioural Approach 
With the recognition of affective pain came the gate control theory first espoused by 
Melzack and Wall in 1965. This theory emphasises the cognitive-evaluative and 
motivational affective processes in addition to the sensory discriminative processes [73]. As 
a result of the gate theory many clinicians turned their focus of attention to affective pain 
and the cognitive behavioural approach. There is an extensive body of literature indicating 
that patients suffering depression experience pain more intensely, and that when the 
depression is successfully treated pain also reduces. Consequently clinicians have come to 
view the relationship between experienced pain and psychosocial variables in unidirectional 
terms, i.e. chronic pain may be either caused by psychosocial factors, or could provoke 
psychosocial sequelae [73]. Recent evidence based research, however, indicates that 
psychological distress is the consequence of chronic pain, not the catalyst (74] 12• But, 
when pain extends past normal healing time, and is sometimes overwhelming and 
12 In a double-blind randomised controlled trial, evaluating a definitive treatment for chronic neck pain, all patients who 
obtained complete relief from pain exhibited resolution of their pre-operative psychological distress 74. Wallis, B.J., 
S.M. Lord, and N. Bogduk, Pain and psychological symptoms of Australian patients with whiplash. Spine, 1997. 
22(1): p. 114-5 .. 
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uncontrollable, psychological factors may come to play a major role in influencing the 
subjective responses to pain [70]. Therefore, measures based on a cognitive behavioural 
theory are a necessary component of the battery of measures required to comprehensively 
measure quality of life in people with chronic pain. 
Which Instrument to Measure Sensory Pain :- First Choice the VAS 
Many different scales for assessing pain have been developed over the years. Many are 
ordinal rating scales13 and do not have ratio scale properties, 14 therefore, should only be 
analysed using non-parametric statistical techniques. As discussed previously the adjectival 
descriptors, used for each item in many multi-item interval scales are a version of the 
ordinal rating scale [ 40]. Numeric rating scale of 6-10 numbers are also commonly us·ed in 
multi-item interval scales. Yet, as discussed before they are not valid measures of pain 
intensity. To summarise, the assumption that multi-item interval scales warrant parametric 
statistical analysis is the subject of considerable debate in the literature [ 40, pp 38]. 
Some researchers report higher reliability for the 101 point numeric rating scale when 
compared with the VAS especially when completed by illiterate or elderly patients. 
However, a search of the literature indicates that there is no experimental evidence attesting 
to the ratio scale properties of the 101 NRS. Further, although there is some evidence 
indicating no difference between the two instruments there is also evidence that attributes 
greater sensitivity to the VAS [75]. Several researchers into neck and/or low back pain used 
the VAS to measure pain intensity [24, 25, 57, 76-78]. In these trials the VAS appeared 
sensitive to change over time. 
Measuring Sensory Pain by Generic Measures 
Many studies measure pain intensity by the scales in validated generic questionnaires such 
as the SF-36 General Health Questionnaire or the Multi-dimensional Pain Inventory ( MPI). 
For the pain reductions experienced by patients in the proposed trial to be directly 
compared with those of other chronic pain populations the same instruments should be 
used. The SF-36 was developed as a multi-purpose survey of general health status for both 
u Numbers on ordinal scales refer only to rank ordering and cannot be interpreted to reflect ratios of magnitude. 
14 The numbers on ratio scales reflect ratios of magnitude, therefore, conclusions about percentage change over time are 
valid 
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national and international use. The psychometric properties of the translations and English 
language adaptations of the SF-36 have been validated in over forty different countries. 
Further, there, are established population norms for many different general populations and 
populations with specific medical conditions [68]. The MPI is a multifactor instrument 
designed to address the broad domain of psycho-social factors pertinent to chronic pain, 
and is based on the cognitive-behavioural perspective of chronic pain. It is a fifty-two item 
inventory divided into three parts, each containing several sub-scales [79]. 
The SF-36 Bodily-Pain scale 
The Bodily-Pain scale in the SF-36 comprises of two categorical scale items, one with six 
categories and the other with five. Where pain is the focus of evaluation it is recommended 
that the SF-36 be used in conjunction with other instruments more specifically designed to 
measure pain [80]. 
The Multi-dimensional Pain Inventory (MP]) Pain Severity Sub-scale 
The MPI pain sub-scale contains three, seven point numeric rating scales. Since the MPI 
was published in 1985 studies have demonstrated its sensitivity to pain reduction [81 ]. The 
pain severity scale has been validated as a brief and reliable measure of pain intensity [82]. 
Pain Recollection 
Conceivably, hourly ratings in pain diaries over a period of one to two weeks is the most 
accurate measure of pain, if they are completed according to the instructions. However, it is 
not feasible to use pain diaries in a randomised controlled trial where respondent burden is 
an issue. Jensen's research addresses the question of how long do people accurately recall 
sensory pain [83]. Jensen et al. asked 44 chronic pain patients to record 14 days worth of 
hourly pain ratings in a daily pain diary. After two weeks the patients then recorded 
retrospective ratings over the previous two weeks of their worst, least and usual pain. The 
pain diary records correlated well with the arithmetic mean of patients' recalled least and 
usual pain for the preceding two weeks As discussed previously, contextual factors can 
significantly influence memory for pain [84, 85,, 86-88], therefore, a short retrospective 
interval is most effective. 
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Measuring Affective Pain 
Harkins et al. developed a battery of five visual analogue scales for measuring the 
emotional components of pain namely, fear, frustration, anxiety, anger and depression [89]. 
Test-retest reliability was good and validation against the appropriate scale of the 
Minnesota Multiphasic Personality Inventory and the Beck Depression Inventory yielded 
significant correlation (72]. The results of the study by Wade et al. (90] indicated that each 
emotion visual analogue scale made a unique contribution to the overall magnitude of pain 
related emotional distress. However, as the emotion visual analogue scales explained only a 
moderate amount of the overall variability, the researchers recommend that they be used in 
conjunction with, rather than in lieu of, validated questioIUlaires such as the Beck 
Depression Inventory (72]. Further, as is the case for sensory pain, it is important to 
measure affective pain by validated questioMaire so as to be able to compare the results 
from the pain population in the proposed trial with other chronic pain populations. 
The Short Form Beck Depression Inventory 
The Beck Depression Inventory (BDI) was developed specifically to assess the existence 
and severity of depression for clinical and research purposes. It relies heavily on cognitive 
symptoms and is reported to be particularly appropriate for monitoring the effect of 
therapeutic interventions on patients' levels of depression over time (91]. The short form of 
the Beck Depression Inventory comprises thirteen items selected from the original twenty 
one. These items showed the highest correlation to the total BDI score, and to clinical 
ratings (80]. 
The MP! Affective Distress Scale 
The MPI was developed on patients with a long duration of pain and a history of failed 
treatment efforts [79] so it is particularly aimed at assessing affective distress an~ the 
impact of pain on daily life. The Affective Distress scale of the MPI comprises 3 seven 
point numeric rating scales. 
SF-36 scales that measure Affective Distress 
The Mental-Health scale of the SF-36 assesses depression, anxiety, behavioural-emotional 
control and general positive effect. However, other scales such as the Vitality and Role-
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Functioning Emotional also address aspects of affective distress. The scales of the SF-36 
are substantially intercorrelated and most have complicated physical and mental factor 
content [92]. 
Analgesics Intake 
Several trials have measured patients' analgesics intake [24, 57, 93-97]. Since different 
patients use different medications and often one patient will be taking several forms it is 
difficult to measure change in analgesic intake. Randlov's method of a simple yes/no 
response to the question 'Are you using medication?' was not effective. Methods where 
medications were classified and group proportions for each classification counted at 
assessment periods seemed most effective. In the trials included in this review no inter-
group differences for medication intake were detected, although some trends were noted 
(see Table 5). 
Disability 
The World Health Organisation's theoretical framework of health related quality of life, is 
based on a multidimensional perspective of health as physical, psychological and social 
functioning, collectively termed 'functional status'. It is important that investigators clarify 
which aspect of functional status they intend to measure and select scales accordingly [98]. 
It is also important to choose a generic questionnaire that clearly distinguishes between the 
health concepts of disability and social function by separation of sub-scale scores. 
Researchers focussing on neck pain are most concerned with measuring Physical-
Functioning (for the purposes of this thesis termed disability) and social functioning. 
Disease specific and generic questionnaires have different advantages and disadvantages. 
Disease specific functional measures are focussed clearly on neck related problems and 
therefore have obvious relevance to patients. They usually will be a more responsive 
measure to neck pain treatments than the generic measure. However, as discussed 
previously, use of generic questionnaires facilitates comparisons with a common metric 
between the impact of treating neck problems and other medical conditions, i.e. lower back 
pam. 
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The Physical-Functioning and Role -Physical scales o(the SF-36 
The SF-36 has clearly defined sub-scales measuring, (1) physical functioning or activities 
of everyday life, (2) role function or the extent to which physical health interferes with. the 
performance of instrumental activities of everyday life, and (3) social function, or the 
degree to which physical health or emotional problems interfere with normal social 
activities (68]. 
The Multi-dimensional Pain Inventory 
The MPI also has clearly defined scales separately addressing disability and role function. 
Section three of the MPI includes four separate scales measuring disability in instrumental 
daily activities concerned with four dimensions, these being, household chores, outdoor 
work, activities away from home and social activities. In addition to the individual scale 
scores a general activity score that is a combination of the four activity scale scores can be 
derived. The MPI Pain-Interference Scale measures the patient's perception of the handicap 
caused by their disability, being interference by pain in vocational, social and family 
functioning. 
Specific Fullctional Status Measures 
At the time of selecting instruments there were only two pain and disability questionnaires 
specific to neck pain, the Northwick Park Neck Pain Questionnaire [99] and the Neck Pain 
Disability Index [100). Both of these are based on the Oswestry Low Back Pain Disability 
Index. Only the Neck Pain Disability Scale had been used in a randomised controlled trial 
where it detected significant inter-group differences and changes over time 15 [101). 
Addressing Confounds 
Although the randomisation method will increase the likelihood th·at confounds are evenly 
balanced across groups it is important to verify this by measuring possible confounds. But, 
respondent burden must be considered when deciding what confounds to measure and what 
instruments to use (see Table 8 ). 
is Fitz Ritson' s trial, however, was methodologically flawed in that groups were not matched on a number of variables, 
therefore, not a rigorous test of the instrument's sensitivity. 
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Measuring the Relationship between Self-reported Pain and Disability and 
'Social Desirability' 
When relying on self-report measures of pain and disability it is important that the 
relationship between the desire to give the culturally acceptable response and levels of 
disclosure in self-report measures be recognised. Chronic pain patients tend to complete 
self report measures in ways that emphasis physical complaints, such as pain severity and 
disability, and minimise symptoms that might suggest a psychosomatic element [102]. As a 
population they have higher levels of social desirability bias than the general population. 
Some research indicates that within a chronic pain population there is a negative correlation 
between social desirability bias, as measured by the Crowne & Marlowe Social Desirability 
Scale, and reported levels of depression and anxiety [102]. Further, there is a positive 
correlation between reported pain severity and disability, and social desirability bias [I 02]. 
To summarise, the battery of pre and post-treatment self report measures of pain and 
disability should include both generic and specific questionnaires. Further, any instrument 
for assessing outcomes, whether it be a generic or specific multi-interval scale, or a single 
measure, must have been previously assessed for reliability and validity [l 03]. 
Sick Leave 
Sick leave is sometimes used as an outcome measure, but as discussed, it can be influenced 
by a number of psycho-social and economic factors. 
Secondary Outcomes 
As physiological measures such as muscle strength, muscle endurance and range of 
movement are less important to the patient than reductions in pain and functional status it is 
recommended that they be regarded as secondary outcomes [3 7]. However, as discussed in 
the introductory chapters, muscle function can be regarded as a putative mechanism 
through which the intervention affects the primary outcomes of pain and disability. 
Measuring Muscle Strength 
Prior to the advent of iso-technology cervical muscular strength was difficult to measure. 
Levoska et al. used a dynamometer, specially constructed and tested for the study, which 
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-demonstrated satisfactory reliability. Jordan and Highland both used the MedX Extension 
Machine to quantitatively assess cervical strength in the sagittal plane. Randlov used a 
strain-gauge dynamometer that measured in the sagittal plane. Prior to the advent of 
equipment such as the ergometer designed for Berg's study, and the MedX Rotary Neck 
Machine (see Figure 3) cervical muscle strength in the rotational plane had not been 
measured. There are now some population norms available for the strength measures iri the 
rotational plane (33) and some data from patient populations (48, 49). 
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Figure 3 MedX Rotary N eek Machine 
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Table 8 Summary of Instruments Selected for the Proposed trial 
u 
-
Instrument Reason Accepted Reason Rejected 
Pain Intensity vas Experimentally validated 
& widely used 
Analgesics Widely used 
intake 
SF-36 Psychometrically sound, 
widely used, population 
norms available 
MPI Requested by clinician, 
based on cognitive 
behavioural approach 
SIP Too long 
Mcgill Pain Q ~ Too long 
Palpation Unreliable [29] 
Pressure point Unreliable and not 
Algometry sensitive enough [29) 
101NRS Not experimentally 
validated 
Pain Affect VAS Experimentally validated 
BDI Psychometrically sound, 
widely used 
SF-36 As above 
MPI As above 
SF-36 As above 
MPI As above 
Disability NDI Used in another trial 
Northwick Neck Not used in any of the 
pain studies reviewed 
Questionnaire 
SF-36 As above 
MPI As above 
Health related SF-36 As above 
QOL 
Quality of Crowne& Well recognised in 
reporting Marlowe psychological circles and 
widely used 
Measuring Muscular Endurance 
Cervical muscular endurance has proved difficult not only to measure, but also to 
differentiate from measures of muscular strength. The isometric endurance of shoulder 
muscles has been more commonly measured. The mean number of elbow flexions and arm 
repetitions whilst holding a weight were both sensitive to change over time in the trial 
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conducted by Levoska et al.. Randlov used a timed hold of a weight with arms stretched out 
perpendicularly from the shoulders. Significant improvement over time was recorded for 
both groups, but there was no significant inter-group difference. Muscular endurance of the 
flexors and extensors is also difficult to measure with iso-technology. Jordon used a timed 
position hold on the MedX Cervical Extension Machine at 30 degrees of extension with 
loads at sixty percent of maximal extension strength values. This measure proved sensitive 
to change over time in all groups. Randlov et al. used a similar measure with their 
dynamometer using sixty percent of maximum flexor and extensor muscular strc;:ngth 
values, but the angle of the measure is not recorded. This measure showed significant 
improvement over time, but no significant inter-group difference. Nelson measured cervical 
extension endurance by assessing the increase in the amount of weight and the number of 
repetitions a patient could perform until volitional fatigue was reached. There is no 
literature on measurement methodology for muscular endurance in the rotational plane. 16 
Measuring Range of Movement 
Measuring range of movement with iso-machines is relatively straight forward. Jordon used 
the MedX Cervical Extension machine to measure range of movement in the sagittal plan 
[51). Likewise Priest use the MedX Rotary Neck Machine to measure range of movement 
in the rotational plane [ 49) (see methods for discussion) 
Summary 
In the final analysis, it is important to consider respondent burden. Remembering that the 
respondents in the proposed trial will be patients with neck pain there should not be too 
much time spent completing questionnaires. Likewise measures of strength and endurance 
can be painful for people with chronic neck pain. Therefore, there must be some 
compromise between quantity of information sought and patients' comfort, if reasonable 
compliance is expected. 
16 After the proposed trial was completed some unpublished literature on dynamic testing with the McdX neck rotator was 





This chapter outlines the methods used in the PRIMS 17 trial. This entails describing the 
setting and sample, the recruitment and eligibility, the blinding and randomisation. The 
treatment protocols and the definitions of withdrawal and low adherence to protocol are 
outlined as well as the instruments selected to measure the primary and secondary 
outcomes. The sample size required to detect a clinically meaningful inter-group difference 
for the primary outcome of pain is calculated. A test-retest reliability study of the MedX 
machine measures and the newly developed muscular endurance measures is imbedded into 
the research design. 
The Setting and Sample 
The trial was conducted at a secondary care centre in Canberra in the Australian Capital 
Territory, Australia. Study participants were recruited from Occupational Health and 
Rehabilitation Services (OHRS). This is a small private rehabilitation clinic that employs 
two rehabilitation specialists, one exercise therapist, one occupational therapist and. one 
psychologist. OHRS draws its patients from (1) the city of Canberra, which has a large 
public service sector as well as business and industrial sectors, and (2) the industrial city of 
Queanbeyan, located nearby in New South Wales. 
The Time Frame and Accrual Procedure 
The Australian National University ethics conunittee approved the project in 1997. The 
accrual period of the trial ran for two years from April 1998 to May 2000. Consecutive 
patients attending OHRS during that period were considered for the trial. At the patients 
first visit (see Figure 4) either one of the two resident rehabilitation specialists made a 
17 PRIMS= Progressive Rcgionalised Intensive Muscular Strengthening 
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preliminary determination of a patient's eligibility for the trial according to the defined 
eligibility criteria (see Table 9 and Table 10). If the patient met the eligibility criteria the 
attending specialist informed them of the research and requested their participation. At the 
next visit I requested that the patient read and sign the letter of informed consent (see 
Figure 4). They then completed the pre-treatment questionnaires, which took approximately 
twenty minutes. Patients' names did not appear on the questionnaires, only an identification 
code. The questionnaires (see Appendix I, Appendix 2, Appendix 3, Appendix 4, Appendix 
5, Appendix 6, Appendix 7 and Appendix 8) were colour coded and presented to all 
patients in the same order, to ensure a standardised method of completion. (see Table 11 for 
details of questionnaires used and the order of administration). A therapist then recorded 
the patient's strength and endurance (see Secondary Outcomes). Three to four days later the 
same therapist measured the patient's strength and endurance again. A test-retest interval of 
at least seventy-two hours is necessary to ensure complete muscular recuperation [13]. The 
second set of measures was necessary to verify the reliability of the MedX machine 
measures and the new endurance measures that were developed for the trial. The patient 
then visited the same rehabilitation specialist again and a final determination of suitability 
was made. This second determination was necessary because at the first visit the patients 
had neither seen nor experienced the MedX. The main criterion for suitability was the 
patient's perception of the MedX and their willingness to complete up to sixteen training 
sessions. The patients then attended their first treatment session. At the start of this session 
the treatment therapist opened the randomisation code and entered the patient into their 
allocated treatment program. The patients attended up to sixteen training sessions o~er a 
period of 8-12 weeks. On completion of the treatment program the patient completed the 
questionnaires and physical measures again. 
The Intervention and Alternative Treatments 
Strength-training was the intervention treatment and endurance-training the alternative 
treatment. Both treatment protocols were comprised of 2 half-hour individual sessions per 
week on the MedX for a period of eight to twelve weeks18. The treatment programs were 
based on general principles of progressive resistance exercises outlined in Egger and 
Champion 1983 and McArdle et al [12, 54]. The implementation of the principles of 
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progressive resistance exercise into a protocol for the treatment of people with chronic neck 
pain was determined in accordance with the only published guidelines for regionalised 
strength and endurance-training [11]. The same standardised warm up procedure was 
implemented for both treatment sessions. This entailed the therapist positioning the patient 
in the MedX and securing the thoracic and lumbar restraints. She then adjusted the seat so 
that the patient's ears were aligned with the head restraint pads and gently tightened the 
pads so that no slippage would occur during rotation The therapist then followed the 
clinic's warm up practice of gently rotating the patient's head two or three times. 
The Strength-Trainillg Protocol 
The strength-training version of progressive resistance exercise is geared towards the 
exerciser moving slowly with a heavy weight. Therefore, in a strength-training session, 
patients were required to perform one set of rotations19 with a weight load that allowed for 
10-12 repetitions to volitional fatigue, or repetition maximal (RM). However, the patient 
was permitted to perform as many repetitions as they could in that one set. The initial 
weight loaded into the MedX was typically ~60% of measured isometric strength by the 2nd 
or 3rd training session. After that, subject to patient tolerance, the goal was to increase the 
weight by approximately ten percent at each of the remaining sessions endeavouring to 
maintain the RM at 10-12. 
The Endurance-Training Protocol 
In contrast to strength-training the endurance-training version of progressive resistance 
exercise is geared towards the exerciser moving quickly with a light weight. Therefore, in 
an endurance-training session the patient was required to perform one set of 20 repetitions 
with a minimal weight. At the first session usually no weight at all was loaded into the 
MedX. The patient was permitted to perform as many repetitions as they could. The goal of 
the treatment thereafter was to increase the repetitions by approximately ten percent each 
session until the patient reached 30-35 repetitions before increasing the weight. Therefore, 
patients should not incur more than one or two increases in weight during the program. 
18 Most patients took more than eight weeks to complete the course, as sometimes they were unable to attend an 
appointment because of conflicting family or work considerations. 
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Table 9 Inclusion Criteria 
• People presenting to the clinic with neck pain of more than six weeks duration 
• Natural history included initial trauma of motor vehicle accident, work related 
injury, sport or leisure related injury 
• Patients who had had previous surgery 
• Patients who had had previous treatment failures 
• Patients currently taking medication 
• Patients receiving compensation for either workers compensation or third party 
insurance. 
Table 10 Exclusion Criteria 
• People aged < 16 due to problems associated with gaining infonned consent from 
people under the legal age. 
• People aged > 60 years. Degenerative joint disease is always present to some 
degree in people' aged sixty and over. 
• People experiencing acute neck pain ofless than six weeks duration. Many 
people experiencing acute spinal pain recover spontaneously within a few weeks. 
• Medical or clinical evidence indicating inflammatory disease, tumour or other 
disorders 
• Radiological or clinical evidence of cervical fracture or dis!ocation 
• Medical history or clinical signs of nerve root compression. e.g. radiating pain to 
the anns or hands 
• Patients whose main symptom was pain in either the thoracic or lumbar spine 
with neck pain as a secondary symptom. 
• Patients unavailable or unwilling to attend all sessions and follow ups. 
• Patients whose English language and literacy skills were insufficient to 
accurately complete the questionnaires 
• People who were receiving concurrent treatment, other than massage, to 
eliminate other treatment effects 
• Pregnant women because of confounding effects associated with pregnancy. 
• History of severe psychiatric illness such as schizophrenia or major depression. 
• Private paying patients. There were very few private paying patients, therefore 
they would be a very small, demographically different sub-group, which might 
confound the overall result 
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Table 11 Instruments used in the PRIMS Trial 
~ Instruments used ' Variable a 
1 Demographics (mauve) Year of birth 
Sex 
Age at first episode of neck pain 
Month and year of injury 
Cause of injury 
Duration of symptoms 
Dominant side 




2 15 cm visual analogue scales pain sensation 





Name and number of analgesics 
consumed in previous two days( see 
appendix for details) 
3 Multi-dimensional Pain Interference of pain on social function 
Inventory (grey) and interpersonal relationships 
Pain severity 
Affective distress 
Patients' perceptions of the response of 
others to their complaints of pain 
Impact of pain on everyday activities 
4 Short Form-36 General Health Physical-Functioning 







5 Neck Disability Index (blue) Disability 
6 Work Environment Job satisfaction 
questionnaire (yellow) 
7 Short form Beck Depression Affective distress 
Inventory (pale blue) 
8 Crowne and Marlow Social Quality of Reporting 
Desirability Scale (orange) 
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Definition of Withdrawal 
The consensus of opinion is that twelve to sixteen treatments are required to show treatment 
effect. Therefore, if a patient failed to complete eight treatment sessions they were 
considered to have withdrawn from the program, although their results were still analysed 
according to the intention to treat principle. Usually the decision to withdraw was made in 
discussion with the attending specialist, who was blinded to group allocation. But 
sometimes the patient ceased attending sessions without giving any explanation. 
Measuring Adherence to Protocol 
When using the MedX Neck Rotator, in a strength-training program, the weight should 
increase from session to session while the number of repetitions stays constant, at between 
ten to thirteen each side By contrast, in an endurance-training program the number of 
repetitions should increase regularly, up to thirty to thirty-five each side per session, before 
any further weight is added. This ensures that over the duration of the treatment the weight 
does not increase by a substantial amount. The number of repetitions and weight pushed 
was recorded in the PRIMS trial. Therefore, it was possible to develop a method of 
awarding bonus, or penalty, points depending on the quality of the each training session. 
The systematic ranking method is discussed in chapter five. 
Outcome Measurement 
Pre-treatment measures of all outcomes were conducted at the first and second sessions, 
prior to randomisation. Post-treatment measures were taken at the last session by blinded 
observers (see Figure 4). 
Pain 
Sensory and affective pain were the first primary outcomes for the trial. Fifteen centimetre 
visual analogue scales were used as the core measures for pain intensity, frustration, fear, 
anger, anxiety and depression (see Table 11). The Bodily-Pain scale of the SF-36 and the 
Pain Severity scale of the MPI were also used to measure pain intensity. The Beck 
Depression Inventory, the SF-36 Mental-Health scale, and Role-Emotional scales, and the 
Affective Distress scale of the MPI were used to measure pain affect. 
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Disability 
The second primary outcome was disability. This was measured by the Physical-
Functioning and the Role-Physical scales of the SF-36. The General Activity and Pain 
Interference scales of the MPI were also used. 
Medication Intake 
Patients were asked to record the quantity and type of medication they had taken in the 
previous two days at the pre and post-treatment measures. These were categorised into 
simple analgesics, weak opioids, strong opioids, anti-inflammatories, anti-neuritics and 
anti-depressants. There was also a category for miscellaneous medications. 
Addressing Confounds 
We used the work satisfaction index developed by Tuomi as a brief measure of job 
satisfaction [104]. Other possible confounds were addressed in the demographics 
questionnaire (see Table 11 ). The results of the self-report measures of pain and disability 
were correlated against the Crowne-Marlowe Social Desirability Scale to measure the 
degree of social bias. 
SAMPLE SIZE AND POWER CALCULATIONS FOR PAIN MEASURED BY 
VISUAL ANALOGUE SCALE 
The research question essentially asks if reductions in pain experienced by the strength-
trained group are significantly larger than those for the endurance-trained group. As we 
used 150mm visual analogue scales in the PRIMS trial the sample size calculations were 
based on detecting a minimum of 15mm inter-group difference with a significance level, a, 
of 5% or less, at a power of 90%. A review of trials shows that an inter group differen_ce of 
at least 15mm is feasible in single-blind trials. (see Table 12). There is no reliable data on 
double-blind trials. Assuming a 10% loss to follow up in the PRIMS trial the final sample 
size of 45 per group is adequate to detect an inter group difference of l 5mm (SD 22), and 
can detect an inter-group difference as low as 1 lmm (SD 22) (see Table 13). These figures 
are based on the formulas contained in the Win episcope statistical package [105]. For 
comparison to pain reductions in other pain populations, change on the l 50mm visual 
analogue scale was converted to percentage change. 
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Table 12 Trials Evaluating Neck Pain Which Used Visual Analogue Scales.To 
Measure Pain 
Treatment Pre Treat. Post Changeover Inter-
VAS Treat Time Group 
scores VAS (mm) difference 
(mm) scores (mm) 
(mm) 
Revel head, eye coupling 50.5(22) 28.7(?) 21.8(25.2t 17 x 
(1994) exercises to wait list 45.9(25.7) 41.6(?) 4.3(19.6) 
Taimela Active general exercise to -46.8(21) 22(?) 24.8x l 7x 
(2000) home exercise to -46.5(16) 39(?) 7.5 ? 
recommendation for 
exercise (control) 
'= Significance <.05 
?= Information not supplied 
Table 13 Lowest Detectable Estimated Clinically Meaningful Differences 
~ Minimum SD Number required meaningful in each group .. inter-group Power90% differences 
l 50mm Visual analogue scale llmm 22 44 
15mm 22 24 
Secondary Outcomes 
Secondary outcome measures were machine and non-machine measures of muscular 
strength and endurance, and range of movement. These measures were recorded in the 
sequence listed below. 
Static Muscle Endurance Measure of Neck Flexion 
The first measure to be taken was the static endurance measure. For this measure the patient 
lay in the supine position with his/her hands resting on his/her abdomen. The measurer 
placed a sheet of paper under the patient's chin and instructed him/her to try and touch the 
paper with his/her chin and hold that position. The number of seconds the patient's .head 
remained clear of the couch was recorded. An upper limit of 120 seconds was set for the 
static test. As we developed this measure for the PRIMS trial a reliability test was 
imbedded into the research design. 
For the remainder of the measures the therapist seated the patient in the MedX Neck 
Rotator. The patient was secured in the same manner as for a dynamic training session. The 
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therapist then measured, isometric strength, range of movement and finally dynamic m~scle 
endurance. 
MedX Machine Measures of Muscle Strength 
To measure muscular strength the therapist locked the movement arm into one or other of 
the three selected angles (24°,0° and -24°) and asked the patient to apply maximal force to 
either the left or right head piece. These particular angles were selected as they were in the 
comfortable range for most patients. Those who experienced discomfort at these angles 
were measured at 18 °, 0 ° and -18 °. The measures were conducted in both directions of 
the rotational plane equalling six measures of isometric strength in total 
Dynamic Muscle Endurance Measure 
We also developed a dynamic muscular endurance measure using the MedX. The number 
of continuous repetitions a patient could complete at his/her comfortable pace was 
recorded. For patients whose measured isometric strength was less than 30lb no weight was 
set on the MedX20. If measured isometric strength exceeded 30lb the weight for the 
endurance test was 20lb. An upper limit of 30 repetitions was set for the dynamic test. 
Range of Movement 
No weight was set on the MedX. Patients were encouraged to tum their head first to the 
right as far as they comfortably could, then to the left. The angle at end of range was 
recorded electronically. 
Randomisation 
Non-stratified randomisation was considered suitable for the PRIMS trial as there were at 
least fifty participants in each group. Any increase in statistical precision from stratification 
is inconsequential once the number of participants in each group reaches fifty or more [59]. 
A sample stratified by sex and age, the latter classified into three levels, requires six 
separate allocation strata. The complexity of administering such a process for only a small 
statistical gain, at best, was the underlying rationale for non-stratified randomisation in the 
PRIMS trial. We anticipated an accrual period of one year. As seasonal variation can 
20 20lb is the lowest weight that can be set on the MedX, after which it can be incremented by units of21b 
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significantly influence outcomes [77] block allocation was used to ensure that equal 
numbers of participants were assigned to each group during the different seasons. Large 
block sizes of about twenty help to reduce predictability in a non-stratified trial involving 
100 participants [55]. Variable block sizes are preferable to fixed blocks as they further 
reduce predictability (55]. Therefore, to reduce predictability at frequent intervals during 
winter and spring, when patient numbers might have been larger the PRIMS trial had larger 
sequential variable block sizes. Smaller variable block sizes during summer and autumn, 
when patient numbers were reduced, ensured that group numbers would be equal for the 
interim analysis. The key to randomisation codes was secured in the department safe at the 
National Centre for Epidemiology and Population Health at the Australian National 
University. 
Disadvantages associated with simple randomisation procedures where subjects 
corresponding to odd numbers may be allocated to one group and those corresponding to 
even numbers to the other, are: (i) odd and even numbers may be unequally generated 
requiring the last few subjects in each block to be assigned the same treatment [106], and 
(ii) group allocation can be detected from the subject number requiring a further random 
code allocated to each subject. In the PRIMS trial to ensure equal group numbers in each 
block, half of the random numbers required for a block were computer generated on the 
epidemiology information statistical package, which is in the public domain. These 
numbers were assigned to the treatment group and the missing numbers assigned to the 
control group21 as outlined by Bland [106]. Sealed envelopes containing the group 
allocation advice were numbered 1-10022. As discussed previously these were opened by 
the treatment therapist at the start of the first treatment sessio~. She then commenced 
treatment according to the patient's allocated program. 
21 For example for block size of ten in chronological order from 11-20 the computer may generate the random numbers 
12, 13 17, 19 and 20. these numbers were assigned to the strength-training group, whereas, the missing numbers ( 11, 
14, 15, 16 and 18) were assigned to the endurance-training group 
22 Because some participants had dropped out after on one session the therapist was instructed to randomise a further three 
patients to the same group/s that those participants had been in. 
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Figure 5, (left +24, The left sternocleidomastoid muscle is extended) Figure 6 (left 0, Neutral 
Position) and Figure 7 (left -24, The left sternocleidomastoid muscle is contracted) All 




Figure 8 (right-24, The right sternocleidomastoid muscle is extended) Figure 9(left 0, Neutral Position) and 
Figure 10 (right +24, The right sternocleidomastoid muscle is contracted) All figures indicate the 





Participants were blinded to the treatment option they were receiving. They were informed 
that two slightly different forms of therapeutic exercise were being compared. They .were 
naive as to which was the preferred treatment, and as they were individually trained on the 
MedX they could not compare their treatment with that of any other patient. All pre-
treatment questionnaires and measures of muscle strength and endurance were recorded 
prior to randomisation. Throughout the duration of the treatment the rehabilitation 
specialists were blinded as patients' progress charts were formatted so that improvement 
could be assessed without the reader becoming cognisant of group allocation. The 
measurement therapist and I were still blinded at the time of administering the post-
treatment questionnaires and measures. The treatment therapist could not be blinded. 
Therefore, each patient was contacted two months post-treatment and asked specific 
questions regarding his/her perception of the therapist's enthusiasm and commitment to the 
treatment (see Appendix 10). 
Statistical Analysis 
The Statistical Package for Social Sciences (SPSS [ 107] was used for data entry and 
analysis. Data was assessed for normality. Significance of difference between means for 
normally distributed variables was determined by ANOV A. Eta-squared was used to 
determine effect size [108]. Chi squared and logistic regression analysis was used to assess 
differences in non-parametric outcomes. There was an interim analysis when fifty patients 
had completed treatment. If reported inter-group differences for pain and disability had 
been achieved at 5% significance the trial would have been stopped. I remained blinded as 
to which group was prescribed strength-training until late in the final analysis when all 




D EMOGRAPIDCS OF SAMPLE FOR THE WHOLE GROUP AND TOP 
ADHERERS ANALYSES, AND COMPARISON OF MEASURES OF 
ADHERENCE TO PROTOCOL 
This chapter presents the trial profile, which summarises participant flow. Participant's 
demographic characteristics, pre-treatment measures, loss to follow-up and withdrawals 
from treatment are discussed. The development of a points-based ranked adherence system, 
which produces ranked lists of adherence to protocol for each group is described. The 
ranked adherence group lists for each group are compared with a blinded classification of 
the patient's recorded exercise programs to ascertain their validity. To ascertain the 
sensitivity of the ranked adherence lists they are compared with the ranked lists of. total 
weight for strength-training and total number of repetitions for endurance-training. The 
demographic characteristics of the 'top adherers' as defined by the ranked adherence lists 
are then discussed. 
Participant Flow 
One hundred and thirty-four patients attended OHRS during the accrual period complaining 
of neck pain (see Figure 11 ). Thirty-one patients did not participate in the trial. Eighteen of 
these patients did not return for their second pre-treatment measure thereby excluding 
themselves. The measurement therapist excluded nine patients on the grounds that they 
exhibited too great a degree of fear-inhibited movement. One patient's insurance company 
refused to pay for the treatment. Two other patients were not eligible, one because she was 
unable to attend for regular sessions, the other because she was receiving concurrent 
treatment from a chiropractor. The attending physician decided that one patient would not 
benefit from the treatment as her pain was naturally subsiding. The pre-treatment 
demographics of non-participants are compared with those of the study group in Table 14. 
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Figure 11 Flow Chart of Patient Participation in the PRIMS Trial 
Patients considered for the trial 
(n = 134) 
Not Randomised (n =31) 
Randomised 103 
No = 51 
Received standard strength-training 
(n =40) 
Did not receive standard 
endurance-training (n =11)* 
... 
Followed up Primary Outcomes (n 
= 45) 
Followed up Secondary Outcomes 
(n = 35) 
Withdrew from treatment before 8th 
session (n =6) 
Completed Treatment (n = 45) 
No = 52 
Received standard endurance-
training (n =37) 
Did not receive standard strength-
training (n = 15) 
Followed up Primary Outcomes (n 
= 46) 
Followed up Secondary Outcomes 
(n =39) 
Withdrew from treatment before 8th 
session(n =8) 
Completed Treatment (n = 44) 
* These figures are taken from the blinded classification of exercise (se 
Appendix 11) 
59 
Table 14 Baseline Demographic-s for Participants and Non Participants 




Age (yr) 101 38.13 25 40.89 t(124) = 1.960, (P- = .246) 
(10.54)1 (10.86) Diff. Means= -2.76 · 
[-1.88, 7.40) 
Body mass index 80 26.34 23 29.14 t(lOl) = l.983, (P- = .018) 
(4.96) (4.8) Diff. Means= -2.8 
Cl.95 [-0.48, 5.11) 
Proportion Males 29 28% 10 32% z = 2, (P- = .708). 
P1 - P2 =4% 
CI.95 [-.176, .258) 
Age at first pres 103 34.2 28 37 t(l29) = l.960, (P- = .415 
(yrs) (9.93) (9.8) Diff Means= -2.8 
Cl.95 [-1.33, 6.93) 
Months of 95 30.87 30 26.57 t(124) = 1.960, (P- = .356) 
continuous pain (50.07) (27.12) Diff Means = 4.3 
Cl.95 [-23.06, 14.46) 
Occupational 97 60% 31 45% z = -1.4074, (P- = .508) 
Prestige (Median) <=4.6 <=4.6 P1- P2 = 15% 
Cl.95 [-.287, .579] 
Only Secondary 47 46% 12 39% Z= .314, (P-= .753) 
Education P1 -P2= -7% 
Cl.95 [-.039, .512) 
Pain Intensity VAS 100 84.15 30 92 t(l28) = 1.978, (P- = .2.21) 
(30.93) (29.84) Diff. Means = -7 .85 
Cl.95 [-4.78, 20.48) 
Depression VAS 96 63.73 28 79.79 t(l22) = 1.960, (P- = .093 
(45.23) (40.42) Diff Means= -16.06 
Cl.95 [-2.55, 34.67] 
I Standard deviations are bracketed 
Baseline Demographics 
The pre-treatment demographics for each group are similar (see Table 15). As a body mass 
index between 2523 and 30 is considered overweight the group means catagorise the 
participants as slightly overweight. Gender balance, age, age at first presentation and 
duration of symptoms are not significantly different. Neither is the combined medication 
intake significantly different. See chapter six for the break down of different categories of 
medication. The majority of participants in both groups reported a motor vehicle accident 
as the initial trauma. The medians and quartiles for the education scale indicate that half the 
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sample have no tertiary education, one quarter have diploma or trade certificate level 
education, and the remaining quarter are university educated. Occupational prestige was 
measured on the Congalton scale [109]. The group medians and quartiles indicate that half 
the sample were white collar workers, mainly non-executive level clerical staff, teachers 
and keyboard operators. One quarter were blue collar workers, ie storemen, cleaners or 
tradesmen. The other quarter were solicitors, pilots, administrators, and executive officers 
in the public service. Seventy-six percent of the sample were employed in some capacity. 
The work environment score shows that eighty-four percent of the sample report positive 
work attitudes. The Crowne and Marlow social desirability scale scores of 18 and 20 out of 
33 are similar to the scores of other chronic pain populations [102), but considerably higher 
than the mean score of 14 for a healthy population [ 11 O]. The number of sessions attended 
in each group is similar, and the frequency of treatment is also similar. However, the 
frequency of sessions for both groups indicates that they attended less than two sessions per 
week for half of the treatment period. While one training session per week is beneficial two 
sessions per week gives better results [47]. 
Loss to Follow-up on Primary and Secondary Outcomes. 
Twelve patients, six from each group, did not complete the post-treatment visual analogue 
scales for pain (see Table 16). This represents a twelve percent loss to follow-up. Thirty-
seven participants, 21 from strength-training and 16 from endurance-training, failed to 
complete medication intake either at the pre or post-treatment measurement session. 
Sixteen participants from the strength-training group and thirteen from the endurance-
training group did not complete post-treatment measures for the physical outcomes. 
23 Standard deviations for all means Cited in the text are shown in the appropriate tables. 
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Table 15 Baseline demographics and Treatment Details of the Strength and 
Endurance-training Groups 
v~ N Strength- N Endurance- Between groups effect training training 
Age (yr) 50 38.76(10.83) 50 37.60(10.42) t(98) = 0.547, (p =.586) 
Diff. Means = 1.16 
Cl.95 [-3.06, 5.38] 
BMI 40 26.11(5.12) 40 26.58( 4.84) t(78) = -418, (p = .(J77) 
Diff. Means= .47. 
Cl.95 [-2.68, 1. 75] 
Proportion Males 18 35% 11 21% z =1.591, (p =.112) 
P1 - P2=14%, 
Cl..95 [-3%, 32%] 
Age at first pres (yrs) 50 34.86(9.19) 51 33.56(10.64) t(99) = 0.584, (12 = .560) 
Diff. Means = 1.3 
Cl.95 [-2.59, 5.20] 
Result of MV A 41 80% 36 69% x2 (4) = 4.449 (p =.349) 
Result of Work injury 8 15% 12 23% 
After surgery 2 3.9% 1 1.9% 
No clear reason 0 0% 1 1.9% 
Accident at home 0 0% 2 3.8% 
Continuous pain 47 92% 48 92% x2 (1) = .OOl(p =.977) 
Distinctly episodic 4 8% 2 8% 
Duration of continuous 47 26.6(40.56) 48 35.06(58.03) t(93) = -0.823, (p = .413) 
pain (months) DiffMeans. = 14.46 
CI.95 [-28.90, 11.97] 
Duration of current 3 14.67(10.26) 3 11(8.89) t(4) = 0.468, (p = .664) 
pain episode (months) Diff. Means 3.67 
Cl.95 [-18.10, 25.43] 
Combined Medication 51 4(5) 52 4(5) t(lOl) = -.115, (p = .908) 
Intake Cl.95 [-2.07, 1.85] 
Occupational Prestige 49 4.43 48 4.57 t(95) = -0.648, (p = .519) 
Diff. Means = .14 
Cl.95 [-.562, .286) 
Only secondary educ. 23 45% 24 46% x2 (IO) = 9.310, (p =.503) 
Work Satisfaction 38 22. (3.07) 43 20.41(4.99) t(79) = -1.615, (p = .110) 
Diff. Means = -1.58 
Cl.95 [-.3.52, .367] 
Social Desirability 42 20.42 (4.48) 44 18.31(6.72) t(84) = 1. 704, (p = .092) 
Diff. Means = 2.11 
Cl.95 [-.353, 4.55] 
Treatment Details 
No of visits 51 13.08(4.14) 51 12.35( 4.61) t(lOO) = .836, (p = .405) 
Diff. Means = . 73 
Cl.95 [-1.00, 2.45] 
Duration (weeks) 50 9.01(3 .63) 50 8.09(7.63) t(98) = 0.774 (p = .441) 
Diff. Means .92 
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Table 16 Number of Participants who did not complete one of either the Pre or 
Post-Treatment Measures 
liiSUw ~ No not 
completed 
ST ET 
Pain Intensity VAS 6 6 
Frustration VAS 7 6 
Anger VAS 7 7 
Fear VAS 7 7 
Anxiety VAS 7 7 
Depression VAS 7 6 
Medication Intake 21 16 
Multi-dimensional Pain Inventory 6 8 
SF-36 General Health Survey 20 20 
Neck Disability Index 6 5 
Work Environment Questionnaire 13 9 
Beck Depression Inventory 12 11 
Crowne and Marlow Social Desirability Scale 27 27 
Muscle strength and endurance measures 16 13 
ST = strength-training, ET = endurance-training 
Withdrawals from treatment 
By the 8th session, approximately midway through the treatment, six participants from the 
strength-training group and eight from the endurance-training group had withdrawn from 
treatment. The group comprised of eight females and six males. Only three stated too much 
pain as a reason for withdrawing. These were two females, one from either group, and a 
male from the endurance group. The reasons given for withdrawing are listed in Table .n. 
Table 17 Reasons for Withdrawing from Treatment less than Halfway through 
the Program 
~ ET Reasons given 
1 2 Too much pain 
1 Moved inter-state 
1 Interfered with work 
1 Too busy 
1 2 Did not attend at all, no reason given x 
l Attended once then changed mind 
2 Treatment not helping 
l Caused head aches 
1 Developed claustrophia in MedX 
~ These participants were randomised at the start of session one, but did not have any treatment at 
that session, ST= Strength-training, ET = Endurance-training 
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Development and Validation of the Points-based Adherence System by Post-hoc 
analysis of the Training Data 
Traditional methods of measuring adherence to protocol were considered. Regression 
analysis for total weight in strength-training and total number of repetitions in endurance-
training were conducted. However, there are two limitations to regression analysis when 
used to measure adherence to protocol. Firstly, regression analysis of total weight, or total 
number of repetitions, does not take into account the individual muscular strength and 
endurance of each participant, i.e. a strong male will always be ranked higher than a 
female, even if that female makes a greater percentage increase on baseline strength 
measures. Secondly regression analysis only measures the end result of adherence over the 
whole training program, and fails to measure adherence to protocol at each particular 
session. As the aim of progressive resistance training is to increase resistance, be it weight 
or number of repetitions, at each session, an analysis that compares these two variables over 
sequential sessions will provide the most comprehensive measure of adherence. As far as 
can be ascertained from the literature, the PRIMS trial is the first in its field to have the 
weight and number of repetitions recorded at each session for the entire sample. Best use of 
these data is to use an analysis based on sequential sessions comp·arison as the basis for a 
point allocation system (see Table 18 and Table 19 for details). The bonus and penalty 
points are based on the principles of the strength and endurance versions of progressive 
resistance training, and are awarded in accordance with the degree of adherence to allocated 
protocol. In strength training the weight pushed was the allocated variable. If it exceeded 
53lb in a given session it attracted a bonus of 7 or 8 points regardless of the number of 
repetitions performed (see Table 18). Likewise in endurance training if the number of 
repetitions in a given session exceeded 50 it attracted 7 or 8 bonus points regardless of the 
amount of weight pushed (see Table 19). The rest of the sessions were categorised as either 
good, average or poor. Bonus points were earned if the variables of weight and number of 
repetitions were in accordance with the allocated version of progressive resistance training, 
but penalty points were awarded if they did not. 
The points system yields a ranked listing, for each group, of all participants, in order of 
adherence to protocol. The correlation between the ranked adherence lists, the blinded 
classification of the exercise sheets, and ranked lists of total weight for strength-training 
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and total number of repetitions for endurance-training is very good (see Table 20 and Table 
21 ). The blinded classification was the less sensitive measure because of the broadness of 
the categories (see Table 22). However, it clearly indicated that participants 32, 102 and 
103, allocated to the endurance-training group, had been administered high quality 
strength-training and participants 75 and 91 had received moderate quality strength-training 
( see Appendix 11 ). Participant number 92 was randomised to the strength-training group 
but received moderate endurance-training. In terms of sensitivity the points-based ranked 
adherence system is clearly superior to the ranked lists of total weight and total number of 
repetitions as it ranks those administered the incorrect protocol lower (see Appendix 12· and 
Appendix 13). 
The only subjectively based difference between the adherence to protocol requirements is 
the allowable increase in the contra indicated variable before penalty points are awarded. 
For example, in strength-training, while weight is the variable that should increase each 
session, it is permissible for a small increase in the number of repetitions to occur. The 
decision made at the post-hoc analysis was that approximately three repetitions should 
equal one increment, and that the therapist should not deviate from protocol by more than 
three and a half increments. Therefore, the allowable increase in repetitions per session 
should not exceed ten before it attracted penalty points. In endurance-training two pounds, 
which is one weight from the weight stack, should be one increment, and that, as in 
strength-training, the therapist should not deviate by more than three and a half increments. 
Therefore, the allowable increase in weight per session was set at seven pounds. Appendix 
14 demonstrates that the ranked order for the endurance group is stable over increment 
sizes of seven and ten. 
Results of the points-based ranked adherence method 
Nine exercise sheets were missing, seven from the strength group and two from the 
endurance group. The points system was applied to the remaining ninety-four exercise 
sheets. The data indicated therapist, and patient driven, deviations from protocol (see Table 
23). But there were more therapist driven than patient driven deviations from protocol, 
which indicates that regular monitoring of the treatment therapist's activities would have 
been desirable. However, this was not possible in the PRIMS trial. It was conducted in a 
small private clinic using clinical staff. The treatment therapist was the only unblinded staff 
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member. As the principal investigator, which· was myself, also needed to be blinded, there 
were no unblinded personnel available to monitor the therapist's adherence to protocol. 
The analysis for top adherers is conducted on the top seventeen participants from each list, 
because at that level of adherence inter-group differences for affective pain and disability at 
= .05 emerge. However, the influence of the ranked order on the level of significance was 
fairly stable over group sizes of fourteen to seventeen. 
Table 18 Points-based Adherence Ranking System for Strength-training 
Grade Details of weight Weight up Weight = Weight 
and number of 
repetitions down 
Excellent Weight>= 60 +8 +8 +8 
Very Good Weight 53-59 +7 +7 +7 
Good Repetitions up & 
+5 +3 +1.5 
weight 40-52 
Good Repetitions = & 
+6 +4 +2.5 
weight 40-52 
Good Repetitions down 
+6 +4 +2.5 & weight 40-52 
xcontra to protocol Repetitions t> 10 -7 -7 -7 
Average Repetitions up & 
+1 -1 -3.5 
weight 25-39 
Average Repetitions = & 
+2 0 -2.5 25-39 weight 
Average Repetitions down 
+2 0 -2.5 & weight 25-39 
Contra to protocol Repetitions j> 10 -7 -7 -7 
Poor Quality Repetitions up & 
weight <25 -3 -5 -7.5 
Poor Quality Repetitions =& 
weight <25 -2 -4 -6.5 
Poor Quality Repetitions down 
-2 -4 -6.5 & weight <25 
Contra to protocol Repetitions j> 10 -7 -7 -7 
.. 
x Contra to the protocol in Strength-training is where the number of repetitions has been increased 
by more than three and a half increments (3 repetitions equals 1 increment). This caveat applies to 
all grades 
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Table 19 Points-based Adherence Ranking System for Endurance-training 
Grade Repetitions Repetitions Repetitions 
up = down 
Excellent Repetitions 
+8 +8 +8 
>=60 
Very Good Repetitions 50-
+7 +7 +7 59 
Good Weight up & 
repetitions 40- +5 +3 +1.5 
49 
Good Weight = & 
repetitions 40-
+6 +4 +2.5 49 
Good Weight down & 
repetitions 40- +6 +4 +2.5 
49 
Contra to protocol Weight i > 7 -7 -7 -7 
Average Weight up & 26-
+l -1 -3.5 39 
Average Weight = 
+2 0 -2.5 Repetitions 26-39 
Average Weight down 
+2 0 -2.5 Repetitions 26-39 
Contra to protocol Weight i > 7 -7 -7 -7 
Poor Quality Weight up & 
repetitions<25 -3 -5 -7.5 
Poor Quality Weight =& 
repetitions <25 -2 -4 -6.5 
Poor Quality Weight down & 
-2 -4 -6.5 
repetitions <25 
Contra to protocol Weight i > 7 -7 -7 -7 
xContra to the protocol in Endurance-training is where the amount of weight has been increased by 
more than three and a half increments (2lb equals 1 increment). This caveat applies to all grades 
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I U 11-'K 
NBLCL 
TOTWT 
Table 20 Comparison of Ranked Adherence list (TOTPR) to the Blinded 
Rating of Exercise Sheets (NBLCL) and Total Weight (TOTWT) in the 
Strength Group 
Strength 
TOTPR NBLCL TOTWT 
Pearson correlauon 1.000 .618* .744" 
Sig. (2-tailed) 
.000 .000 
N 51 46 44 
Pearson Correlation 
.618*' 1.000 .713"' 
Sig. (2-tailed) 
.000 .000 
N 46 46 44 
Pearson Correlation 
.744*' .713*' 1.000 
Sig. (2-tailed) 
.000 .000 
N 44 44 44 





Table 21 Comparison of Ranked Adherence list (TOTPR) to the Blinded 
Rating of Exercise Sheets (NBLCL) and Total Number of Repetitions 
(TOTRPS) in the Endurance Group 
Endurance 
TOTPR NBLCL TOTRPS 
Pearson correlation 1.000 .745* .849" 
Sig. (2-tailed) 
.000 .000 
N 52 48 48 
Pearson Correlation 
.745*' 1.000 .567" 
Sig. (2-tailed) 
.000 .000 
N 48 48 48 
Pearson Correlation 
.849*' .567*' 1.000 
Sig. (2-tailed) 
.000 .000 
N 48 48 48 
· Correlation is significant at the 0.01 level (2-tailed). 
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Table 22 Categories of the Blinded Classification 
~ No of Participants per group 
Failure 9 
One Star 16 
Two Star 30 
Three Star 24 
Four Star 11 
5 Star 4 
Total 94 
Table 23 Deviations from Protocol 
Reasvu Therapist Patient 
------------
driven driven 
More than three and a half increments 43 
of xcontra variable added 
Indicated variable = contra variable 1' 104 
Indicated variable ..V contra variable 1' 50 
Indicated variable ..V contra variable ..V 22 
Unequal repetitions on each side 190 
Total no of sessions (1297) 193 (15%) 112 (9%) 
xln strength-training the contra-indicated variable is number ofrepetitions, in endurance-training it 
is weight, % of total treatment sessions is bracketed 
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Baseline demographics for the Top Seventeen Adherers in each group 
The top seventeen adherers in each group are demographically similar (see 
Table 24). They are also not significantly different from the other participants for most 
demographic variables (see Table 25). Not unexpectedly, the top adherers had significantly 
more treatment sessions. However, significantly less of the top adherers had only secondary 
level education. Further, a significantly higher proportion of the top adherers reported their 
pain as distinctly episodic rather than continuous. If they reported continuous pain it was of 
considerably less duration than the other participants (J2 = .065). The proportion of males is 
also significantly higher in the sub-groups oftop adherers. 
Discussion 
The unstratified randomisation resulted in demographically balanced groups as was 
anticipated in a sample size of one hundred. But, because there was a lower than anticipated 
number of males recruited, randomisation stratified by gender would have ensured that the 
proportion of males per group was as balanced as possible. The strength and endurance-
trained groups of top adherers, identified by the points system, are also balanced on all 
demographic variables. The fact that they differ from the other participants, on some 
demographic variables should not be interpreted as introduction of bias. Instead it should be 
recognised that the point system is providing useful information. It identifies which type of 
patient is most likely to be able to adhere to a program of intensive, therapeutic exercise. 
There are plausible explanations for the differences between the top adherers and the other 
participants. Firstly it is recognised that education is positively correlated to adherence to 
protocol and outcome [ 111]. It is also plausible that patients who are worn down by 
continuous pain will have less ability to adhere to intensive exercise, compared with those 
reporting episodic pain. Finally, it is plausible that males will be more inclined than females 
to adhere to an intensive, weight bearing exercise program24 as they may be more 
psychologically receptive to the concept of weight bearing exercise. 
24 Particularly when supervised by an attractive young female, as was the case in the PRIMS trial. The treatment therapist 
often commented on the high levels of enthusiasm manifested by the males 
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Table 24 Baseline Demographics And Treatment Details For Top Seventeen 
Adherers In Each Group. 
~ No Strength- No Endurance- Between groups effect training training (n=l7) (n=l 7) 
Age (yr) 16 42.46 (10.86) 16 35.75 (9.67) t(30) =0.441, (12 = .75) 
Diff Means = 6.71 
Cl.95= [-.70, 14.14) 
BMI 13 24.81 (8.18) 15 27.86 (5.16) t(26) = 1.193, (12 = .243) 
Diff. Means= 3.05 
Cl.95 [-2.19, 8.28] 
Proportion Males 8 47% 5 29% z = .869 (J2 = .384) 
P1-P2 =18% 
Cl.95 [-.265, .640] 
Age at first pres (yrs) 16 34.81 (9.36) 16 32.69 (9.64) t(30) = -.623, (!2 = .538) 
Diff. Means= 2.12 
Cl.95 [-9.09, 4.84J 
ResultofMVA 13 81% 12 75% x2 (2) = 1.70, (!2 = .426) 
Result of Work injury 2 12% 4 25% 
After surgery 1 7% 0 0% 
Continuous pain since 13 81% 14 87% z = -.386 (!2 = 1.30) 
initial trauma P1 - P2=6% 
Cl.95 [-.40, .28] 
Distinctly episodic 1 2% 1 2% NSD 
Duration of continuous 13 23 .23 (31.06) 14 15.29 (10.89) t(25) = -.901, (J2 = .376) 
pain Diff. Means= 7.94 
Duration of current 2 19(9.90) 2 9.5 (12.02) t(2) = -.863, (!2 = .479) 
pain episode (months) Diff. Means= 9.5 
Cl.95 [-56.9, 37.9) 
Medication 16 5(6) 16 (5) t(30) = -.334,(!2 = .740) 
Cl.95-4.7, 3.6] 
Occupational Prestige 14 4.04 (.86) 16 4.45 (1.09) t(28) = 1.115, (12 = .274) 
Diff. Means .41 
Cl.95 [-.341, 1.15] 
% only secondary educ 30 2 30 2 x2 (6) = 6.715 fa = .348) 
Work Satisfaction 13 21.46 (3.12) 15 20.60 (5.09) t(26) = -.529, (J2 = .602) 
Diff. Means = .86 
Social Desirability 13 20.38 (5.75) 16 17.56 (5.80) t(27) = -1.307, (12 = .202) 
Diff. Means= 3.19 
Cl.95 [-7.25, 1.60] 
Treatment Details 
No of visits 16 15.31 (1.35) 16 15.34 (1.09) t(30) = .287, (12 = .776) 
Diff. Means = .03 
Cl.95 [-.76, 1.01] 
Duration (weeks) 16 9.28 (4.86) 16 9.30 (1.76) t(30) = .010, (12 = .992) 
Diff. Means .02 
Cl.95 [-2.62, 2.65] 
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Table 25 Demographics Of The Top Adherers And The Other Participants. 
Jp No Top Adherers No Others Between groups effect 
--------
(34) (34) ( 69) 
Age (yr) 34 40(11) 67 39(15) t(99) = .342 (12 = .73) 
Diff. Means = l 
Cl.95 [-4.80, 6.80] 
BMI 29 27(5) 50 26(5) t(77) = 1.367 (12 = .18) 
Diff. Means .1.6 
Cl.95 [-.72, 3.88] 
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Age at first pres (yrs) 34 35(10) 69 34(10) t(lOl) = .212 (R = .83) 
Result of MV A 27 79% 50 72% x2 (4) = 1.707, (12 = .79) 
Result of Work injury 6 18% 14 20% 
After surgery 1 3% 2 3% 
Accident at home 0 2 3% 
No clear reason 0 1 2% 
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Duration of current 4 14(10) 2 10(6) t(4) = .514 (12 = .63) 
pain episode (months) Diff. Means 4.25 
Cl.95 [-18.71, 27.21] 
Medication 33 4(4) 69 4(5) t(lOO) = .461, (12 = .65) 
Diff Means .45 
Cl.95 [-1.49, 2.40] 
Occupational Prestige 32 4.4(1.06) 67 4.6 t(95) = -.940 (12 = .35) 
(1.04) Diff. Means .35 
Cl.95 [-.663, .237] 
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Work Satisfaction 30 21 (4.5) 52 21 t(80) = -.170 (12 = .76) 
(4.7) Diff. Means -.94 
Cl.95 [-3.65, 1.77] 
Social Desirability 31 19(5.8) 56 20(6.2) t(85) = -.689 (12 = .44) 
Diff. Means .07 
Cl.95 [-3 .78, 1.74] 
Treatment Details 
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·-· 
-. ~ ; ., • .L ·~ .... ~ 
Duration (weeks) 34 9 (3) 66 8 (7) t(98) = .940. (12 = .26) 
Diff Means 1.2 
Cl.95 [-.88, 3.29] 
xSignificant and close to significant differences are shaded 
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CHAPTER SIX 
RESULTS OF THE ANALYSIS FOR PA.IN 
Overview 
This chapter discusses the results of the analysis of medication intake, and the sensitive and 
affective dimensions of pain, measured both by visual analogue scale and validated multi-
item scales. The whole group analysis is according to the intention to treat principle. The 
analysis for top adherers is also according to the intention to treat principle. It is conducted 
on the top seventeen adherers in each group as determined by the points-based ranked 
adherence list. 
The Analysis 
In the following analysis, unless stated to the contrary, strength-training results are shown 
in front of endurance-training. Reported percentage changes are relative to pre-treatment 
measures. Standard deviations for all means cited in the text are shown in the tables. The 
normality distributions indicated the presence of a possible outlier for each of the post-
treatment measures of anger, fear and depression. However, no participants were excluded, 
as the effect of the outlier did not distort the results. 
There are no inter-group or gender differences for pain sensation or affect at the pre-
treatment measure. Unpaired students t-tests indicated that there are also no significant 
inter-group differences, for reductions over time in pain sensation or affect, for most 
measures. Therefore, to reduce the probability of a type I error ANOV A is used for the 
analysis. Output from the 150mm scales is converted to 1 OOmm in order to compare. pain 
reductions with those experienced in other studies. 
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Evaluating Clinical Meaningfulness 
Research into acute pain indicates that a thirty-six percent reduction on pre-treatment levels 
is of reasonable clinical value [112]. However the outcome of interest in acute pain is 
possible cure. This is in sharp contrast to amelioration of symptoms, which is the outcome 
of interest in chronic pain [113]. There is very little literature regarding what is considered 
a clinically meaningful reduction in pain intensity or affective pain for patients with chronic 
neck pain. The American College of Rheumatology has developed a core set of outcome 
measures with attached definitions of clinical value for use in clinical trials. They define a 
change of twenty percent as holding minimal level clinical value. [114]. There are also 
guidelines from trials evaluating rheumatoid arthritis, which qu~tify levels of clinical 
meaningfulness for changes in each of the SF-36 scales [ 115]. The study by Patrick et al. 
into sciatica yields similar results for the scales of the SF-3 6 [ 116]. 
Table 26 shows the levels of clinical value as adapted from the literature. To be consistent 
with the literature on clinical value, changes for the SF-36 scales are expressed in absolute 
values rather than relative percentage change. 
Levels of clinical meaningfulness for affective pain measured by other instruments are 
more difficult to define as, while research confirms the multidimensional nature of pain, the 
recognised number of dimensions and the terminology to describe them varies between 
researchers [1 17]. For the purposes of the PRIMS trial affective pain refers to the emotional 
aspect of pain, i.e. the accompanying emotional distress, whether it is termed depression, 
anxiety, fear, anger or frustration. The literature is particular1y .unclear about levels of 
clinical meaningfulness for the Multi-dimensional Pain Inventory especially as some 
researchers seem to confuse statistical significance with clinical meaningfulness [118]. 
Clinical value is not synonymous with statistical significance [69], nor is it synonymous 
with clinical significance as described by Turk [119]. A search of the literature does not 
yield any studies that are useful for determining levels of attached clinical value for change 
over time for the Multi-dimensional Pain Inventory scales. Therefore, for the purposes of 
the PRIMS trial levels of clinical value are ascribed to changes over time in the MPI scales 
which approximately equate to the percentage changes required by the American College of 
Rheumatology (see Table 26). 
74 
Table 26 Levels of Clinical Meaningfulness for Pain Sensation and Affect Measur.ed 
by the SF-36 Bodily Pain, Mental Health and Role-Emotional Scales, and the Visual 
Analogue Scale Measures of Pain Intensity and Depression 
~ No Clinical Minimum Moderate to Very Good Value Clinical Value Good Clinical Clinical value Value 
Pain Intensity <20% 20 - 35% 36-50% 51+% 
VAS 
MPIPain -<20% -20 - 35% -36-50% -51+% 
Severity 
SF-36 Bodily < 8.3 8.4-10.8 10.9-24.7 25+ 
Pain 
SF-36 Mental <7.3 7.4-8.4 8.5-11 11.1+ 
Health 
All negative <20% 20-35% 36-50% 51+% 
emotion vas's 
Sf-36 Role <17.8 17.9-22.3 22.4-37.7 37.8+ 
Emot. 
MPI Affective <20% 20 - 35% 36-50% 51+% 
Distressx 
• Approximate percentage for absolute values 
Methodological Problems encountered with Dual Pain Intensity Visual 
analogue scales 
Participants in the PRIMS trial were asked to mark their minimum and usual pain for the 
preceding two weeks on two separate 150mm visual analogue scales. However, there were 
twenty-two incidents where patients marked the VAS for minimum pain higher than that 
for usual pain, at either the pre, or post-treatment measure, or both. All except two of the 
marks on the minimum level VAS were within 15mm of the mark for usual pain. A 
plausible interpretation for this discrepancy, therefore, is that patients intended to mark the 
VAS for minimum pain about the same as for usual. As Linton notes "The patient may 
have the intention of putting a mark on the line at exactly the same place as previously, but 
cannot do this because the scale does not have some other markings apart from th<?. end 
points" 25 [120 translated by Robert Gregson]. Because a considerable proportion of the 
sample completed the minimum pain VAS incorrectly, only the VAS for usual pain was 
25 Linton concludes that there is a 10% error margin associated with the Visual analogue scale. 
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used. Jensen et al. 's study indicated that the ·101 NRS for usual pain over a period of two 
weeks had a correlation coefficient r = 0. 78 with pain diaries over the same period [ 121]. 
Whole group analysis of Pain Intensity measured by Visual analogue scale 
The VAS pre-treatment measures for pain intensity are similar for both groups 57mm for 
strength-training and 54mm for endurance-training (see Table 27). These pain levels are 
slightly higher than those for other neck pain populations where pre-treatment levels range 
from 34 to 50mm26 [57, 78, 122), but are still within the category of moderate pain [123]. 
The ANOV A two-way repeated measures indicates that while there are significant 
reductions in pain intensity of twenty-one and twenty-six percent for strength and 
endurance respectively, E(l,89) = 26.27 (12< .0001), there are no significant inter-group, 
E(l, 89) = .190 (12 = .66), or gender differences E(l, 87) = .26, (12 = .608). However, 
according the guidelines of the American College of Rheumatology the reduction 
experienced by both groups holds minimum clinical value (see Table 26). The estimated 
treatment effect for change over time is medium, 112=.228. As can be seen from F~gure 
12 the mean of the absolute difference (-2) and the direction of the confidence interval 
Cl.95 (-12, 8) indicate that these results are more likely if the null hypothesis is correct. 
Analysis for Top Adherers of Pain Intensity 
Top adherers' pre-treatment measures of 56 and 51 are not significantly different from each 
other, or from the other participants. The results for top adherers indicate reductions in pain 
intensity of thirty-six percent for strength-training and twenty-five percent for endurance-
training E(l,31) = 16.76, (12< .0001) (see Table 27). Although the inter-group difference is 
not significant E(l,31) =.831 (12 =.37), the pain reduction experienced by the strength-
trained top adherers is greater than that experienced by the endurance-trained group. It also 
has a higher level of clinical value (see Table 25). Compared to the whole group analysis, 
the between group trend is reversed, with the strength-training group demonstrating a 
greater pain reduction. The estimated treatment effect, 112 = .351, is large, and considerably 
26 Few clinical trials on neck pain have used the visual analogue scale, most used the box scale. 
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greater than that for the whole group analysis. As can be seen from Figure 12 the mean of 
the difference (7) and the direction of the confidence interval Cl.95 (-9, 23) now indicates 
that these results are more likely to occur if the alternative hypothesis is true. 
Whole group analysis of MP/ Pain Severity Scale 
The six point pain severity scale of the Multi-dimensional Pain Inventory also measures 
pain intensity. The pre-treatment measures are not significantly different being 3.7 and 3.57 
for strength and endurance-training respectively ( see Table 27). These figures indicate that 
the PRIMS population experienced slightly more pain than neck and back pain patients 
attending physiotherapy and chiropractic treatment in the Netherlands [56), but less than 
low back pain patients attending pain clinics in Australia, where pre-treatment levels were 
4.67 [124). Post-treatment measures for the PRIMS trial are 3.32 and 3 for strength and 
endurance-training respectively, with the endurance group experiencing a slightly larger 
reduction in pain. As discussed previously, the literature is unclear as to what constitutes a 
clinically meaningful pain reduction according to the MPI. However, whilst the reductions 
are significant over time, E(l,72) = 14.09, (R<.0001), there is no significant inter gtoup 
difference, .E..(1,72) = .831, (R =.43), 112 .009. Further, there is no clinical value attached to 
a one quarter of a point reduction on a six point scale, as it equates to approximately four 
percent. The estimated treatment effect, ,.,2 = .164, for change over time is medium, but 
considerably less than that of the VAS measure of pain intensity. As can be seen from 
Figure 12 the mean of the difference (-.20) and the direction of the confidence interval Cl.95 
(-.70, .30) indicate that these results are more likely to occur if the null hypothesis is true. 
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Analysis for Top Adherers of MP/ Pain Severity Scale 
Strength and endurance-trained top adherers' pre-treatment measures of 3.59 for each group 
not significantly different, nor are they significantly different from the other participants. 
Reduction over time for top adherers is also significant E(l,26 ) = 11.86 fu =.002) 
(see Table 27), and slightly greater than for the whole groups. However, as it equates to 
approximately seven percent, it still has no clinical value. But, the trend is reversed with the 
strength-training group experiencing a greater reduction in pain. The treatment effect for 
change over time, 112 = .313, is also considerably larger than for the whole group analysis. 
Again, there is no significant inter group difference .E(I ,26) = .130, (U = .72), and the 
estimated treatment effect, 112 = .005, is very small. As can be seen from Figure 12 the 
mean of the difference (.11) and the direction of the confidence interval Cl.95 (-.70, 1.0) 
now indicate that these results are more likely to occur if the alternative hypothesis is true. 
Whole group analysis of the SF-36 Bodily-Pain scale 
Pre-treatment measures of 7327 and 69 for strength and endurance-training are not 
significantly different. They are nearly three times the magnitude of the median value 26 
for the general population. As the SF-36 Bodily-Pain scale measures both pain intensity, 
and the impact of pain on normal daily activities, pre-treatment measures, and percentage 
reductions are expected to be larger than those recorded by the VAS, which measures only 
pain intensity. Changes in the expected direction of 11 points for strength-training and 12 
points for endurance-training are statistically significant E(l,81) = 41.19, fu<.0001) 
(see Table 27). As can be seen by Table 26 they are of good clinical value. However, there 
are no significant inter-group differences E(l ,81) =.084 fu = . 77). Post-treatment levels of 
62 and 57 are still well above the median for the general population. The large estimated 
treatment effect for change over time, 112 = .337, is greater than the VAS, which is to be 
expected. As discussed above, the SF-36 Bodily-Pain scale is measuring two aspects of 
pain. As can be seen from Figure 12 the mean of the difference(-1) and the direction of 
27 To provide a scale orientation that is consistent with the Visual analogue scale and MPI (i.e. higher scores represent 
more pain) the SF-36 subscales are transformed. The score is subtracted from 100, therefore 73=27. 
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the confidence interval CI.95 (-8, 6) indicate that these results are slightly more likely if the 
null hypothesis is correct. 
Analysis for Top Adherers of the SF-36 Bodily-Pain scale 
Strength and endurance-trained top adherers' pre-treatment levels of 67 (ST) and 72 (ET) 
for Bodily Pain are not significantly different. Neither are they significantly different from 
the other participants. The pain reductions of 14 points for strength-training and 13 points 
for endurance-training are slightly larger than those yielded in the whole group analysis. 
They are significant over time, .E(l,29) = 18.49, (12<.0001) (see Table 27), and have good 
clinical value [115]. However, there is no significant inter-group difference .E(l ,29) = .055, 
(12 =.82). The estimated treatment effect for change over time, 112 = .389, is greater than for 
the whole group analysis. However, as can be seen from Figure 12 the mean of the absolute 
difference (2) and the direction of the confidence interval Cl.95 (-11, 15) now indicate that 
the trend has reversed to favour strength training. 
Whole group analysis of Frustration Visual analogue scale 
Frustration is the highest affective dimension of pain ( see Table 27). Other studies of upper 
back pain have also found frustration to be the highest affective dimension of pain [125]. 
Pre-treatment levels of frustration of 56 and 59 are not significantly different (see Table 
27). Frustration reduced by, a clinically meaningful, twenty-one percent for strength-
training and thirty-four percent for endurance-training .E(l,84) = 22.45, ( p< .0001). 
However, there is no significant inter-group, .E(l, 84) = 1.55 (p_ = .22),or gender difference 
.E(l, 82) = .20 (p_ = .65). The estimated treatment effect for change over time, 112 = .211, is 
medium. As can be seen from Figure 12 the mean of the absolute difference (-8) and the 
direction of the confidence interval CI.95 (-21, 5) indicate that these results are more likely 
if the null hypothesis is correct. 
Analysis for Top Adherers of Frustration Visual analogue scale 
Strength and endurance-trained top adherers' pre-treatment measures of 56 and 64 are not 
statistically different, nor are they different from the other participants. Frustration is also 
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the highest affective dimension of pain for. the top adherers. It decreased by forty-five 
percent for strength-training and thirty-nine percent for endurance-training (see Table 27). 
Reductions over time are statistically significant E.(1,31) = 20.19 (12<0001 ), but there is no 
significant inter-group difference E.(1,31) =.000(=.99). However, by comparison to the 
whole groups, the between group trend is reversed, with the strength-training group 
demonstrating a greater percentage reduction in frustration. The very large estimated 
treatment effect for change over time, 112 = .394, is considerably greater than that yielded by 
the whole group analysis. As can be seen from Figure 12 the mean of the absolute 
difference (0) and the direction of the confidence interval Cl.95 (-22, 22) indicate that these 
results are equally likely if either hypothesis is correct. 
Whole group analysis of Anger Visual analogue scale 
The pre-treatment group means of 41 and 44 for anger are not significantly different. Anger 
reduced by twenty-four percent on baseline for strength-training and forty-three percent for 
endurance-training E.(1,8 1) = 18.60, (12<.0001). However, there is no significant inter-
group, E.(l, 81) = 1.48, (12 = .22), or gender difference E.(l, 79) = .07 (12 = .79). The 
estimated treatment effect for change over time, 112 = .187, is medium. As can be seen from 
Figure 12 the mean of the absolute difference (-8) and the direction of the confidence 
interval CI.95 (-21, 5) indicate that these results are more likely if the null hypothesis is 
correct. 
Analysis for Top Adherers of Anger Visual analogue scale 
Strength and endurance-trained top adherers' pre-treatment measures of 34 and 43 are not 
significantly different, nor are they different from the other participants. Anger reduced 
significantly over time, E.(1,28) = 5.39, (12 =.03),by fifty-three per('.ent for strength-training 
and thirty percent for endurance-training (see Table 27). However, there is no significant 
inter-group difference E.(1,28) =.005, (12 =.71). But, by comparison to the whole groups, the 
between group trend is reversed, with the strength-training group demonstrating a greater 
reduction in anger. The medium sized estimated treatment effect for change over time; ·112 = 
.161 is smaller than for the whole group analysis, which possibly reflects the difference in 
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inter-group pre-treatment measures. Another contributing factor is that the shape of the 
distribution for pre-treatment usual anger is positively skewed, because many participants 
denied experiencing anger, or reported extremely low levels. Further, the shape of the 
distribution for top adherers indicated a higher degree of variance due to the small sample 
size. However, as can be seen from Figure 12 the mean of the absolute difference (5) and 
the direction of the confidence interval Cl.95 (-22, 32) now indicate that these results are 
more likely to occur if the alternative hypothesis is correct. 
Whole group analysis of Fear Visual analogue scale 
The pre-treatment measures of 32 and 30 for fear are the lowest of the affective dimensions 
of pain. Fear was also lowest in Price et al.'s upper back pain population [125]. Fear 
reduced by thirty-one percent on baseline for strength-training and twenty-seven percent for 
endurance-training E(l,82) = 8.65, (n = .004), but there is no significant inter-group E(l, 
82) = .06, (n = . 79) or gender difference E.(l, 80) = .21, (n = .64). The estimated treatment 
effect, 1')2 = .095, is medium. As can be seen from Figure 12 the mean of the absolute 
difference (2) and the direction of the confidence interval Cl.95 (-10, 14) indicate that these 
results are more likely if the null hypothesis is correct. 
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Table 27 Results for Sensory and Affective Pain from the Analyses of the Whole Groups and only Top Adherers Part I 
K Grp No Pre-Treat Post Treat x % l12 x F,12-values for change over T)2 time F,12 values for timexgi-oup over change over time x interaction group time time 
WG ST 45 57 (19) 45 (21) 12 21 .228 E(l,89) = 26.27, {12< .0001) .002 E(l ,89) = .190, (12 = .66) 
Intensity ET 46 54 (22) 40(24) 14 26 
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Pain Sev ET 38 3.57(.85) 3(1.3) .57 n/a 
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Table 28 Results for Sensory and Affective Pain from the Analyses of the Whole Groups and only Top Adherers Part II 




WG ST 42 40(30) 34(28) 6 15 
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time 
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Allalysis for Top Adherers of Fear measured by Visual Analogue Scale 
Top adherer's pre-treatment measures of 19 for strength-training and 25 for endurance-
training are not significantly different (12 = .392), but they are significantly lower than 
the other participants (12 = .019). When other differences in aetiology are considered 
(see Table 25, chapter Five) it is plausible that top adherers will have lower levels of 
fear compared with the other participants.23 Fear reduced over time by fifty-eight 
percent for the strength-training group, but increased by one percent in the endurance· 
group (see Table 27). Change over time is not statistically significant, .E(l,29) =.96 (12 = 
.34), nor is there any significant inter-group difference .E(l,29) = 1.46 (12 = .24). As in the 
whole group analysis the strength-training group demonstrates a greater reduction in 
fear. But, the estimated treatment effect for change over time, 112 = .032, is smaller than 
for the whole group analysis, whereas the estimated treatment effect for inter-group 
differences 112 = .048 is larger. As can be seen from Figure 12 the mean of the absolute 
difference (12) and the direction of the confidence interval Cl.95 (-7, 33) indicate that, 
again, these results are more likely if the alternative hypothesis is correct. 
However, the positively skewed distributions, significant difference between top 
adherers and whole groups for pre-treatment levels of fear, and small sample size for 
top adherers, make the VAS results for fear difficult to interpret. 
Whole group analysis of Anxiety Visual analogue scale 
The pre-treatment group means for anxiety of 40 and 45 mm are similar to the means of 
43, 46 and 51 measured by VAS in clinically depressed patients [126). Anxiety is least 
reduced over time, with strength-training resulting in a fifteen percent reduction and 
endurance-training resulting in a twenty-four percent reduction E(l,82) = 6.52, (12 = 
.01), (see Table 28).29 There are no significant inter-group, E(l, 82) = .58 (12 = .45 ), or 
gender differences E(l, 80) = .05 (12 = .813). The estimated treatment effect, 112 = .074, 
is small. As can be seen from Figure 12 the mean of the absolute difference( - 5) and 
the direction of the confidence interval CI.95 (-18, 8) indicate that these results are more 
likely if the null hypothesis is correct. 
28 Top adherers had lower baseline measures for all the negative emotion scales, but the differences were not <.05. 
29 there is a laminated copy of Table 28 in the back cover of the thesis 
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Analysis for Top Adherers of Anxiety measured by Visual analogue scale 
The top adherer's pre-treatment measures of 28 and 44 are not, significantly different (I! 
=.109), but they are marginally, significantly lower than the other participants (I!= .06). 
Reductions of thirty percent for strength-training and twenty-five percent for endurance-
training are not significant over time E(l,29) = 2.04 ( p = .16), nor is there any 
significant inter-group difference E(l ,29) = .13 (Ji = .87) (see Table 28). But, by 
comparison to the whole groups, the between group trend is reversed, with the strength.:. 
training group demonstrating a greater percentage reduction in anxiety. However, the 
estimated treatment effect, ~2 = .066, is smaller than for the whole group analysis, 
possibly reflecting the inter-group difference at the pre-treatment measures. As can be 
seen from Figure 12 the mean of the absolute difference -2 Cl.95 (-29, 24) and the 
direction of the confidence interval indicate that these results are only slightly more 
likely if the null hypothesis is true. 
Once again positively skewed distributions, inter group differences in pre-treatment 
measures, and small sample size for the top adherers make the results difficult to 
interpret. 
Wltole group analysis of Depression Visual analogue scale 
The depression VAS measure seems to approximate the SF-36 Mental-Health scale, as 
studies which have used the VAS to measure depression in non depressed populations 
record 26 mm as the group mean (127). This is similar to the SF-36 median value for a 
non-depressed population of 20. Therefore, the pre-treatment depression levels of 43 
and 42 for the strength and endurance-training groups in the PRIMS trial are 
approximately twice the magnitude of the normal population, as measured by the SF-36 
[68) and the VAS [127). They are three-quarters the magnitude of the population norm 
of 56, and mean of 59, for the clinically depressed, measured by the SF-36, and the 
VAS (127]. According to the interpretation manual of the SF-36 (68) these levels 
indicate that the PRIMS participants were moderately depressed at the pre-treatment 
measure. 
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The twenty-three percent reduction in depression for strength-training, and thirty-one 
percent for endurance-training, measured by VAS, are statistically significant fll ,83) = 
15.22, ( p < .0001), (see Table 28).and have minimum clinical value. But, there are no 
significant inter-group, E(l ,83) = .34, ( p = .56), or gender E(l, 75) = 2.32, (Jl = .132), 
,.,
2 
= .155, differences. As can be seen from Figure 12 the mean of the absolute 
difference (- 3) and the direction of the confidence interval CI.95 (-14, 8) indicate that 
these results are more likely if the null hypothesis is correct. 
Analysis for Top Adherers of Depression Visual analogue scale 
Strength and endurance-trained top adherers' pre-treatment measures of 37 and 40 are 
not significantly different, nor they are significantly different from the other participants 
(I! = .16). Reductions over time of forty-nine percent for strength-training and twenty 
percent for endurance-training are significant E.(1,30) = 7 .19 (Jl = .0 l ), but there is no 
significant inter-group difference .E(l,30) = .93, (Jl = .34). (see Table 28). However, the 
reduction in depression experienced by the strength-trained top adherers holds good 
clinical value while the reduction for the endurance-trained group is of minimal clinical 
value. Once again, by comparison to the whole groups, the between group trend is 
reversed, with the strength-training group demonstrating a greater reduction in 
depression. Further, the estimated treatment effect, ,.,2 = .193, is greater than for the 
whole group analysis. As can be seen from Figure 12 the mean of the absolute 
difference (10) and the direction of the confidence interval Cl.95 (-10, 30) now indicate 
that these results are more likely if the alternative hypothesis is correct. It is worth 
noting that the estimated treatment effect, yielded by VAS measure of depression in· 
both the analyses for whole groups and for top adherers is higher than that yielded by 
any of the multi-item interval scales. 
Whole Group Analysis of the Shor t-for m Beck Depression Inventory 
The participant's pre-treatment scores for the short form Beck Depression Inventory, 
7.24 and 6.94 for strength and endurance-training respectively, indicate moderate 
depression [80)(see Table 28). The pre-treatment means are comparable to those 
recorded by the long-form Beck Depression Inventory (128]. The BDI indicated a very 
small reduction in depression for the strength-training group, and a very small increase 
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in depression for the endurance-training group E(l,73) = .002 (11 =.96). But the changes 
over time are too small to be of any clinical value. Post-treatment scores are still within 
the range of moderate depression. The estimated treatment effect, 112 =.000, is close to 
zero. As can be seen from Figure 12 the mean of the difference (.21) and the direction 
of the confidence interval CI.95 (1 .95, 2.37) indicate that these results are more likely to 
occur if the alternative hypothesis is true. 
Analysis of the short-form Beck Depression Inventory in Top 
Adherers 
Pre-treatment measures of 6.36 and 7.80 are not significantly different, nor are they 
significantly different from the other participants. Change over time is not significanr 
Fl,27) == .23, (p = .64), or clinically meaningful for either group, but the trend of the 
whole group analysis is reinforced. The estimated treatment effect, 112 = .008, is larger 
than for the whole group analysis, but still very small (see Table 28). However, as can 
be seen from Figure 12 the mean of the difference (2.1) and the direction of the 
confidence interval Cl.95 (-2.24, 6.59) indicate that the likelihood of the alternative 
hypothesis being true has increased with the more valid measures of the top adherers. 
Whole group analysis of SF-36 Mental-Health scale 
The detrended normality plot indicated the presence of one outlier for change in mental 
health, which was separated from the rest of the data by more· than three standard 
deviations. This participant was excluded from the analysis. The SF-36 Mental-Health 
scale pre-treatment scores of 41 for strength and 42 for endurance-training are well 
above the US population norm of 20 [68). They are close to the median of 56 for the 
clinically depressed. Improvement over time of 3 points for strength and 1 point fot. 
endurance-training (see Table 28) are not statistically significant, E(l,80 ) = 1.15 (11 = 
.29), or clinically meaningful [115](see Table 26). Post-treatment group means of 38 
and 41 are still close to the median value for the clinically depressed. The estimated 
treatment effect, ri2 = .014, is small. There is no significant time by group interaction 
E(l,80) =.40, (11 =.53). As can be seen from Figure 12 the mean of the absolute 
difference (2) and the direction of the confidence interval Cl.95 (-4, 8) these results are 
slightly more likely if the alternative hypothesis is correct. 
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Analysis for Top Adherers of SF-36 Mental Health Scale 
The pre-treatment levels of 30 and 43 for top adherers are marginally, significantly 
different (12 = .07), but they are not significantly different from the other participants (12 
= .12) (see Table 28). Change over time of 3 points for strength-training and 5 points for 
endurance-training is not statistically significant E.(1,28) = 1.28, en = .26) or clinically 
meaningful. Nor is there any significant inter-group difference E.(1,29) = .167, (12 = 
.69). The estimated treatment effect for change over time, ll2 = .006, is greater than that 
yielded by the whole group analysis. But, as can be seen from Figure 12 the mean of 
the absolute difference (-2) and the direction of the confidence interval Cl.95 (-14, 10) 
indicate that these results are more likely if the null hypothesis is correct, i.e. the trend 
has reversed. Possibly, however, the results for the analysis for top adherers of the· 
Mental-Health scale should not necessarily be taken at face value as baseline differences 
are marginally significant. 
Whole group analysis of SF-36 Role-Emotional Scale 
The role-emotional scale of the SF-36 purports to measure the extent to which 
emotional problems interfere with work or daily activities. It consists of three yes/no 
responses, therefore, pronounced floor and ceiling effects can occur. Pre-treatment 
levels of 56 and 59 for strength and endurance-training are not significantly different. 
(see Table 28). The strength-training group improved their mental health by 8 points 
while the mental health of the endurance group deteriorated by 9 points. Changes over 
time are not significant E(l, 78) =.032 en =.86), and they have no clinical value (see 
Table 26). But, inter-group differences are marginally statistically significant E(l , 78) 
= .. 040, en =.076), and the absolute value of 17 for inter-group difference does represent 
a clinically meaningful difference. The estimated treatment effect for change over time; 
Tj2 = .000, is tiny, and for group by time interaction it is still small, Tj2 = .040. As can be 
seen from Figure 12 the mean of the absolute difference (17) and the direction of the 
confidence interval Cl.95 (-1.81, 35) indicate that these results most likely to occur if the 
alternative hypothesis is correct.30 
A frequency count indicates that in the strength-training group the percentage of 
participants reporting themselves as extremely emotionally distressed reduced from 
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thirty-seven percent ( n =15) at the pre-treaonent measure to thirty-two percent (n = 13) 
at the post-treatment measure Change over time was not significant (McNemar's test, I! 
= .774). By contrast in the endurance-training group the percentage of participants 
reporting themselves as extremely emotionally distressed increased from forty percent 
(n = 16) to sixty-two percent (n = 25) over the same time, (McNemar's test, p = .02). 
Non-parametric analysis indicates that the group proportions at the post-treatment 
measure are significantly different x.2 (5) = 25.71, (12< .0001). 
Analysis for Top Adherers of SF-36 Role-Emotional Scale 
The pre-treatment measures of 51 and 60 for the SF-36 Role-Emotional scale indicate 
that the sub-groups of top adherers are not significantly different from each other, nor 
are they significantly different from the other participants. The strength-training group. 
improved over time by 20 points while the endurance-training group deteriorated over 
time by 8 points (see Table 28). Change over time is not statistically significant, 
E(l,29) =.713, (12 =.40) while the time by group interaction is significant, E(l,29) 
=4.20, (Q =.050). The strength-training group's change over time is of good clinical 
value. The estimated treatment effect for change over time, 112 = .024, is small, but 
larger than that yielded in the whole group analysis. The estimated treatment effect for 
time by group interaction, 112 = .127, is medium, and again, greater than for the whole 
group analysis. As can be seen from Figure 12 the mean of the absolute difference (28) 
and the direction of the confidence interval CI.95 (0, 57) indicate that the likelihood of 
these results occurring if the null hypothesis is correct have reduced to one in twenty. 
A frequencies count indicates that at the pre-treatment measure thirty-six percent (n = 5) 
and thirty-seven percent (n = 6) of strength and endurance groups respectively reported· 
themselves as extremely emotionally distressed. However, this figure reduced to 
fourteen percent (n = 2) at the post-treatment measure in the strength-training group, 
whereas in the endurance-training group it increased to fifty-six percent. (n = 9). Again 
a non-parametric analysis indicates that group proportions are significantly different at 
the post-treatment measure x2 (5) = 16.04, ( p = .007). 
30 There is less than, or equal to a one in twenty chance that these results would have occurred if the null hypothesis is 
correct. 
89 
Whole group analysis of MPI Affective Distress Scale 
The pre-treatment scores for the MPI Affective Distress scale of 3.38 and 3.29 are not 
significantly different, and are similar to other chronic pain populations [ 129]. The 
reductions of .46 and .24 for strength, and endurance-training are statistically significant 
E(l,7.) = 5.48 (12 =.02), but too small to hold clinical value (see Table 28). The 
estimated treatment effect for reduction in affective distress, ,,2 = .072, is small, but 
larger than that yielded for inter-group difference, ,,2 = .008. There is no significant 
inter group difference E(l,71) = 3.58, (12 = .07). As can be seen from Figure 12 the 
mean of the difference (.22) and the direction of the confidence interval CI.95 (-.37, .82) 
indicate that these results are more likely to occur if the alternative hypothesis is true. 
Analysis for Top Adherers of MPI Affective Distress Scale 
The pre-treatment measures of 3 .1 and 3 .04 are not significantly different, nor are they 
significantly different from the other participants. Affective distress reduced in the 
strength-training group by .60, but increased in the endurance-training group by .18 (see 
Table 28). Change over time is not significant E(l ,26) = 1.18, (12 =.29), however, the 
inter-group difference is marginally significant, E(l ,26) = 3.38 (l! =.07). The estimated 
treatment effect, 112 = .052, for change over time is small and less than for the whole 
group analysis. The medium sized estimated treatment effect for inter-group differences, 
,,
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= .125, in the top adherers is larger than that yielded in the whole group analysis. As 
can be seen from Figure 12 the mean of the difference (.93) and the direction of the 
confidence interval CI.95 (-.08, 1.94) show that the likelihood of the alternative 
hypothesis being correct has increased with the more valid measures of the top adherers. 
The inter-group pre-treatment measures for top adherers are not significantly different, 
and the shape of the distribution of the pre-treatment measures is nonnal for both whole 
groups and top adherers. Therefore, these results can be interpreted as representing a 
clinically meaningful difference in the reduction in symptoms between the strength and 
endurance-trained top adherers at a marginally statistically significant level. 
Analyses of Medication Intake 
Both whole groups actually increased their intake by one unit over time E(l,71) = 1.70, 
( p = .19) (see Appendix 15, Appendix 16, Appendix 17 and Appendix 18 for details of 
drug categories). The top adherers pre-treatment levels of medication intake of 5 units 
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for strength-training group and 3 for the endurance-training group are not significantly 
different from each other, or the other participants. The strength-training group reduced 
their intake by half a unit over time, while the endurance-training group increased their 
intake by two units over time, neither group's change over time is significant E(l,23) = 
.17, ( p = 69) nor is there any significant inter-group difference E(l,23) = .36, (p, = .55). 
As 16 of the endurance trained participants and 21 of the strength-trained participants 
did not complete both the pre and post-treatment measures for medication intake these 
results should not be taken at face value. 
Discussion 
Considering the varying degrees of adherence to allocated protocol (described in 
chapter five), it is not surprising that there are no inter-group differences for most of the. 
measures of pain intensity or affect in the Whole Group analysis. Further, as discussed 
above, although groups were balanced for medication usage at the pre-treatment 
measure, a considerable number of participants failed to complete both the pre and post-
treatment measures. Therefore, it is difficult to measure the possible influence of 
medication intake on measures of pain intensity. However, given the limitations of the 
study, the results for the analysis of pain are intriguing. The VAS measures, of pain 
intensity and affect consistently indicate that the endurance group experienced slightly 
greater reductions in sensory and affective pain. Yet, in the analysis for top adherers all 
the visual analogue scale measures consistently indicate that the trend is reversed. The 
strength-training group of top adherers experienced, at least equal, but in most cases, 
greater reductions in pain sensation and affect. The inter-group differences may not be 
statistically significant at <.05 levels. But, the consistent directional move of the mean 
of the difference, and associated confidence intervals indicates that even though the 
sample of top adherers is considerably smaller, the more valid measures produce results,· 
which are consistently less likely to occur if the null hypothesis is correct. 
As would be expected, the estimated treatment effect for pain intensity, depression and 
frustration is larger in the top adherers group, reflecting the more valid measures. The 
estimated treatment effect for the top adherers is less than for the whole groups for 
anger, fear and anxiety. A possible explanation for this, however, is that the top adherers 
had a greater inter-group difference at the pre-treatment measures by comparison to the 
other participants. 
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The multi-item scales, particularly for pain affect, did not behave as consistently as the 
visual analogue scales. But, by comparison to the whole group analysis, a consistently 
greater degree of the variance is explained by the treatment effect in the analysis for the 
top adherers. Parametric and non-parametric analysis of the SF-36 Role-Emotional scale 
show significant post-treatment differences favouring strength-training, both for whole 
groups, and only the top adherers. But, the fact that the post-treatment differences can 
be attributed partly to an increase in emotional distress in the endurance-trained group 
by comparison to a reduction in the strength-trained group, raises some questions. 
Firstly, is the increase in emotional distress negative placebo, or genuine treatment 
effect? The post-treatment measure of patients' perceptions of the therapist's attitude 
indicates that the endurance-trained patients had no idea they were receiving the less 
preferred treatment (see chapter eight). Therefore, these results reflect patients' genuine 
dissatisfaction with endurance-training, which understandably, has increased their 
emotional distress. Further the Beck Depression Inventory and, to a lesser extent the 
MPI Affective Distress scale, reflect the same trend as the SF-36 Role-Emotional scale. 
It is disappointing that the 'Gold Standard' Beck Depression Inventory explained such a 
small proportion of the variance in the PRIMS trial (the psychometric performance of 
the scales is discussed in more detail in chapter nine). 
One interpretation of these results is that the treatment effect is small enough to be 
swamped by the combined influence of confounds, or covariate interaction, in the whole 
group analysis. But, for the I/3rd of patients who managed to adhere to progressive 
resistance exercise therapy, possibly, strength-training elicited greater reductions in pain 
sensation and affect. The alternative explanation, that inter group differences are 
accidental, is also possible, but more difficult to claim. Firstly, in the whole group 
analysis the only significant inter-group difference favoured the strength-training group. 
Further, this difference is even more apparent in the analysis for top adherers. Secondly1. 
the trend consistently reverses for all visual analogue scales when only the data of the 
top adherers is analysed. The more valid measures of the top adherers shows a clear 
directional trend favouring the alternative hypothesis. 
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CHAPTER SEVEN 
RESULTS FOR DISABILITY 
Overview 
This chapter addresses the results for disability measured by the Neck Disability Index, 
and the General Activity and Pain Interference scales of the Multi-dimensional Pain 
Inventory. The results of the Physical-Functioning and Role-FW1ctioning scales of the 
SF-36 are also discussed. All sub-scales of the SF-36, and the MPI General Activity 
scale are transformed to negatively directed scales31 in order to be consistent with the 
Neck Disability Index. 
Evaluating Levels of Clinical Meaningfulness for Changes in Disability 
As in the analysis for pain, levels of clinical meaning for the SF-36 scales are adapted 
from criteria developed for clinical trials of patients with rheumatoid arthritis [115]. 
Based on the same criteria, twenty percent is the minimum level of clinical 
meaningfulness for the Neck Disability Index [114]. As discussed previously, the 
literature is W1clear about levels of clinical meaningfulness for the Multi-dimensional 
Pain Inventory. For the purposes of the PRIMS trial changes in the Pain Interference 
and General Activity scales are expected to approximately equate to twenty percent to 
warrant any clinical value [114]. 
31 Higher scores equate to higher levels of disability 
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Table 29 Levels of Clinical Value Measured by the Neck Disability Index and the · 
Physical-Functioning and Role-Physical scales of the SF-36 
~ No Clinical Minimum Moderate to Very Good Value Clinical Value Good Clinical Clinical value Value 
Neck Disability <20% 21-35% 36-50% 51+% 
Index 
MPI General <20% 21-35% 36-50% 51+% 
Activity 
MPIPain <20% 21-35% 36-50% 51+% 
Interference 
SF-36 Physical < 7.9 8-13.1 13.2-20.4 20.5+ 
Functioning 
SF-36 Role < 19.4 19.5-30.8 31.8-50.7 50.8+ 
Physical 
Whole group analysis of the Neck Disability Index 
Disability specifically relating to neck pain is measured on the Neck Disability Index 
(100], which is based on the Oswestry Low Back Pain Disability Index. It consists of 
ten, six category adjectival (see Glossary) scales, rated 0 equalling least disabled to 5· 
equalling most disabled. The authors do not provide a strategy for dealing with 
questions that are left blank by the respondents (130]. Researchers, therefore, have used 
the Oswestry scoring algorithm, which converts the score to a percentage of the 
maximum possible score for the number of questions answered ( 130]. It is possible that 
this scoring system may result in inaccurate scores as a participant's possible score for a 
missed item is unknown. In the PRIMS trial eight participants missed at least one 
question at the pre-treatment measure, and another eight at the post-treatment measure. 
One participant who missed six items at the post-treatment measure was excluded 
because the scoring algorithm distorted the results. Two other participants had also 
missed six items, but as their scores were not distorted they were not excluded. 
The pre-treatment measures for the Neck Disability Index of forty-three and forty-two 
percent categorise the participants as moderately disabled (see Table 30) [ 100]. 
Similarly, most other neck pain populations are moderately disabled at the pre-treatment 
measure with scores ranging between 30-48% [130-134]. Reductions in disability of 
seven to ten percent are statistically significant, E(l ,86) = 12.52, (J2 = .001 ), but they 
have no clinical value (see Table 29). The estimated treatment effect, ri2= .128, is 
medium. Other neck pain populations have also experienced similar reductions to the 
PRIMS sample, (130] while others experienced reductions of fifty percent or more 
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[ 131-134]. However, m the main, large reductions have only been detected m 
uncontrolled studies. 
In the PRIMS trial there are no significant inter-group, E(l,86) = .30, (R = .58), or 
gender E(l,85) =.25, ( p = .62), differences. The mean of the absolute difference (-1) 
and the direction of the confidence interval CI95 (-6, 4) indicate that these results are 
more likely to occur if the null hypothesis is correct (see Figure 12). 
Analysis for Top Adherers of the N eek Disability Index 
Strength and endurance-trained top adherers' pre-treatment measures of thirty-nine and 
forty-three percent for strength and endurance-training respectively are not significantly 
different, nor are they are significantly different from the other participants. Change 
over time of thirteen percent for strength-training and nineteen percent for endurance-
training is significant, E(l,30) = 14.58, ( p< .001), and yields a large estimated 
treatment effect, 112= .327 (see Table 30). But, the reductions are not sufficient to 
warrant any clinical value (see Table 29). The time by group interaction is not 
significant E(l ,30) = .684, (12 = .58). The mean of the difference (-3) and the direction 
of the confidence interval, ci95 (-10, 4), indicate that these results are still more likely to 
occur if the null hypothesis is correct (see Figure 12). 
It is surprising that the NDI should produce results that are contradictory to those of the 
SF-36 scales, and to the consistent trend of most of the other scales. The Neck 
Disability Index has the largest estimated treatment effect of all the measures for 
disability. But, this is to be expected as specific questionnaires have higher content 
validity [135]. The psychometric properties of the NDI are reported to be sound [136]. 
But, as mentioned previously, it does not provide a strategy for dealing with missed 
items, other than to adjust the total possible score to correspond to the number of items 
answered when calculating percentage change. Furthermore, when considered ~· 
context, the absolute values for change over time detected by the Neck Disability Index 
is very small, with an inter-group difference of about one percent. Therefore, very 
possibly these results could have occurred by chance and should not be taken at face 
value. (The psychometric performance of all measures is discussed in chapter nine) 
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Whole group analysis of the Multi-dimensional Pain Inventory General 
Activity Scale 
The General Activity scale consists of the averaged results of eighteen seven-point box· 
scales, which address the capacity to perform everyday activities. It is an amalgamation 
of the four sub-scales of section HI of the Multi-dimensional Pain Inventory, these being 
household chores, outdoor work, and activities away from home and outdoor activities. 
The pre-treatment scores of 3.54 and 3.20 for general daily activity are similar to other 
chronic pain populations [137) (Table 30). Disability slightly increased over time for the 
strength-trained participants by .26 (approximately four percent) while it decreased in 
the endurance-trained group by .07 which equates to about one percent, E.(1,47) = .907 
(p = .35), equalling an approximate five percent inter-group difference. There is no 
clinical value attached to a difference of five percent, even though it is marginally 
statistically significant, E.(1,47) = 2.73, ( 12 = .06). However, the variance explained by 
the estimated treatment effect, 112= .019, is very small. The mean of the difference (-.33) 
and the direction of the confidence interval, ci95 (-.71, .07), indicate that the results are 
slightly more likely to occur if the null hypothesis is correct (see Figure 12). 
Analysis for Top Adherers of the Multi-dimensional Pain Inventory 
General Activity Scale 
Strength and endurance-trained top adherers' pre-treatment scores of 3.56 and 3.68 are 
not significantly different from each other, nor are they significantly different from the 
other participants. Change over time is minimal and not significant for either group, 
E.(1, 19) = 240, ( p = .63) (see Table 30). The variance explained by the estimated 
treatment effect, 112= .012, is tiny, and ~ than that yielded for the whole group 
analysis. There is no significant inter-group difference, (El,19) = 1.42, (p. = .25). The 
mean of the difference (-.35) and confidence interval ci95 (-.98, .27), indicates that even 
with a considerably smaller sample, and more valid measures the results are still slightly 
more likely to occur if the null hypothesis is correct (see Figure 12). 
There is no clinical value attached to the small changes over time in either the analysis 
for whole groups or for top adherers for the General Activity scale. As can be seen in 
Table 30 the General Activity scale indicated the same contradictory trend as the Neck 
Disability Index. However, the other similarity between the MPI General Activity scale 
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and the Neck Disability Index is that detected change over time and inter-group 
differences are very small, therefore, very unreliable. Another unusual contradictory 
result yielded by this scale is that the estimated treatment effect yielded by the analysis 
for top adherers, which is conducted on more valid measures, is less than, as opposed to· 
greater than, that yielded in the whole group analysis. 
The problem of missing items arises quite often in the Multi-dimensional Pain 
Inventory [138), particularly in the General Activity scale, as several scales are not 
applicable to all patients. Many of the items could be regarded as gender specific (see 
Appendix 3). Due to a collation error ten percent of participants missed as many as ten 
items from the General Activity scale at the pre treatment measure. A further ten 
percent missed one or two items, for reasons unlmown. The authors do not describe a 
strategy for dealing with missed responses [73) although there is a reference to a 
strategy of inserting the scale mean for missing items [138). In the PRIMS trial that 
strategy was not used, because if a proportion of the sample omit at least ten items a 
strategy based on the mean of the remaining eight items may not be useful. Participants 
with more than three items missed were eliminated from the analysis. 
Whole group analysis of the Multi-dimensional Pain Inventory Interference 
Scale 
The MPI Pain Interference scale score is the average of nine seven point box scales. The 
pre-treatment levels for each group are similar, 3.66 and 3.68. Reductions over time of 
around one quarter of a point, are significant E(l, 73) = 6.51 ( p = .01), but they have no 
clinical value, as they equate to about four percent. The estimated treatment effect, TJ 2= 
.082, is small (see Table 30). There are no significant inter-group, E(l,72 = .004, ( p = 
.95) or gender E(l,70) = .004, ( p = .95) differences. The mean of the difference (-.002) 
and the direction of the confidence interval ci95 ( -.38, .36) indicate that the results are 
equally likely to occur if either the null or the alternative hypothesis is correct (see 
Figure 12). 
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Analysis for Top Adherers of tb·e Multi-dimensional Pain Inventory 
Interference Scale 
Strength and endurance-trained top adherers' pre-treatment measures of 3.25 and 3.69 
are not significantly different, nor are they significantly different from the othe~_ 
participants. Reduction in disability over time is significant E(l,26) = 10.95, ( p = 
.003), and twice the magnitude of that yielded in the whole group analysis (see Table 
30). But, the reduction amounts to less than half a point (approximately eight percent) 
and still has no clinical value. The estimated treatment effect, 112=.289, is medium, and 
comparatively larger than in the whole group analysis. There is no significant time by 
group interaction, E(I ,27) = .005 ( p = .95). The mean of the difference (-.002) and the 
direction of the confidence interval ci95 ( -.64, .57) indicate, as in the whole group 
analysis, an equal possibility of these results occurring if either the null or the 
alternative hypothesis is correct (see Figure 12). 
Whole group analysis of SF-36 Physical-Functioning scale 
The Physical-Functioning scale of the SF-36 measures the extent to which health limits 
physical activities. It consists of ten, three category, adjectival scales. The pre-treatmenr. 
levels of 48 and 43 are not significantly different (12 = .29). Reductions in disability of 8 
points for strength-training and 1 point for endurance-training are significant over time, 
E(l,84) = 7.0l(g =.01), (see Table 30). But, only the strength-trained participants 
experienced a clinically meaningful reduction (see Table 29) [115]. The treatment 
effect, 112 = .077, for change over time is small. The time by group interaction is also 
significant E(l,84) = 4.19, (12 = .04). But, it yields a small estimated treatment effect of 
TJ = .048. The mean of the difference (7) and the direction of the confidence interval 
ci9s(l, 13) indicate that the results are only likely to occur if the alternative hypothesis is 
correct (see Figure 12).32 
32 There is less than a one in twenty chance that the null hypothesis is correct. 
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Table 30 Disability Results from the Analyses of Whole Groups and Top Adherers 
~ Gro- No Pre-Treat Post Treat x % 112 x F and p values for Change 112 Time F, p values for time*group up over change over over Time *group interaction time time 
WGNDI ST 43 43(14) 40(18) 3 7% .127 F(l,86) = 12.52, ( p = .001) .003 F(l ,86) = .279, ( p = .58) 
ET 45 42(13) 38(16) 4 10% 
e~~~~ ::~] ~s;r.:··-"r r-f6;,: ~3~fol~lt · ; : rs~{'.l'.Q.)~ . _ ~, . ~ ~ "".~3~ ~~-:- ~ -3~7 ~ 11F(tr 30J ~ ;~4'.~8~ (t~ '<;OOW I r U23 . .,_I F(1l;30) - .701, (rp - :4'1). i 
" 3'.i(i!~6) c - c _ 1 I 8L ..... , ·J '.9.:% " 
..... ·' """ -- "}~~:.J , ~- .. -~- ·~: -, .~ I JE;fr:;"__j ',J!J)~' 'fi'l~1l 2<Ji ~ - ~-; 
' 
_.:._ • ~ '. - M 
'- -
WGMPI ST 25 3.54 (1.08) 3.8 (1) -.26 n/a .019 F(l,47) = .907, ( p = .35) .055 F(l,47) = 2.73,( p =.06) 
General ET 24 3.2 (.98) 3.13(.79) .07 n/a 
Activity 
"''.FA'MPlG ·'.t qs.LT'i.- ·:i f9.· '"l ~3.-Sp~f.go'T.7 [3':66J(KH~. _ i 1,.,-:'.»1_Q.!1. ] l.W~~~~:_: 1 .01r2 r1 ~ 1J?;~l .1!;9F~·_;i~q;7( ~ ·~ ~6~J ,fOitOJ~ ~F:(l,19) ? 'l.4i, (p = ~25) ~~~lilif -'.~:~:! ~EiF" ... .. 1"112rj 1~~4-!8),~~ ~ i ~A3~t§gi)_1 .-', ~:~ ~.! c;nJa ~ ·~ • - I I . :-· 41:, I -~·, . . ,_. I • I ~ :~:·!~. :_t f: . ..,, : i-· " f'~~ ~ ' .~ctiVfty.,k _/ · '. . £~.-1~ ·~-' _· -· _'_. .. [ - ---' ~' _· - ~--·'-:I ~--~ 'L I L_ -~ f' ~t;._·· -- --'---- -
- - -- - -
WGMPI ST 37 3.66(1.23) 3.44(1.33) .22 n/a .082 F(l,73) = 6.51, ( p = .01) .000 F(l ,72) = .004, ( p = .951) 
Pain Interf. ET 38 3.68(1.22) 3.44(1.37) .24 n/a 
Scale 
l~~~~~:l K.SJ'l\~~ f\13~ J3\~~~ )~_ 72/Z:lc~l ~'l1)'r' ~: f.48_i~_J :,n[~__c__, \ :~~9 ~I~ 1·'F:W2'Zr ··· ~1>~·9~ ·(W- ,-003)1 ~.QUQ _ I J?Jil;z'l), = .Q05,,J•p:-~;i9~1!fl ~: ... ~(1.~:.. ~,.~ ;:!. '~"loo' .. ::..:~-} ~= 4~ -~ ~mliit~~ · ~Sf'r ~ ~r$;·~ ·~~9~~;:-~~l~~ : ".'3',2/3Ql::'59j, .. r ;~l)~ ~ lvt'a . ,: I ~ - . - . ' ·~'r"- + --. ~ !"· ~ • ·~ ,, 
... -- +,. i .. ~· l :M- .:jf, ' .... b ' I l C!l'l~ ;'_,,~,,\ ~ ; 11. ,.) E. ·~ r~· •· ,,. r4 + 111 _· _. _; 1_ ·~ - - - - I . <Ii!. .... , • - ~ 4. 
-
WG SF-36 ST 43 48 (25) 40 (23) 8 17% .077 F(l,84) = 7.01 , ( p = .01) .048 F{l,84) =4. 19, ( p = .04) 
Physical ET 43 43 ( 20) 42 (21) I 2% 
Function 
rmA.,;sF~'~ :1s¥ , ·~ '· fP ~ ~!Ji ~~2l{k --,, . - r 3~~~23), ~ ; 1·76' 1 ~ 3:S%i ,,,_ l ·f9._5,1~ tf~!~1Jl,) ~·-~f-9~ •~Ir"" jQO~)~ ~ .J22!, - ' I F(J ,3lh 4:31, (P'"" i0'5), ~ij}i'~~~  ~-~ ~ ~ i lfJ1 ~ ·:~~:~2~J)f~ .~ -~ '~2' (25)" .,,,.. ·~ ';ilj ;~~~ ---~' J I - "·, . . "' . ._, . . .. , I , • •:rJ" · - ' • • l··~ . ::,;_ .. ~- '" .~ .~ ~ .. ~ - 'll . :F~'<ti°Qri, :': . ·---~~~--~-~·~j ~- _.;« ~ I' •'· ~"~"""""""' . ~~l1 ·:.~ ~ -:...~· • . ~'&J.O<..:&" ~"' r . ;.~ - , I l - L_,. ~ ~ ··~- ........ -.. • 71 . -
WG SF-36- ST 43 87 (25) 79 (35) 8 9% .032 F{l,83) = 2.71, ( p = .10) .003 F{l,83) = .305, ( p = .59) 
Role Physic ET 43 90 (19) 86 (30) 4 4% 
f w~ss;i~.t. rj J~\Ir, -~ :2.JI6J] .::s3:'.(2:l~ - ~---~ ~.6g;('4J 1!._ ... ._:: !1_81~_, ~M~- - ~·rmw ' ~ P£!i3-1)-=~:Q8~ 1( ,p '-'°-,09) [ .D~4 ',. lF('11;31) = l.Cp ," (;p, = :30) ., l'~.9~~y~ ~E[~ i:-'f71.' . 18_;$-'~6-0)j ~ - i ~4~f3lt)_i - : •4-"- '3 ""._5%1~·~- " r -~~ II > ' • ' ~ P-----..% - - - - - _......_ ~-
-
~ 
WG = Whole Groups TA= Top Adherers 
99 
Analysis for Top Adherers of SF-3 6 Physical-Functioning scale 
Strength and endurance-trained top adherer' pre-treatment levels of 49 and 46 are not 
significantly different from each other, nor are they significantly different from the 
other participants. Reductions in disability of 17 points for strength-training and 4. 
points for endurance-training are significant over time E(l,31) = 12.98, (J2 = .001), and 
yield a large, estimated treatment effect, 112 = .295, which is greater than that yielded by 
the whole group analysis (see Table 30). However, the change experienced by the 
strength-trained participants is of moderate to good clinical value, whereas the change 
experienced by endurance-trained participants is too small to hold any clinical value 
(see Table 29). The time by group interaction, E(l,31) = 4.31, ( 12 = .05), is also 
significant, and as the inter-group difference exceeds twenty percent it is regarded as 
clinically meaningful [114]. On a 5 category scale disability for the strength-trained 
participants has decreased by two levels, which represents medium level clinical value, 
whereas it has not changed for endurance-trained participants [115] (see Table 29). The 
estimated treatment effect for time by group interaction, 112 = .122, is medium, and is 
larger than for the whole group analysis. Once again, the mean of the difference (13) 
and the confidence interval ci9s( .22, 25.86) indicate that even with a considerably 
smaller sample, the results are still only likely to occur if the alternative hypothesis is· 
correct (see Figure 12). 
Whole group analysis of the SF-3 6 Role-Physical scale 
The Role-Functioning scale of the SF-36 consists of four yes/no response items. 
Consequently it has pronounced floor and ceiling affects. It purports to measure the 
extent to which health interferes with work or daily activities. Group levels of 87 and 90 
for strength-training and endurance-training are very high compared with the SF-36 
population norm of 50 for people with back pain [68]. Reductions of 8 and 4 points are 
marginally statistically significant, E(l,83) = 2.71, (J2 = .10) (see Table 30) but, have no 
clinical value [115] (see Table 29). The estimated treatment effect, 112 = .032, is small. 
There is no significant time by group interaction E(l,83) = .28, ( g = .59), and the 
estimated treatment effect, 112 =. 003, is tiny. However, the mean of the difference (4) 
and the direction of the confidence interval, ci95 (-11, 19), indicate that the results are· 
more likely to occur if the alternative hypothesis is correct (see Figure 12). 
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Analysis for Top Adherers of the SF-3 6 Role Physical 
Strength and endurance-trained top adherers' pre-treatment levels of 84 and 88 are not 
significantly different from each other, nor are they significantly different from the 
other participants. Reductions over time of 18 points for strength-training and 4 for 
endurance-training are marginally significant over time, E(l,31) = 3.08, (I!= .09), (see 
Table 30), but have no clinical value (115] (see Table 29). The medium estimated 
treatment effect, TJ2 = .094, is larger than that yielded in the whole group analysis. The 
time by group interaction is not significant E(l ,31) = 1.07, (p_ = .30). But, the mean of 
the difference (14) and direction of the confidence interval ci95 (- 13, 41) demonstrates 
that even with a considerably smaller sample, but more valid measures, the likelihood 
that the alternative hypothesis is correct increases (see Figure 12). 
Discussion 
The disability results have raised some interesting issues regarding the lack of a 
relationship between clinical value and statistical significance in the Multi-dimensional 
Pain Inventory and Neck Disability Index. As power and sample size calculations for 
clinical trials are based on finding minimum clinical value, at a predetermined level of 
statistical significance possibly there should be a relationship between these two 
concepts (see chapter nine for further discussion). Further, there is some uncertainty~· 
the literature regarding the internal consistency of the MPI scales (139, 140]. 
The psychometric properties of the SF-36 Health Survey, however, are well established. 
In both the analysis whole groups and for top adherers, the Physical-Functioning scale 
showed that strength-training elicits a significant and clinically meaningful greater 
reduction in disability. In support of this finding the Role Function scale also favours 




RESULTS OF PHYSICAL MEASURES AND PATIENTS' PERCEPTIONS OF THE 
THERAPIST'S ATTITUDE 
Overview 
The purpose of this chapter is to present the results of the analysis of the test-retest 
reliability data for the MedX Neck Rotator. It also presents the results for the muscular 
strength and endurance, and range of movement measures. As all isometric strength 
measures are highly correlated the analysis is conducted on the average of all six 
measures. As the Med.X measurement unit is inch pounds these are converted to newton 
meters (run) to be able to compare with other studies. The results of the analysis of 
patients' perceptions of the therapist's enthusiasm and commitment to the treatment are 
also discussed. 
The normality plots indicated the presence of one outlier whose measure of isometric 
strength at the second measures was separated from those of the other participants by 
close to one standard deviation. This was a male patient who was observed to react very 
positively to the presence of a female observer at the second measure. That was the only 
occasion when a female observer was present. This case is excluded from the test-retest 
reliability study, and analyses for both Whole Groups and Top Adherers. 
Test-Retest Reliability 
As described in the methods chapter in the reliability test for the physical measures 
there was a test-retest interval of at least 3-4 days. Paired t-tests were used to measure 
the test-retest reliability for the isometric strength and range of movement measures of 
the Med.X Neck Rotator. The results indicate that with the exception of the left 
extended position the scores for machine measures of isometric strength are very 
similar, with IL values ranging from .34 to .85 (see Table 31 ). The slightly higher results 
for the isometric strength measures in the second test indicate a small learning affect. 
This is to be expected and has been reported in other studies[33]. Machine measures of 
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range of movement are stable over time and there is no apparent learning effect. The 
static endurance measure of neck flexion (described in Methods Chapter) is also 
reliable, E.(69) = .696, ( p = .49), and has minimal floor and ceiling effects. Only four 
out of eighty 33 participants were unable to attempt the position hold at the pre-treatment 
measure, while another four could hold the position for the maximum time of 120 
seconds. 
It is very difficult to measure isometric or dynamic muscular endurance on the Med~. 
Neck Rotator because 20lb is the lightest weight that can be set. Isometric endurance in 
the sagittal plane has been assessed at 30° extension with a load of 60% of the 
participant's peak isometric torque [51) . But, the cervical spine is considerably stronger 
in the sagittal, by comparison to the rotational plane (see Figure 13). The biomechanical 
explanation for this is that movement in the rotational plane is gravity neutral where 
movement in the sagittal plane, particularly in extension is substantially influenced by 
gravity, therefore the musculature is stronger. As the isometric strength of at least half 
the sample ranged from five to twenty-three inch pounds it was not possible to load a 
percentage of the participant's strength value for an isometric endurance measure. 
During the pilot period we experimented with a timed isometric endurance measure 
with the lightest weight of 20lb at +24°, but as the patients expressed discomfort we 
decided against an isometric endurance measure in the rotational plane. 
In other anatomical regions of the body muscular endurance is measured by ascertaining· 
how many repetitions can be performed at 80-90% of lRM. We also experimented with 
an isotonic measure where patients were required to push 20lb to +24 ° and hold the 
position, but several patients could not do this in the pilot study. For this reason it was 
impossible to establish lRM values. The final compromise was the dichotomous 
dynamic measure as described in the methods chapter. In terms of sensitivity it was 
partially effective, but there was a pronounced ceiling effect. Twenty-seven percent of 
participants were able to perform the maximum output of thirty repetitions at the pre-
treatment measure and forty-eight percent at the post-treatment measure. We decided 
against increasing the maximum output level above thirty repetitions because, 
particularly when no weight was set, some patients indicated that they were bored with 
the measure if it continued too long. 
33 Numbers are lower for both the static and dynamic endurance measures as they were phased in after the trial had 
conunenced 
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Table 31 Test-Retest Reliability Results For MedX Muscle Strength And Range Of 
Movement, And The Static And Dynamic Muscular Endurance Measures 
Variable No 151 test 2°0 test 2nd_ P value 
1 SI 
test 
Left 97 ·23.93(16.15) 24.30(17.39) -.37 t(96)=-.373, (12 = .71) 
contracted Cl.95 r-2.34,.1.601 
Left neutral 97 26.56(19.40) 27.61(19.97) -1.05 t(96) = -.923, ( p = .36) 
Cl.95 (-3.31, 1.221 
Left Extended 97 26.52(18.87) 28.43(19.60) -1.92 t(96) = -1.720, (n = .09) 
Cl.95 [-4.13, .30) 
Right 97 26.25(17.42) 27.20(17. 11 ) -.95 t(96) = -.959, ( p = .34) 
Contracted Cl.95 [-.2.91, 1.011 
Right Zero 97 30.52(19.8 1) 30.80(19.8 1) -.29 t(96) = -.244, ( p = .81) 
Cl.95 [- 2.64, 2.06] 
Right 97 29.30(18.36) 34.40(3 1.56) -.22 t(96) = -.185, ( p = .85) 
Extended Cl.95 (-2.54, 2.11] 
Static 70 33.19(30.98) 31.74(30.50) -1.44 t(69) = .696, ( p = .49) 
Endurance Cl.95 [-2.69, 5.58] 
(seconds) 
Dynamic 59 16(10) 16(10) 4 t(58) = -.785, ( p = .44) 
Endurance Cl.95 [-I .56, .68] 
(rotations) 
Left ROM 96 52(14) 52(15) - .44 t(95) = .497, ( p = .62) 
Cl.95 [-1.31, 2.19) 
Right ROM 96 51(15) 52(15) .3 1 t(95) = -.296, ( p = .77) 
Cl.95 [-2.4J, 1.78] 
x Unit of measurement for reliability testing is inch-pounds 
Evaluating Different Levels of Clinical Value for Changes in Physical 
Measures 
There is no literature indicating what constitutes a clinically meaningful increase in· 
isometric strength of the cervical musculature in the rotational plane. Further, there are 
several problems associated with determining its clinical value. Apart from the data on 
the Med.X graphical output there is only one source of population norms. This source 
indicates that there is a very wide range of isometric strength in the normal population, 
of 2.8- 24.4 run [33). Another problem is that population norms are gender, but not age 
stratified, and there is no other demographic information for the sample. From the 
unreferenced population norms on the Med.X graphical output it is possible to calculate 
a weighted average (9.95 nm) for a sample with the same gender proportions as the 
PRIMS sample. An average of the pre-treatment measure of the PRIMS sample 
indicate that they are approximately 65% weaker than the population norm. One 
approach would be to base levels of clinical value on how closely the post-treatment 
measure of isometric strength approach the population norm. However, as the Med.X 
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population norms cannot be accepted at face value34 this approach may not be useful. 
Another reason for not using this approach is that the range in cervical muscular 
strength for a healthy population is very wide [33]. 
Another method of evaluating clinical meaningfulness is to investigate for a threshold 
level of strength gain, which is related to a meaningful reduction in pain intensity. An 
uncontrolled study reports strength increases of thirty-five percent resulting in 
significant pain reductions. In the PRIMS sample .85 nm, which is approximately 
twenty percent increase on baseline, is related to a statistically significant reduction in 
pain. Therefore for the purposes of the PRIMS trial zero to twenty percent increase ill 
isometric strength is of no, to limited, clinical value (see Table 32). Twenty to thirty-
nine percent is minimum to moderate clinical value, forty- fifty-nine percent is 
moderate to good, and over sixty percent very good clinical value. By comparison to 
studies in the sagittal plane, where strength gains range from zero to twenty-two percent 
[ 10, 51, 141] the size of the increase in isometric strength required to warrant clinical 
value in the PRIMS trial may seem high. But, the following points are taken into 
account: -
• The PRIMS population are considerably weaker than the general population. 
• A problem associated with measuring change over time in isometric strength, is 
that is that the influence of change over time in levels of pain or fear inhibited 
effort can confound the results. As PRIMS is a randomised controlled trial these 
effects will be balanced in the groups, but they can never be eliminated from the 
sample. Therefore, true percentage gains for both groups in the PRIMS trial arc::. 
presumed to be less than reported. 
• Strength gains are specific to the training equipment used. 
• It is possible that there is a disproportionate neurological and physiological 
adaptation as very little resistance is encountered in the rotational plane during 
every day activities. To some extent muscle hypertrophy may occur. 
• Percentage increases based on low values will always be greater than those 
based on higher values, which probably accounts for some of the difference 
between measures derived from the rotational and sagittal planes (see Figure 
13). 
}4 MedX has two different sets of populations nonns. The nonns that appear on the MedX graphical output are 
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There is no literature on what constitutes a clinically meaningful increase in either 
dynamic muscular endurance in the rotational plane or static endurance in flexion, as 
they were both developed for the PRIMS trial. Using the same approach as was used for 
evaluating clinical value for strength gains, an increase of twelve seconds in static 
endurance is the threshold where a ten percent reduction in pain intensity occurs, and a 
fifteen percent reduction in pain occurs at twenty-two seconds after which there is no 
apparent relationship. Therefore, for the purposes of the PRIMS trial less than twelve 
seconds increase in static endurance seconds is of none to limited clinical value, twelve 
to twenty-one seconds is of minimum to moderate clinical value and above twenty-two 
is of moderate to good clinical value (see Table 32). 
There is no consistent relationship between increases for dynamjc muscular endurance 
and reductions in pain in the PRIMS data. More research is required to develop and test 
measures of dynamic endurance in the rotational plane, before attached clinical value 
can be meaningfully discussed. Therefore, no clinical value is reported for this measure 
in the PRIMS trial. There was also no consistent relationship between increases in range 
of movement and pain reductions. The only recorded increase for range of movement in 
the rotation plane for a clinical population was approximately nine degrees, which was 
associated with a very small statistically non-significant reduction in pain. In the 
PRIMS trial, therefore, levels of clinical value attached to increases in range of 
movement are broad. The purported values are zero to nine degrees increase equalling 
none to limited clinical value and above nine degrees minimum to moderate clinical 
value. 
quoted in the PRIMS trial. 
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Table 32 Levels Of Clinical Meaningfulness For Physical Measures 
~ None- Min to moderate Moderate to good Very limited Value Value good s value value 
Isometric Str <20% 20-39% 40-59% ~60% 
Static Endurance <12 sec 12-21 secs ~22 seconds 
ROM <9 ~9 
Whole Group Analysis of Isometric Strength 
Pre-treatment measures of 3.22(1.84) and 3.53(2.1) for strength and endurance-training 
respectively are not significantly different (Table 33). Both groups made statistically· 
significant, E(l,71) = 45.008, (12<.0001), gains in isometric strength. The sixty-three 
percent increase in isometric strength resulting from strength training has very good 
clinical value. The forty-six percent for endurance training, has moderate clinical value. 
The estimated treatment effect, TJ2 = .388, is very large. There is no significant inter-
group difference E.(1,71) =.919, (n = .34), and the estimated treatment effect for inter-
group differences is small, TJ2 = .013. However, the mean of the difference (.50) and the 
direction of the confidence interval, ci9s (-.62, 1.50), indicate that these results are more 
likely to occur if the alternative hypothesis is correct (see Figure 12). 
Analysis for Top Adherers of Isometric Strength 
Pre-treatment measures of 3.77 (1.94) and 3.17 (1.81) nm for strength and endurance-
trained top adherers are not significantly different (n = .19), but they are marginally, 
significantly different from the other participants (n = .10). Both groups of top adherers 
made statistically significant, E.(1,29) = 26.62, ( p< .0001 ), gains in strength of eighty-
four percent for strength-training and forty-two percent for endurance-training. The 
clinical value of the strength group's increase was very good whereas that of the 
endurance group was moderate. The time by group interaction is significant .E(l ,29) = 
4.53, (n = .04) with a medium estimated treatment effect, T]2 .135, which is larger than 
that yielded in the whole group analysis. The estimated treatment effect for change over 
time, TJ2 = .479, is also larger than that yielded in the whole group analysis. The mean of 
the difference (1.85) and the direction of the confidence interval (.00, 3.63,) also 
indicate that these results are more likely to occur if the alternative hypothesis is correct 
(12 = .04)(see Figure 12). 
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Chi-Square Analysis of Dynamic Endurance: Whole Group Analysis 
As there is a pronounced ceiling effect associated with the dynamic endurance measure 
two different statistical methods are used. Chi- Square is used to compare the proportion 
of participants in each group who managed to perform thirty repetitions at either the pre 
or post-treatment measures. 
Thirty-three percent (n = 8) of the 24 participants in the strength-training group and 
eighteen percent ( 4) out of the 22 participants in the endurance-training group could 
perform thirty repetitions at the pre-treatment measure. At the post-treatment measure 
sixty-three percent (n = 15) in the strength-training group and fifty percent (n = 11) in 
the endurance-training group could perform thirty repetitions. The twenty-six percent· 
change in proportion for the strength-training group is significant x2 (1) = .7.20, 
(McNemar's test, n = .016). Likewise, the thirty-two percent proportional change for the 
endurance-training group is also significant -x.2 (1) = 4.88, (McNemar's test, p = .016) 
(see Table 33), However, there is no significant inter-group difference for post-
treatment group proportions x.,2 (1) = .689, (12 = .41). 
108 
Table 33 Physical Measures From The Analyses Of Whole Groups And Only Top Adherers 
~ Gro- No Pre-Treat Post-Treat Xover % 112X Change over time 112 Time*group interaction up time change over T*G time 
WG Isometric ST 34 3.22(1.84) 5.24(3.4) 2.02 63% .388 F(l,71) = 45 .00, ( .013 F(l,71) = .91 , ( p = .34) 
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ANOV A Analysis for Dynamic Muscular Endurance 
ANOV A is used to evaluate change over time for the twenty participants who could not 
perform thirty repetitions at either the pre or post-treatment measures. The strength-trained 
participants increased their dynamic muscular endurance from ten rotations at the pre-
treatment measure to fifteen at the post-treatment measure (see Table 33). Endurance-
trained participants increased the number of rotations from ten at the pre-treatment measure 
to twenty at the post-treatment measure. The increases are significant over time for both 
groups E(l,18), =31.13, ( p< .0001), and the inter-group difference is close to being 
marginally significant E(l, 18) = 2.32,( p = .15). The mean of the difference (-4) an~ the 
direction of the confidence interval ci9s [-10, 1] indicate that these results are much more 
likely to occur if the alternative hypothesis is correct (see Figure 12). However, these 
results should possibly be interpreted with caution though as group sizes are very small . 
Chi-Square Analysis of Dynamic Endurance: top Adherers 
Pre-treatment group proportions of participants who could perform thirty repetitions at the 
pre-treatment measure of fifty four (n = 6) and seventeen percent (n = 2) for strength and 
endurance-training are marginally if not significantly different x 2 (1) = 3. ( p = .08). But, 
they are not significantly different from the other participants x2 (1) = 1.37, ( p = .24). At 
the post-treatment measure the proportion of strength-trained top adherers who could 
perform thirty repetitions had increased to eighty-three percent, ( no = 10) whereas the 
proportion of endurance-trained top adherers had increased to fifty-eight percent (n. := 7) 
(see Table 33). These changes of twenty-one percent for strength-training and forty-one 
percent for endurance-training are marginally significant over time x2 (1) = 2.93 
(McNemar's test, Il = .08) for strength-training, but not for endurance-training X2 (1) = 1.71 , 
(McNemar's test, n = .47). There is no inter-group difference at the post-treatment measure 
x2 (1) = .006, ( p = .94). However, group sizes are very small for this measure also, 
therefore, results should be interpreted with caution. There were only six top adherers who 
could not perform thirty repetitions at either the pre or post measure, two from the strength-
trai.ning group and four from the endurance-training group. These participants are included 
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in the ANOVA whole group analysis, and tbis sub group is too small to warrant further 
analysis. 
Whole Group analysis of the Static Muscular Endurance Measure in the 
Sagittal Plane 
Group pre-treatment measures of 31(26) and 35(34) seconds for static endurance are similar 
( see Table 33). Increases in static endurance of fifty-eight percent for strength-training and 
twenty-nine percent for endurance-training are statistically significant over time, E(l ,56) = 
23.792, ( p< .0001), and yield a large estimated treatment effect, ri2 = .298. As can be seen 
from Table 32 the increase of 18 seconds for the strength-training group is of moderate 
clinical value, whereas the I 0 seconds increase for endurance-trained participants ·fs of 
limited value. There is no significant inter-group difference E( 1,56) = 2.156, (P- = .15), but 
the mean of the difference (8) and the direction of the confidence interval, ci9s [-2.96, 
19.24], indicate that these results are more likely to occur if the alternative hypothesis is 
correct( see Figure 12). 
Analysis for Top Adherers of Static Muscular Endurance Measure in the 
Sagittal Plane 
Pre-treatment measures of 40(31) and 31 (32) seconds for the strength and endurance-
trained top adherers are not significantly different ( p = .32) (see Table 33). Nor are they 
significantly different from the other participants (P- = .12). Increases of fifty-five and 
thirty-two percent, for strength and endurance-training respectively, are similar to those 
experienced by the other participants, and also are statistically significant over tline, 
E(l,27) = 14.48, (11< .001). The clinical value of the 22 second increase for strength-
training is moderate to good whereas the 10 second increase for the endurance-trained 
group is of limited clinical value. The estimated treatment effect ri2 = .356, is very large, 
and larger than that yielded in the whole group analysis. There is no significant inter-group 
difference, E.(1,25) = 2.46, ( p = .13), but once again the mean of the difference (12) and 
the direction of the confidence interval ci95 [-4.87, 31.14], indicate that these results are 
more likely to occur if the alternative hypothesis is correct( see Figure 12 ).The estimated 
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treatment effect for time by group interactio~, ri2 = .084, whilst classified as small, i~ still 
larger that yielded in the whole group analysis. 
The results of both the whole group, and top adherers, analyses contradict the alternative 
hypothesis because maintenance of posture is regarded as a function of muscle endurance. 
Therefore endurance-trained participants are expected to improve more than strength-
trained participants. It could indicate that the null hypothesis is correct. Alternatively, it 
could indicate that maintenance of posture to the point of volitional fatigue causes fast 
twitch fibres to become progressively involved in the activity [16], therefore, to a certain 
extent muscle strength will also be measured. 
Whole Group analysis of Range of movement 
Pre-treatment measures of 53°(14) and 54° (14) range of movement are similar. They 
indicate that the PRIMS participants have greater range of movement than those in the 
study by Priest et al. [ 49]. The increase in range of movement for both groups of 
approximately ten degrees is significant over time E(l,72) = 70.42, ( p< .0001), and of 
clinical value. The estimated treatment effect 112 = .494 is very large (see Table 33). There 
is no significant inter-group difference E.(1,72) = .238, ( p = .63), but the mean of the 
difference (1) and the direction of the confidence interval ci95 (-4, 6] indicates that these 
results are slightly more likely to occur if the alternative hypothesis is correct (see Figure 
12). 
Analysis for Top Adherers of Range of movement 
Strength and endurance-trained top adherers' pre-treatment measures of 57°(13) and 
54°(14) range of movement are not significantly different ( p = .81), nor are they 
significantly different from the other participants ( see Table 33). Increases of 11° for 
strength-training and 8° for endurance training are significant over time E.(1,30) = 27.01, 
(p_<.0001), but only of clinical value for the strength training group. The estimated 
treatment effect 112 = .474 is very large. There is no significant inter-group difference 
E.(1,30) = .92, ( p = .35), 112 = .030, but once again the difference of the mean (3) and the 
direction of the confidence interval, ci9 (-4, 1 O], suggest that the these results are more 
likely to occur if the alternative hypothesis correct (see Figure 12). 
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Discussion 
The test-retest reliability study for the physical measures has shown the MedX measures of 
isometric strength and range of movement to be reliable. The results of the MedX strength 
measures indicate that for patients who are able to adhere to an intensive exercise program, 
strength-training, by comparison to endurance-training, elicits statistically significant and 
clinically meaningful greater gains in muscle strength. The amount of the variance 
explained by the treatment effect is consistently larger in the analysis for top adherers for 
all physical measures. The difference of the means and direction of the confidence interval 
indicate that with a considerably smaller sample, but more valid measures the strength-
trained participants are more likely to make considerably greater strength gains ( p<.04). 
The parametric analysis of dynamic endurance, in the small subset of participants who 
could not perform thirty repetitions at either the pre or post-treatment measure, tends to 
favour endurance-training, at close to marginal significance. The trend of the ·non-
parametric analysis also favours endurance-training. These results further support the 
alternative hypothesis as endurance-trained participants are expected to increase their 
muscular endurance more so than the strength-trained participants. 
However, a problem associated with the dynamic endurance measure is one of training 
specificity, i.e. in terms of muscle function, the dynamic endurance measure is similar to 
the endurance-training protocol, but dissimilar to the strength-training protocol. Therefore, 
the greater gains of the endurance-training group for this measure may be partly due to the 
confounding effect of training specificity. Possibly, the trend displayed by this measure 
should not be accepted at face value. The question is:- how does one measure the results of 
strength-training and endurance-training separately without the confounding effect of 
training specificity? The fatigue response test (see 
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Appendix 19), developed by MedX, may address this problem. The advantage of the 
fatigue response test is that it is the difference between two isometric measures. As· both 
training protocols in the PRIMS trial are dynamic the element of training specificity in the 
measures would be balanced. However, the fatigue response test still has only limited use 
for measuring muscle function in patients, because 20lb is the lowest weight that can be set 
on the MedX. There is no published reliability data available for this test, and it has never 
been used in neck pain research before. 
The fact that the top adherers had marginally, significantly greater isometric strength than 
the other participants at baseline should not be interpreted as the introduction of bias. It can 
be regarded as a valuable aid in identifying those patients who are able to adhere to an 
intensive exercise program. It is impossible to ascertain whether the difference represents a 
true difference in muscular strength, or whether it is measuring different levels of pain or 
fear inhibited effort at the baseline. Kinesophobia has not been measured in a randomised 
controlled trial evaluating exercise for neck pain before. However, a possible limitation of 
the PRIMS trial was that such a measure was not included in the assessment. Inclusion of 
the fear of movement questionnaire [142] may have provided another indicator of top 
adherers. It also may have facilitated the development a strategy for recalibrating reported 
strength measures in accordance with the results of the fear of movement data. 
Patients' Perceptions of the therapist's Attitude and Enthusiasm 
To ascertain whether the blinding of patients was effective patients were contacted two 
months post-treatment and asked specific questions regarding their perception of the 
therapist's commitment to the prescribed exercise protocol (see Appendix 10). All patients 
rated the therapist's attitude and enthusiasm as either 'very supportive and enthusiastic' or 
'supportive and enthusiastic'. There was no significant inter-group difference x2 (1) =·.271, 
( p = .60). Therefore, the data indicate that patients who were allocated to endurance-
training were not aware that the therapist was administering the less preferred treatment. 
Consequently the double-blind status of the PRIMS trial is supported by the data. The 





In this chapter limitations of the study are discussed. The psychometric performance of the 
scales is discussed in relation to the different validation processes they were initially 
subjected to. The possible influence of the validation process on researchers' choices of 
measurement scales is also discussed. The results of the PRIMS trial are then discussed in 
relation to the hypotheses raised in Chapter One, and the relationship between the 
hypotheses explored. 
Study Limitations 
The one limitation of the study is that there was no long term follow up measuring the 
primary outcomes of pain and disability. This would have been desirable, but it was not 
possible to conduct such a follow up within the allowable time frame. The majority of 
trials in the field of therapeutic exercise for chronic neck pain reported in the literature have 
not incorporated a long term follow up on pain or disability into their research design [27, 
57, 101 , 143, 144]. A long term follow up on measures of muscle function would be of 
limited value because, as the principle of reversibility indicates, when training ceases the 
ability to perform exercise at the same intensity deteriorates slowly over time [145]. 
Psychometric Performance of the Visual Analogue Scales and the Multi-Item 
Interval Scales 
As both multi-item and visual analogue scales were used to measure sensory35 and affective 
pain in the PRIMS trial the opportunity exists to compare the psychometric performance of 
these, very different, scales. The multi-item scales used in the PRIMS trial have been 
validated by the traditional methods of face and content validation [73, 100, 136, 140, 146, 
147]. As discussed in chapter three multi-item interval scales are necessarily comprised of 
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many items addressing the same construct. As can be seen from Table 34, however, the 
number of items per scale for the validated questionnaires used in the PRIMS trial was 
sometimes quite low. Also the number of categories per item was sometimes as low as .two. 
35 Pain Intensity and sensory pain are used interchangeably in this discussion 
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Table 34 Number of Items and categories per Item for the Multi-Item Scales 
used in the SF-36 
Scale Items Categories 
MPI Pain Severity 3 7 
MPI Pain Interference 9 7 
MPI Affective Distress 3 7 
MPI General Activity 18 7 
SF-36 Bodily Pain 2 6+5=1 l 
SF-36 Mental Health 5 6 
SF-36 Role-Emotional 3 2 
SF-36 Physical-Functioning 10 2 
SF-36 Role Physical 4 2 
Beck Depression Inventory 13 4 
Most Useful Measures in the PRIMS Trial 
The Visual Analogue Scales 
The pain intensity and negative emotion visual analogue scales were useful measures in the 
PRIMS trial. In terms of respondent burden the visual analogue scale was the most efficient 
instrument as respondents did not have difficulty understanding the concept, and it was far 
quicker to complete than the lengthier multi-item scales. Researcher burden was also 
minimised with the visual analogue scale because although the data needed to be measured 
with a ruler before entered as data, it was still only one data point compared to the many 
data points for the multi-item scales (see Table 34). The visual analogue scales attributed 
statistical significance only to clinically meaningful changes in sensory or affective pain. 
This was to be expected in the PRIMS trial as power and sample size calculations were 
based on the visual analogue scale for pain intensity 
The shape of the distributions indicated that the frustration negative emotion scale appears 
to be less effected by social desirability bias and other psychosocial confounds, than those 
for anger, fear or anxiety. This is consistent with the results of the negative emotion visual 
analogue scales in other chronic pain populations [71]. While it is not within the scope of 
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this thesis to analyse the dimensions of pain in detail, these results support an existing 
hypothesis in the literature. Possibly frustration is magnified in chronic pain populations 
because to some extent it is a precursor for anger [ 148]. 
The visual analogue scale for depression discriminated in terms of percentage reductions, 
which could be linked to levels of clinical value. This is an important characteristic of a 
scale. The fact that the visual analogue scales did not detect inter-group differences in the 
PRIMS trial is because, (1) in the whole group analysis there were none, and (2) in the 
analysis for top adherers the reduced sample size resulted in insufficient power to detect a 
difference, ifthere was one. To summarise, with the more valid measures of the analysis for 
top adherers the trend for all six of the visual analogue scales reversed to be consistent 
with significant findings (see Figure 12). This consistency across both sensory and affective 
pain is interpreted as a demonstration of the sound ratio scale properties of the visual 
analogue scale for pain intensity and the negative emotion visual analogue scales. It 
confirms the evidence of the experimental validation conducted by Price et al. [71] (see 
chapter three for details of experiment) 
The Multi-Item Interval Scales. 
A method of experimental validation for multi-item interval scales is yet to be developed. 
Therefore, the ability of these scales to measure change over time is evidenced anecdotally 
in the literature. Of the scales used in the PRIMS trial the SF-36 has been subjected to the 
most extensive empirical testing. Numerous studies have resulted in the recalibration and 
recoding of the items which form the standardised subscale scores in the SF-36. The 
performance of the individual scales of the SF-36 varied, and they are discussed 
individually below. The SF-36 Bodily-Pain scale showed itself to be a psychometrically 
sound method of measuring pain intensity in the PRIMS trial. The mean of difference and 
direction of the confidence interval followed the same inter-analysis trend as the six visual 
analogue scales, and the significant results of the whole group analysis. However, the 
scoring algorithm for the Bodily-Pain scale is necessarily complex and error prone. It is 
comprised of two items for which the coding values vary according to whether the 
respondent responded to each item, or only one or the other. 
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The dichotomous properties of the Role-Emotional scale were useful in the PRIMS trial, as 
they clarified the direction of the trend. But, dichotomous scales can only detect two levels 
of a construct, therefore their usefulness in determining levels of clinical value is limited. 
The mean of difference and confidence interval for the SF-36 Physical-Functioning _scale 
indicated a significant difference favouring the same group (strength-training), as did the 
other significant finding of the whole group analysis. This consistency between measures is 
interpreted as displaying robust psychometric properties. The mean of difference and 
confidence interval for the Role Function scale trended in the same direction as the 
Physical-Functioning scale. This is also interpreted as consistent psychometric 
performance, as the Role Function Scale requires a larger sample than the Physical-
Functioning scale to achieve the same level of statistical significance (68]. 
Less Useful Measures in the PRIMS Trial 
By contrast to the dichotomous SF-36 Role-Emotional scale where those reporting no 
symptoms earn perfect scores of 100, the bipolar properties of the SF-36 Mental-Health 
scale result in those reporting no symptoms of psychological distress earning a midrange 
score of 50 (68]. The Mental-Health scale was not sensitive to change over time i~ the 
PRIMS trial. This is unusual because, as the authors report, it usually requires a 
considerably smaller sample to detect change over time at <.05 with the Mental-Health 
scale. However, in the PRIMS trial the emotional health of the endurance group actually 
deteriorated over time (see Table 27). Possibly, for some reason the bipolar Mental-Health 
scale did not measure deterioration in symptoms as markedly as the dichotomous Role-
Emotional scale. As can be seen from Appendix 20 the distributions and ranges for each 
scale show the two groups more clearly separated on the Role-Emotional scale. 
The scales of the Multi-dimensional Pain Inventory were not particularly useful in the 
PRIMS trial. The Pain Severity, Affective Distress and Pain Interference sub scales, 
although consistent with the inter-analysis trend of the other measures, attributed statistical 
significance to changes over time that have no clinical value (see tables). Therefore, the 
results should be interpreted with caution. However, the Affective Distress sub seal~ did 
mirror the results of the SF-36 Role-Emotional scale. It attributed marginal significance to 
the inter-group difference that resulted from the deterioration over time for the endurance-
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trained group. The General Activity scale wa5 the only MPI scale not to attach significance 
to very small change over time. However, researchers have questioned the validity of all 
individual scales, and the combined General Activity scale, in section three of the MPI 
[138, 139]. 
When the MPI is used for discriminatory purposes its sensitivity to small abs·olute 
differences is useful.36 But, possibly an instrument which attributes statistical significance 
to clinically meaningless changes over time should not be used for that purpose, because its 
results will be open to misinterpretation. For example, in some studies that have used the 
Multi-dimensional Pain Inventory to measure change over time the emphasis is on 
statistical significance, but the lack of attached clinical value is not emphasised [118, 124). 
The Beck Depression Inventory also reflected the results of the Role-Emotional scale, in 
that depression for the endurance-trained group actually increased over time. A possible 
reason for its non-sensitivity, however, could be that even though each item is a four 
category adjectival scale, in the PRIMS trial they effectively operated as two category 
scales. Over ninety percent of all responses were for the two lower categories of depression. 
Therefore, the analysis was effectively restricted to measuring the difference between the 
two lower levels of a four level adjectival scale. The MPI Affective Distress scale wa·s not 
particularly useful as a measure of depression for the reasons already discussed, although it 
did mirror the consistent inter-analyses trend. 
The Neck Disability Index attributed statistical significance to changes over time which 
have no clinical value [114). Possibly this could be a consequence of the traditional 
validation techniques used to test its psychometric properties. The NDI is reported to have 
high internal consistency (alpha = .92) [136). The pre-treatment measures for the PRIMS 
data also demonstrate high internal consistency (alpha = .84). In light of this the 
contradictory trend of the Neck Disability Index is difficult to interpret. However, the Neck 
Disability Index is based on the Oswestry Low Back Disability Index, which was 
developed in 1980 [149). The Oswestry is not considered as psychometrically sound as 
other similar indices [150, pp 31]. The number of researchers who have emphasised 
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statistically significant reductions in disability and underemphasized the lack of attached 
clinical value indicate the misinterpretation that can occur with this instrument ( 131, 151]. 
Further, a number of researchers report percentage reduction of disability in chronic pain 
populations, which is far in excess of the reduction experienced by the predominately acute 
pain population in the validation study. These studies illustrate the inflated results that can 
occur in uncontrolled studies with this instrument (134, 152] Normally, as the liter~ture 
indicates, pain reduction measured in studies of acute pain is considerably greater than that 
reported by studies of chronic pain. With regard to neck pain this is particularly pertinent as 
there is a spontaneous recovery rate of close to seventy-five percent for acute pain [4). The 
absolute change detected by the Neck Disability Index in the PRIMS trial is very small, and 
possibly this contributes to its contradictory inter-analysis trend. This is the first time the 
psychometric properties of the Neck Disability Index have been tested under double-blind 
conditions. The question is why would the results of the Neck Disability Index be correct in 
the analysis for top adherers when they are against the trend and significant findings of the 
majority of the other instruments (see Figure 12)? This question is addressed on page 128. 
When related to their different underlying validation techniques the different psychometric 
performances of the various scales used in the PRIMS trial provide an insight into possible 
influences on selection criteria for outcome measurement. 
Factors Influencing Choices of Instruments 
What drives "researchers" and "clinicians" choices when selecting instruments to measure 
outcomes? Some factors are ease of use, and reduction of expenses relating to data entry. 
But, with today's technology of computerised interactive questionnaires [153] these should 
no longer be factors. Another factor is the overemphasis on hypothesis testing and the use 
of J2 values to dichotomise significant or non-significant results. This strategy has distracted 
from more useful approaches to interpreting the results of research, such as estimation and 
confidence intervals (69, pg6]. Researchers select 'validated' scales with established 
'psychometric properties'. But, it is important to select an instrument that has demonstrated 
36 The Multi-dimensional Pain Inventory was included in the battery of questionnaires for the PRIMS trial at the request 
of one of the attending clinicians who plans to make use of its discriminatory capacities. 
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sensitivity to change over time. Therefore. researchers are influenced by low n values for 
change over time when selecting instruments. 
Yet another factor driving researchers' choices is the need to compare results to population 
norms. What factors currently drive the establishment of population norms for some 
instruments and not others? The PRIMS data shows that by comparison to the visual 
analogue scale, some traditionally validated multi-item scales achieve lower levels of 
statistical significance. Therefore they will yield significant results for change over time 
with a smaller sample. Possibly this contributes to their popularity and wide usage, which 
in tum leads to the establishment of population norms. However, as discussed previously, 
items in multi-item scales are actually on an ordinal level of measurement [ 40]. For 
example although reliability testing may indicate a linear relationship between adjectival 
scale items, the equidistant categories of the items is assumed, but not proven. 
The visual analogue scale was not used to measure disability in the PRIMS trial. It has 
never been used to measure disability in neck pain trials. A possib]e reason is that there is 
long standing controversy concerning its accuracy when measuring general disability [154, 
155]. However, it would be interesting to compare the psychometric performance of a 
visual analogue scale measure of disability with that of the multi-item scales. 
To summarise, in the PRIMS trial the visual analogue scales performed more consistently 
than the multi-item scales when measuring both sensory and affective pain. Firstly, the 
inter-analysis movement of the confidence intervals for all visual analogue scales was 
unanimous and in the same direction as the significant findings of the whole group analysis. 
Secondly, clinically meaningful levels in change over time were measured. By contrast the 
inter-analysis movement for the multi-item interval scales was not unanimous. Some scales 
showed themselves extremely sensitive to very small changes over time. By contrast others 
measuring the same construct indicated that there was very little change over time. As the 
visual analogue scale is clearly an effective and psychometrically sound instrument, 
possibly it warrants more wide usage. Possibly, future research could be directed towards 
the development, validation and establishment of population norms for paper formatted and 
interactive computerised visual analogue scale measures of affective pain, disability, and 
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even individualised outcomes. The discussion now turns to address the results of the 
PRIMS trial in relationship to its declared hypotheses. 
First Hypothesis 
The first hypothesis of the PRIMS trial is that for patients with chronic neck pain 
regionalised strength-training, by comparison to regionalised endurance-training, elicits 
significantly greater reductions in pain and disability. The SF-36 Role-Emotional and 
Physical-Functioning scales show significant inter-group differences favouring strength-
training, for both affective pain and disability in the whole group analysis (see Figure 12). 
Sixteen statistical tests were conducted to measure these outcomes so it is unlikely that both 
these significant findings occurred by chance. ANOV A was used to reduce the risk of a 
Type I error, but as multiple tests were conducted the risk is still slightly inflated. 
Considering mainly the results of those scales that were most useful in the PRIMS trial, the 
SF-36 and the visual analogue scales, nearly all the trends of the analysis for top adherers 
favoured strength-training. The two exceptions are discussed below. Yet, in the whole 
group analysis nearly all these same scales slightly favoured endurance-training. These 
results pose two questions. Firstly, in the whole group analysis, why are all non-significant 
trends, except for the VAS fear, in contradiction to its significant results? Secondly, why 
does the trend cross over to support significant findings in the analysis for top adherers? 
To address the first question,37 a possible explanation for the inconclusive trend displayed 
in the whole group analysis is that some scales detected very little change over time, 
therefore, the direction of trend could be unreliable. Another explanation for the results of 
the whole group analysis is that confounds, or interaction between covariates, may be 
weakening the validity of the results in the whole group analysis. In a randomised 
controlled trial confounds are usually balanced in each group, as they are in the PRIMS 
trial. But, they can never be eliminated from the sample. The magnitude of the combined 
influence of confounds on treatment outcome cannot be measured accurately. But, 
sometimes, as the PRIMS trial possibly demonstrates, it is sufficiently greater than the 
treatment effect to detract from the validity of measures. For example, a randomised 
37 The second question is addressed on page 128 
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controlled trial which compared two slightly-different versi0ns of 'back school' found that 
work satisfaction was more related to outcome, than was treatment effect [95]. In another 
similar trial social class was more related to return to work, than was treatment outcome 
[76]. 
Significant Findings Supporting the 1st Hypothesis in the Whole Group 
Analysis 
To address the significant findings in the whole group analysis the reduction in emotional '-
distress yielded by the SF-36 Role-Emotional scale is readily interpretable. It reflects the 
increase over time in emotional distress for the endurance-training group compared to the 
reduction over time for the strength-training group. The SF-36 Physical-Functioning scale 
also found significant and clinically meaningful inter-group differences favouring strength-
training in the whole group analysis n< .04. Given the amount of research into and world 
wide recognition of the psychometric properties of the scales of the SF-36 there is no 
apparent reason why the inter-group differences should not be accepted at face value. 
The Relationship Between Phvsical and Mental Health Explored bv the 
SF-36 Role-Physical and Role-Emotional Scales 
The Role Physical and Role-Emotional scales have been shown to distinguish between 
limitations due to physical and mental health [156]. They are both dichotomous scales. 
They address the same work and daily activities, but one attributes limitations to physical 
health, and the other to mental health. According to the Role-Physical scale, physical ability 
increased for the strength-training group, but was effectively unchanged for the endurance-
training group. By contrast, as discussed above, the Role-Emotional scale indicates that 
while mental health improved over time for the strength-training group it actually 
deteriorated over time for the endurance-training group. The difference in the results for the 
endurance-trained group in these two scales is very interesting. Possibly it highlights a bio-
psychosocial interplay between patients' expectations of treatment outcome, or credibility 
[157], and differential changes in physical ability and emotional distress. This concept is 
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Figure 12 All Outcomes Means of Differences and Confidence intervals 
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Beck Depression Inventory 
SF-36 Mental-Health 
SF-36 Role-Emotional 
MPI Affective Distress 
Neck Disability Index 
MPI General Activity 
MPI Interference 
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Figure 13 Comparison of PRIMS data to Population Norms and Other Research 
Highland et al 25.6 + 5.7 = 31.3 (22%) 
Jordon ct al 19+2 =21 01 %) 
Randlov ct al 13.7+3 = 16.7 (22%) 
Population Norms Sagittal Plane 26.5 - 65. l (Jordon 1999) 
I 2 3 4 5 6 7 8 9101112131415161718192021 2223242526272829303132333435363738394041424344454647484950515253545556575859606162636465 
I Populati~~~~. Rotational Plane 2.8-24.4 run -] 
Priest ct al 6.24 +3.48 =9.72 (56%) 
Berg ct al 7.1 + 4.3 = 11.4 (61%) 
PRIMS strength training Whole Group Analysis 3.22+2.02 =5.24 (63%) 
PRIMS strength training Analysis for Top Adherers 3.77 + 3. I 7 = 6.94 (84%) 
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Why Does the Trend Cross Over in the Analysis for Top Adherers 
To address the question raised earlier, 'Why does the inter-analysis trend cross over 
to favour strength training? The analysis for top adherers, is conducted on those 
participants with the highest adherence to allocated protocol, and must, by 
implication, yield more valid measures. Strength and endurance-trained top adherers 
are not demographically different at baseline (see chapter five). Nor are they 
different at baseline for any of the variables measured, except the SF-36 Mental-
Health scale. The most plausible interpretation for the reversal of the trend, 
therefore, is that for patients who were able to adhere to an intensive exercise 
program, strength-training elicited greater reductions in sensory and affective pain, 
and disability. However, as the sample for the analysis of top adherers is 
considerably smaller, the PRIMS trial has insufficient power to detect these 
differences at <. 05 significance- if they truly exist. As the ranked adherence could 
only be determined post-hoc in the PRIMS trial the small sample in the analysis for 
top adherers was unavoidable. But, the trial provides invaluable data for the power 
and sample size calculations of future trials using ranked adherence systems. 
The two exceptions to the inter- analysis trend are the SF-36 Mental-Health scale 
and the Neck Disability Index. The contradictory results of the Mental-Health scale 
might be due to the marginally significant baseline difference, or they may have 
occurred because the absolute differences detected by the scale are very small. The 




The second hypothesis of the PRIMS trial is that regionalised strength-training of the 
cervical musculature will increase muscle strength more so than regionalised 
endurance-training. By contrast, endurance-training is expected to increase muscular 
endurance more so than strength-training. The reason for the second hypothesis in 
the PRIMS trial is to investigate whether there is a causal link from physiological 
change in the cervical musculature to changes in pain and disability. If so, which 
form of progressive resistance training produces changes that are most conducive to 
reductions in pain and disability? Theoretically, in the PRIMS trial the alternative 
and negative hypotheses are equally plausible. Not all clinicians believe that only 
strength-training will redress disuse atrophy. No one really knows what the different 
contributions of fast and slow twitch muscle fibres are to the mobility, and stability 
of the cervical spine. It is very difficult to distinguish the functional and anatomical 
parameters of muscular strength and endurance, let alone try to measure them as 
separate entities. 
Fortunately it is not necessary to understand muscle function at that level of detail to 
test the second hypothesis of the PRIMS trial. It is only necessary to demonstrate 
validity and reliability for measures of muscular strength, and to a lesser degree, 
muscular endurance. The PRIMS trial confirms previous research that measuring 
patients' cervical isometric strength in the rotational plane is reliable. More research 
is required into the development and validation of measures of rotational muscular 
endurance before hypotheses about their relationship to pain and disability can be 
meaningfully tested. Fortunately the current limitations in measuring cervical 
muscular endurance do not compromise the testing of the PRIMS trial hypotheses. 
As can be seen from Table 33 for those participants who were able to adhere to an 
intensive exercise program strength-training elicited clinically meaningful and 
statistically significant ( n<. 04) greater gains in cervical muscle strength. 
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The Relationship Between the Hypotheses Explored Via the Whole 
Group Analysis 
The whole group analysis of the PRIMS trial shows that, as predicted by the 
hypotheses, significant increases over time for cervical isometric strength are 
associated with significant reductions in pain and disability in the strength-training 
group. In the first instance it seems logical that disuse atrophy is a sequel to chronic 
neck pain, therefore, strength-training is the most effective treatment [30, 64, 158]. 
However, both groups experienced more than forty percent increase in strength. 
Considering the magnitude of the strength gains demonstrated in the PRIMS trial, it 
does not seem plausible that the percentage gain required to redress disuse atrophy is 
somewhere between forty-three and sixty-three percent (see Table 30). 
Furthermore, the inter-group difference is accompanied by significant inter-group 
differences for affective pain, and disability, but not pain intensity. If disuse atrophy 
is a contributing factor to ongoing chronic pain the most plausible causal link should 
be from changes in muscle strength to changes in pain intensity, with a further flow 
on to affective pain. As can be seen from Figure 14 pain intensity did not change for 
either group. Consequently, there is no link from pain intensity to pain affect in the 
whole group analysis. If there were such a link pain affect would have remained 
unchanged as did pain intensity. Therefore, the results of the whole group analysis 
throw considerable doubt on the school of thought that simply redressing disuse 
atrophy will produce reductions in pain intensity. If we accept the results of the 
whole group analysis at face value, one interpretation is that redressing disuse 
atrophy has more effect on disability, and that reducing disability bas a significant 
flow on to relieving affective pain (see Figure 14). 
However, pam perception involves a complex interplay of physiological and 
psychological processes. For example, the effectiveness of distraction technique for 
controlling clinical pain is contingent on the patient's perception of its credibility 
[157]. As Figure 14 shows, a possible psychological interpretation for the PRIMS 
results is that when chronic pain patients enter a treatment program they have certain 
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expectations regarding what they perceive to be an effective, or credible treatment. 
Over a period of time they become either satisfied, or dissatisfied with the credibility 
of the treatment. The difference between the SF-36 Role-Emotional and Physical-
Functioning scales, possibly reflects this interplay. Over time endurance-trained 
participants became genuinely disillusioned and dissatisfied with the credibility of 
the treatment, and this sentiment is reflected in increased emotional distress at the 
post-treatment measure. By contrast strength-trained participants perceived that the 
treatment was credible and this was reflected by their reduced emotional distress. 
However, the bio-psychosocial interpretation does not take into account the 
significant reduction in disability for the strength-training group, by comparison to 
no change over time for the endurance-trained group. It requires that the measure of 
disability be subject to positive placebo effects manifest by the strength-training 
group and neutral or no placebo effect manifest by the endurance-training group. 
The Relationship Between the Hypotheses Explored Via the Analysis for 
Top Adherers 
In the analysis for top adherers the statistically significant greater increase in muscle 
strength, for the strength-training group, emerges - and the trend displayed by all 
six visual analogue scale measures of sensory and affective pain intensity reverses to 
favour strength-training. If we accept, as we may have done for the whole group 
analysis, that changes in pain affect, which have occurred in the absence of changes 
in pain intensity, could be related to the bio- psychosocial interplay effect- what is 
reason for the reversal? Did the trend reverse by chance? Only further research can 
address that question. If it did not occur by chance, and we accept the evidence that 
pain intensity and affect are unique and separately measurable dimensions of pain, 
the bio- psychosocial interplay is not a comprehensive explanation for the results of 
the analysis for top adherers. It does not take the additional evidence provided by 
their more valid measures into account. 
The explanation we are left with is that the putative link between redressing disuse 
atrophy, by regionalised strength-training, to reducing affective pain, emerges at a 
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statistically significant level with the more valid measures of top adherers (see 
Figure 15, see Table 33). This seems the most convincing explanation. If we accept 
the validity of self report measures in a double-blind trial, the causal link from 
increased muscular strength to reductions in affective pain and disability are 
statistically significant and clinically relevant. Possibly the causal link from 
increased muscle strength to reduced pain intensity is not yet indicated at < .05 
statistical significance, due to small sample size in the analysis for top adherers. 
However, further research is required into a possible causal link between increased 
muscle strength and reduced pain intensity before the null hypothesis can be ruled 
out. 
The PRIMS data shows consistently that a reduction in pain intensity leads to a far 
greater reduction in affective pain, measured both by the SF-36 Role-Emotional, and 
the depression visual analogue scale. The difference in the exponents of the power 
functions for pain intensity (2.1-2.3) and pain unpleasantness (2.4-2. 7), recorded in 
the experiment conducted by Price et al. support this finding [159, pg 124]. As Price 
points out, ratings for affective pain are influenced by psychological factors 
associated with the patient's previous pain experience and the psychological context 
in which the sensory pain occurs. In fact, affective pain ratings recorded in 
experimental situations where patients are reassured as to the brevity and 
innocuousness of the stimuli will be considerably lower than for affective pain 
measured in normal circumstances. To summarise it is logical that the sample size 
required to detect changes in affective pain will be smaller than that required to 
detect changes in sensory pain, and the PRIMS results reflect this. 
If the above interpretation of the significant findings and supporting trends of the 
analysis for top adherers is correct, the question of how great a percentage gain in 
isometric strength is required to redress disuse atrophy re-emerges. According to the 
PRIMS data, the relative percentage increase is, supposedly, somewhere between 
forty-two and eighty-four percent. Those are the relative increases for endurance and 
strength-trained top adherers respectively. However, as discussed in chapter eight 
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the real increase in muscle strength required to redress disuse atrophy is probably 
considerably lower than indicated. 
Comparison of the PRIMS Results to Those of Other Similar Studies 
As can be seen from Figure 13 in the whole group analysis strength-trained 
participants experienced strength gains of similar magnitude to those experienced by 
participants in the uncontrolled study conducted by Priest et al. (49]. The MedX 
Neck Rotator was also used in Priest's study. Top adherers strength gains of 
approximately eighty-four percent are the largest ever recorded, but by comparison 
to other populations they also started from a lower baseline measure. As discussed 
previously an explanation for the differences in strength values between the 
rotational and sagittal planes, may be due to the 'gravity neutral ', aspect of the 
rotational plane. Figure 13 also demonstrates that strength training in the sagittal 
plane (1 OJ elicits approximately twice the magnitude of strength gains compared to 
endurance training [ 51, 141] 
A question of interest is:- By comparison to other randomised controlled trials do the 
considerably greater gains in muscle strength experienced by the strength-trained 
participants in the PRIMS trial translate to greater reductions in pain and disability? 
Unfortunately it is not possible to draw any conclusions regarding comparative 
reductions in pain and disability because different measurement instruments were 
used. Jordon used three 11 point numeric rating scales to measure pain, and Randlov 
used two. As discussed previously experimental testing has shown that the 11 point 
numeric rating scale does not have ratio scale properties, therefore, cannot be 
converted to a percentage change. Another problem associated with a comparison of 
results between the three randomised controlled trials is that PRIMS is a double-
blind trial and those of Jordon and Randlov are single-blind. Therefore, differences 
in reductions for pain and disability in Jordon and Randlov's trials will possibly be 
confounded by negative and positive placebo effects. Different multi-item scales 
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were used in all three trials to measure disability. A standardised approach to 
measuring outcomes in spinal research would be helpful [3, 160]. 
Generalisability of Results and Methodological Strategies 
Are the results of the PRIMS trial applicable to other chronic neck pain populations? 
If we were to accept the, rather inadequate, bio- psychosocial interplay explanation 
suggested by the whole group analysis, the results of the PRIMS trial would be 
broadly applicable to all therapeutic treatments. The effectiveness of a treatment 
would be contingent on its credibility, more so than its protocol. For chronic pain 
patients prevailing treatments for neck pain are nearly all passive and non-
specifically targeted (see Table 5). If credibility were to be the issue they would 
possibly continue to fail, as they often have done in the past. Treatments likely to 
succeed would be those perceived as credibly different from previous treatment 
attempts. 
If we accept the redress of disuse atrophy explanation, suggested by the analysis for 
top adherers, the results of the PRIMS trial can be generalised to a certain extent. As 
discussed in chapter five, patients who are most likely to adhere to an intensive 
exercise program are those who have episodic, rather than continuous pain, or pain 
of less than two years duration. They are more likely to be males, although this may 
depend on the gender of the therapist. They are also more likely to be tertiary 
educated. 
Possibly the major problem with the issue of adherence to protocol are not the 
patient driven deviations from protocol, but the therapist driven deviations. As 
indicated by Appendix 11 and Table 23 there were more therapist driven, than 
patient driven, deviations from protocol. There were also some cases where the 
contra-indicated protocol was administered for the duration of the treatment. A new 
therapist commenced administering the protocols just before completion of the 
accrual period. Possibly there was a miscommunication between the departing, and 
the new therapist, which may account for the last two cases receiving the incorrect 
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protocol. However, there is no explanation for the majority of the therapist driven 
deviations from protocol. Possibly, in future trials an unblinded observer should be 
available to measure the parameters of adherence to protocol after each session. This 
strategy could enable steps to be taken to reduce therapist driven deviations from 
protocol. However, the above findings do not compromise the generalisability of the 
results of the PRIMS trial because significant reductions in pain and disability were 
identified in the whole group analysis. 
A problem concerned with the application of the PRIMS protocol to other chronic 
neck pain populations is that regionalised progressive resistance training to the 
cervical musculature cannot be administered without specialised equipment such as 
the MedX Neck Rotator. At the commencement of the PRIMS trial the MedX Neck 
Rotator was the only iso-technology available in Australia. However, the Multi 
Cervical Unit (MCU) manufactured by Hanoun is now located in physiotherapy 
clinics in some capital cities of Australia. The MCU has a multi-pivot self-aligning 
head brace, which permits cervical spine movement in the rotational, lateral and 
sagittal planes. However, at this stage the MCU is used by physiotherapists to 
administer a form of endurance-training. Attending physiotherapists feel that it is 
best to train the coordination and proprioception of patients in as many different 
movements as possible with a limited and controlled load. Therefore, they train all 
three planes in the one session, hence a need for speed, as several repetitions in each 
plane are required. The more repetitions performed in a single session the lower the 
intensity of muscle contractions [52]. The most probable outcome from such 
protocols is insufficient intensity of the strength-training component to promote 
favourable physiological and functional change. This may possibly be a failure of 
most combined exercise programs that have incorporated strength-training. 
The methodology of the points-based ranked adherence system is applicable to other 
randomised controlled trials not only in the field of neck pain, but also for trials 
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evaluating progressive resistance training for any region of the human body. It can 
be applied to any research into exercise therapy where the parameters of the exercise 
are quantified and recorded at each session. Regular measurement of adherence to 
declared protocol is an intensification of the methodological strength of a 
randomised controlled trial, by comparison to a survey. It measures what people do 
over time, rather than what they say they will do. Further, it enables steps to be taken 
to increase the likelihood that people i.e. therapists, do what they say they will do. In 
future trials, parameters of adherence could be tailored to suit the protocol. For 
example, in the PRIMS trial weight pushed and number of repetitions performed 
were the only parameters, because they were the only ones recorded on a session 
basis. In future studies of progressive resistance training time taken to perform the 
eccentric phase of a repetition could also be recorded at each session. As discussed 
in chapter four training in the eccentric phase of muscle contraction produces greater 
gains in muscle function. Additional parameters may further strengthen the 
algorithm and, therefore, identify the most valid measures more precisely. The 
results of the points-based system forms the basis of a strategy for clinicians to use 
in predicting which patients are most likely to adhere to an intensive exercise 
program. The difference between the top adherers and the other participants in terms 
of pain history, gender and education are plausible and readily identifiable. 
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Figure 14 Interpretations Yielded by the Whole Group analysis 
Strength 
Training 
Pain Intensity unchanged 
for both groups 









----•~ Redressing disuse atrophy reduces disability, but not pain intensity. 
Reducing disability has a significant influence on affective pain 
• The bio-psychosocial explanation 
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Figure 15 Possible Interpretation from the Analysis for Top Adherers:-




















































The final conclusion is that the PRIMS trial has yielded strong, but not compelling 
evidence for a casual link from regionalised strength-training - reduced disuse 
atrophy - reductions in pain and disability. However, the contribution to research is 
considerable. It is the only methodologically sound double-blind trial in the field of 
therapeutic exercise for chronic neck pain. It is the first trial in its field to develop 
and validate a systematic method of ranking adherence to exercise protocol. The 
ranked adherence system yields more valid measures and provides invaluable data 
for power and sample size calculations for future trials. For the first time research in 
the field of therapeutic exercise for neck pain has shown, under double-blind 
conditions, that increases in muscle strength are positively related to reductions in 






Delayed Onset Muscle Soreness 
(DOMS) 
Disuse Atrophy 








A scale with adjectival descriptions and discrete or 
continuous responses 
A type of muscular contraction in which the tension is 
being developed while the muscle is shortening. E.g. the 
upward phase of a biceps curl 
Returning to training after a layoff from exercise can 
causeDOMS 
Progressive overload causes muscle fatigue DOMS 
Atrophy of muscular structures resulting from inactivity, 
or prolonged reduced activity 
A muscular contraction in which the muscle actually 
lengthens while tension is being developed E.g. the 
downward phase of a biceps curl when performed slowly 
while holding a weight 
A training program aimed at increasing aerobic capacity 
The relative strength level that the exercise stimulus 
places on the appropriate system. In essence, the amount 
of work completed in a specified period 
A generic term for machines such as the Med.X Neck 
Rotation Machine where the effect of progressive 
resistance exercise can be isolated to a specific region of 
the spine by the use of various restraints and pads on the 
seated patient 
A type of muscular activity in which the muscle does not 
shorten, because the forces functioning to lengthen the 
muscle are counteracted by forces that are equal or 
greater than generated by the muscle to shorten. E.G. 
pushing against an unmoveable object. 
Chiropractic techniques of manual traction and massage 
type treatment to tender muscles 
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Mechanical neck pain 
Mobilisation 
Muscular Endurance-training 
Non-isolated (non regionalised) 










Mechanical neck pain is a term applied to neck pain for 
which no inflammatory cause or recognised degenerative 
process can be identified, and which is not associated 
with particular radiologic signs of disease. 
A form of manual therapy involving passive movement 
of mobile segments. 
Training aimed at increasing the capacity of a muscle to 
repeatedly contract over a period of time without undue 
fatigue. 
Progressive resistance exercise which does not use 
equipment to restrict the training effect to a particular 
anatomic region, such as the cervical spine 
See non isolated 
An exercise for muscles in which resistance is 
progressively increased as muscle power improves 
Small movements of the muscle 
Progressive resistance exercise, which entails the use of 
iso-equipment to isolate the training effect to a particular 
anatomical region such as the cervical spine. 
The maximum load that a muscle group can lift over a 
given number of repetitions before fatiguing. 
The use of resistance methods to increase one's ability to 
exert or resist force for the purpose of improving 
performance. The training may utilise free weights, the 
individual's own body weight, machines or other devices 
to reach this goal 
Whiplash is defined as an injury to the neck, usually as a 
result of a motor vehicle collision, where the impact 
causes the neck to be thrown into extension, flexion, 
torsion or lateral flexion and subsequently undergoes a 
recoil motion subjecting elements of the cervical spine to 
shear forces , compression and traction. 
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Appendix 1 Demographics Questionnaire 
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DEMO GRAPHIC QUE STIONNArRE 
CODE ..... -...... DATE .... -.... -................. YEAR OF BIRTH .... _ ... MALE ............. ......... FEMALE ........ . 
Please ansrMer the foTio~\li"ng questic<ns. 
year 
I . How old were you when you first sought professional help for neck pain? D 
2. What was the approximate date of the initial injury? Month 
3. What was the initial inju1y? ... ....... .... ....... .. .. . . .. . . . 
4. Has the pain been one long continuous/episodic 
series since the initial injury? Yes (finish) No (Go to question 5) 
D D 
5. Prior to this episode many previous episodes of neck pain have you experienced for which 
you sought protcssional help'/ 
6. How long was the interval between your last episode of neck pain and tbe cuffent 
one?( Write a number in either the davs. months or vear.Y box) 
Days Mouths Years 
D D D 
7. How long ago did your current episode of neck pain start? fWriw n number in eilher the 
da\~~·. montlzs or vears boxj 
Days Months Years 
D D D 
8. A.re you right 11anded? Yes ~o 
[ -i 
9. What is your height and weight? 
6. What is your presenl, or most recent occupation? ___________ (If Public 
Servant please stale level). 
7. In your working life what has been your main job? ___________ (If 
Public Servant please state JevelJI 
•. 
~ JI now married or widowed: What k.ind of work does/did your spouse do for most of his/her 
life? (If Public Servant please srate levelj 












Secondary school qualification 
Nursing qualification .. · ............... . 
Teach.ing qualification 
Technical Certificate/ 
Apprenticeship ....................... .. 
Certificate other than above ..... . 
· Associate diploma ... . ................ . 
Undergraduate diplo~ .............. , 
Bachelor Degree ..... ....... ....... ., .. .. 
Honours degree . ........... . .. ........ .. 
Post·gra~uate Diploma ...•......•.•.. 
Masters Degree/Doctorate ..... ~ ..• 
Appendix 2 Visual analogue scale measures of Pain Intensity and Affect 
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RETROSPECTIVE P AlN ASSESSMENT FOR 1\1 
YEAR OF B IRTH ... " .. _ ........................ MALE /FEMALE .......... " ... -... 
Please indicate your nlinbpum pain fgtensi!f during the last two weeks by placing a slash through the line. 
I-·····--·--·-·--·----··---·-··-·----····-·-----·--·-·-·····--·-·---·-·-·----! 
0 100 
No pain Pain as bad as it 
can be 
Please indicate how disturbing your pain was when it was at its minimym unpleasanllless over the last two weeks by 
















No anxiety Most anxiety possible 
DEPRESSION 
I····--·--:---·-··-····-·····-········--·---·---------··-··-·-·-····-··· · ----·-----1 
0 100 
~o depression W ~-rst depressio possible 
7) Please indicate your usual pain intensity during the last two weeks by placing a sfo:0h tfu·ough the lino. 
!-·-···············--·-···-····----···-·--·--·-·------·-·--·-··-··-·-······ . -···-·---···--··-·-! 
0 100 
No pain Pain as bad as it 
can be 
Please indicate how disn.u·bin~ your pain was when it was at its!!!!!!! unpleasantness over the last two weeks by 
placing a slash t~.rough the lines for each emoti011 
8) FRUSTRATION 
I·------·-·-----·-····-··------··-·····-···-----·-·---······-··------·· ···-·-----------1 
0 . 100 




No anger Most anger possible 
10) FEAR 
I-·-·····-··-·-----······-······-----------·-----·-·--·-----····-·--·-··-···· .. ···-·-·---·-·--··-·! 
o JOO 
No fear Most fear possible 
11) ANXIETY 
!·-···---·--·--··--············· ·-·-·--------·--·----·--------·. ···-··-·-·--·--··-·! 
0 100 




No depression Worst depression possible 
. 13) Please indicate the n~mber and type of pain killer you took over the 2 days? 
Name of pain killer Number of tablets taken in 
total 
--





CODE ............. DATE ................ , .. . 
. SECI'ION l 
In the following 20 questions, you will be asked to describe your pain and how it affects your 
life. Under each question is a scale to record your answer. Read each question carefully and then · 
circle ~.number on the scale under that question to indicate how tliat specific question applies tc?-
you. 
1. Rate the level of your pain at the present moment. 
0 
No pain 
1 2 3 4 5 6 
Yery intense p~n 
2. In general, how much does your pain problem interfere with your day to ~ay activities? 
0 1 2 · 3 4 s 6 
No interference '-Extreme interference 
3 . .Since the time you developed a pain problem. how muc~ has your pain changed your ability to 
worlc? 
0 1 2 
No change · 
3 ·4 5 6 
Extreme change 
___ Check here, if you have retired for reasons other than your pain problem. 
4. How much has ·your pain changed the amount satisfaction or enjoyment you get from 
participating in social and rec~ational activities? 
0 1 2 
No change 
3 4 5 6 
Extreme change 
S How supportive or helpful is your spouse (significant other) to you in relation·to your pain? 
0 1 2 3 4 5 6 
NC?t at all 
supportive 
6. Rate ·your overall mood during the past week. 










7 On the average, how severe has your pain been during the week? 
. \ 
Q 
Not at all 
severe 
l 3 4 5 6 
Extremely 
severe 
8. How ·m:uch has your pain changed· yolir atiiiitf to .partlC1pate 'in reereationat and othe·r social 
activities? 
0 1 2 3 4 5 6 '. 
No change Extreme change 
9. How much has your pain changed the amount of satisfaction you get from family-related 
activities? · 
0 1 2 3 4 5 6 
.. No Extreme change .. 
. 10~ How worried is your spouse (significant other) about you in relation to your pain problems? 
o · 
Not at hll 
worried 
1 2 3 4 5 6 
Extremely 
worried 
1 L During the past week how much control do you feel that you have had over your life? 
0 i 2 3 4 5 6 
Not at all Extremely 
in control in control 
-. . 
12. How much suffering do you experience because of your pain? 
0 1 2 3 4 5. 6 
No suffering Extreme suffering 
13. How much has your pain ch8:11ged your marriage and other family relationships? 
0 
No change 
1 2 3 4 s 6 
Extreme change 




1 2 3 




15. How attentive is your spouse (significant other) tO your pain problem? 
0 1 2 3 4 5 6-




i 0.l)unng. the week how' miicii.do ·yoti feel that you've been able to deal with your problems? 
o. 1 2 3 .4 5 6 
Not at all Extremely well 
17. llow much has your pain changed your ability to do household chores? 
0 1 2 3 4 s 6 
: 
No change Extreme 
change 
18. During the pa5t week how irritable have you been? 
0 1 2 3 4 5 6 




19.: How In;U~h bas your pain changed your friendships with people other than your family? 
0 1 2 3 4 5 6 
Noc~ge. Extreme change 
20. During the past week how tense or anxious have you been? 
0 l 2 3 4 5 6 
Not at all Extremely 
tense or anxious , tense or anxious 
SECTION2 
In this section, we are interested in knowing how your spouse (or significant other) responds to 
you when he or she knows that you are in pain. On the scale listed below each question, circle a 
numJ?~~.t~. indicate how often your.~~~~-(C?.1'.. ~i~if!-<:~t-~~r) generally ~ponds to you in ~hat 
particular. way when you are in pain. please answer all of the 14 questions. 
***Please identify the relationship between you and the person you are thinking 
of_ 
1. Ignores me. 
0 I 2 3 4 5 6 
Never Very often 
2. Asks· me what he/she can do to help_ 
0 1 2 3 4 5 6 
Never Very often. 
3. Reads to me. 
0 1 2 3 4 5 6 
Never Very often 
4. Expresses irritation at me. 
0 1 2 3 4 5 6 
Never Very often 
5. Talces over my jobs or duties. 
0 1 2 3 4 5 6 
Never Very often 
6. Tatks to me about something else to take my mind off the pain. 
-
0 1 2 3 4 5 6 
Never Very often 
7. Expresses frustration at me. 
0 1 2 3 4 5 6 
Never ' Very often 
-8. Tries to get me· to rest. 
0 1 2 . 3 4 5 6 
Never Very often 
. ,. ··- . . .. 
- -
. . . .. . · . 
.. 
9. Tries to involve. me in some activity. 
0 . 1 2 3 4 · 5 6 
· Never Very often 
10. Expresses anger at me. 
0 1 2 3 4 5 6 
Never Very often 
I I .. Gets me some pain medications. 
0 1 2 :3 4 s 6 
Never Very often 
12. Encourages me to work on a hobby. 
0 1 2 3 4 5 6 
Never Very often 
13. Gets me something to eat or drink. 
0 1 2 3 4 5 6 
Never Very often 
14. Tums on the TV to take my mind off my pain. 
0 1 2 3 4 5 6 
Never Very often 
SECTION3 
Listed below are 18 common daily activities. Please indicate how often y·ou do each of these 
activities by circling a number on the scale listed below each activity. Please co.mplete all 18 
questions. 
. . . . ... . . 
1. Wash dishes. 
0 1 2 3 4 5 6 
Never Verv often 
2. Mow the law. 
0 1 2 3 4 5 6 
Never Very often 
3. Go out ~o e~t. 
0 1 2 3 4 .. 5 .6 
Never Very often 
4. Play cards or other games. 
0 1 2 3 4 5 6 
Never Very often 
5. Go grocery shopping. 
0 I 2 3 4 ·. 5 6 
Never Very often 
6 . . Work in the garden. 
0 1 2 3 4 5 6 
Never Very often 
7. Go to a movie. 
0 1 2 3 4 5 6 
Never 
Very often 
8. Visit friends. 
0 l 2 3 4 5 6 
Never Very often 
9. Help with lhc: house denning. 
0 1 2 3 4 5 6 
Never Very often 
! I 0. Work .on the car. 
0 J 2 3 4 5 6 
Never Very often. 
11. Take a ridt! in a car. 
0 J ') 3 4 5 6 
-Never Very often 
12 . Visit relatives . 
0 1 2 3 4 5 6 
Never Very often· 
13. Prepare a meal. 
0 1 2 3 4 5 6 
Never Very often 
14. Wash che cnr. 
0 1 2 3 4 5 6 
Never Very often 
15. Take a trip. 
0 1 2 · 3 4 5 6 
Never Very often 
J 6. Go to a park or beach. . 
0 1 2 3 4 5 6 
Never Very often 
. Do n load of laundry. 
0 I 2 3 4 .5 6 
Never Very often 
18. Work on a needed house repair. 
0 1 2 3 4 5 6 
Never Very often 
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DATE ............................. CODE ............ . 
YEAR OF BIRTH ................................. MALE/FEMALE ................... . 
1. In general, would you say your health Exccllcnl Very good Good Fair Poor 
is: 
2. Compared to one year ago, how Much Somcwhal Aboul Some- Much 
would you rate your health in general 
belier bcucr now lhcsamc whal worse 
now worse 
now? 
The following items are about activities you might do No, nol Yes, Yes, limilcd 
limilcd limilcda a 101 
during a typical day. Does your health limit you in these al all lilllc 
activities? If so, how much? 
3 Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports 
4 Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling or playing golf 
5 Lifting or carrying groceries 
6 Climbing several flights of stairs 
7 Climbing one flight of stairs 
8 Bending, kneeling or stooping 
9 Walking more than a kilometre 
10 Walking several blocks 
11 Walking one block 
12 Bathing or dressing yourself 
During the past four weeks, have you had any of the following 
problems with your work or regular daily activities as a result of vour 
f!.h')!.sical health? 
13 Cut down on the amount of time you spend on work or other activities YES NO 
14 Accomplished less than you would like YES NO 
15 Were limited in the kind of work or other activities YES NO 
16 Had difficulty perfonning the work or other activities (for example, it YES NO 
took extra effort) 
During the past four weeks, have you had any of the following 
problems with your work or other daily activities as a result of anv 
emotional eroblems (such as feeling anxious or depressed)? 
17 Cut down the amount of time you spend on work or other activities YES NO 
18 Accomplished less than you would like YES NO 
19 Didn't do work or other activities as carefully as usual YES NO 
20 During the past four weeks, to what Not at all Slightly Moderately Quite a Extremely 
extent has your physical health or 
bit 
emotional problems interfered with 
family, friends, neighbours or groups? 
21 How much bodily pain have you had None Very Mild Moderate Severe Very 
during the past four weeks? mild severe 
22 During the past four weeks, how much Not at all A little Moderately Quite a Extremely 
did pain interfere with your normal 
bit bit 
work (including both work outside the 
home and housework)? 
These questions are about how you feel and how things have been with you during 
the past four weeks. For each question, please give the one answer that comes 
closest to the way you have been feeling. 
How much of the time during the past All of Most A good Some of A little None of 
the of the bit of the time of the the time four weeks: time time the time 
time 
23 Did you feel full oflife? 
24 Have you been a very nervous person? 
25 Have you been so down in the dumps that 
nothing could cheer you up? 
26 Have you felt calm and peaceful? 
27 Did you have a lot of energy? 
28 Have you felt down? 
29 Did you feel worn out? 
30 Have you been a happy person? 
31 Did you feel tired? 
32 During the past four weeks, how much None of A 1i1tlc Some of Most of All of 
of the time has your physical health or 
thetime of the the time the time the time 
time 
emotional problems interfered with your 
social activities (like visiting friends, 
relatives etc)? 
How TRUE or FALSE is each of the Definitely Mostly Don't Mostly Definitely 
following statements for you? 
false false know true true 
33 I seem to get sick a little easier than 
other people 
34 I am as healthy as anybody I know 
35 I expect my health to get worse 
36 My health is excellent 
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·;.;.:oRKJ~G ENVJRON~H:NT QUESTIONNATRE 
CODE .......... . 
Please tick th!.! coh:.:.--:-:u. th:it best describes your working environment. (If you are not 
currently in thew;:-~ force but have been within the last two years please answer questions 
with rc.gard to your :;l!:-a working environment) 
-------~-- ---- --
'ICnl and working plan j I can influence my v. ::l-.;:ing cnYircian 





I can use my capabik:(:::;.. and talents 
i----- -
:. 4 I can get po).iti ve fe~·-4)ack and resp ect for my work 
'----~---------· 5 I can rr~~·.Jy commur;~,:.;ne with other employees 
--·- -I can sec the rneanir.~ and results of my work 
!---~---·----------
7 J can ascend in my \'.:~:-::er 
- ----------




---- -·~ervc my working :.kills 8 I cm1 g~t training 10 ~~manc-e or t~" pre 













CODE ................... . 
In each group of 4 s1atcmenlS check the box pertaining to the statcml!nt lhal tx~sl describes your feelings 
during the las! week. 
I am so unhappy 1hal I can't stand it O S 
I am unhappy all the time :ind I can't snap out of 
it. 0 
I feel sad O 
l do not feel sad. o 
I foci that the future is hopeless and that 
things cannot improve 0 · <? 
I feel l have nothing lo look forward to. O 
I feel discouraged about the future. O 
I am not particularly pessimistic or 
discouraged about the future. O 
/0 
I f~l I am a complete failure as a person (parent. 
husband, wife) O 
As J look back on life all I can see is a lot of 
failures. O 
I feel I have failed more than the average person. 
0 
r do not f ecl like a failure 0 
I am dissatisfied with everything O /I · 
I don't get satisfaction out of anything anymore. 
0 
I don't enjoy things they way I used to. o 
I am not particularly dissatisfied. O 
l feel as though 1 am very bad or worthless. O 
I feel quite guilty. O ' 2.. 
I feel bad or unworthy a good part of the time. 
0 
I don't foel particularly guilty. O 
I hate myself. 0 t3 
I am disgusted with myself. O 
l am disappointed in myi:clf. O 
r don't feel disappointed in myself. 0 
l have lost au interest in other people. 0 
I have lost most of my jmerest in other people. 
0 
l am less interested in other people than I used to 
be.a 
t have not lost interest in other people. 0 
I can't make any decisions <>t all any more. o 
I ha\·e grea1 difficulty in making decisions O 
1 try to put off making decisions O 
1 make decisions about as well as ever 0 
I feel that I am ugly or repulsive looking. 0 
I fee! that there are permanent changes in m_y 
appearance and they make me look unattractive. 
0 
1 am worried that 1 am looking old or unattractive 
.o 
I don't feel that I look any worse that 1 use.d to. 
0 
I can't do any work at all. O 
I have to push myself very hard to do anything. 
0 
It takes extra effort to get started at doing 
somelhing. 0 
I can work about as well as before. D 
I get too tired to do anything 0 
I get tired from doing anything 0 
J get tired more easily than I used to. 0 
I don't gel an)'ll\Ore tired than usual. 0 
J have no nppctite at all anymore. 0 
My appe1i1e is much worse now. 0 
My appetite is not as good as it use to be. D 
My appetile is no '>{Orse than usual. 0 
7 l would kill myself if l had the chance. 0 
r have d~finitc plans about committing suicide 0 
I feel I would be belll!r off dead. 0 
I don't have any 1hough1s of harming myself. 0 
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ATTITUDES QUESTIONNAIRE 
Listed below are a number of statements concerning personal attitudes and traits. Read 
each item and decide whether the statement is true or false as it pertains to you 
personally. Circle responses at end of each stutement. 
1. Before voting I thoroughly investigate the qualifications of all the candidates. 
T F . 
2. I never hesitate to go out of my way to help someone in trouble . . T F 
3. It is sometimes hard for me to go on with my work if I am not encouraged T 
F 
4. I have never intensely disliked anyone. . T F 
5. On occasion I have had doubts about my ability to succeed in life.. T F 
6. I sometimes feel resentful when I don't get my way. . T F 
7. I am always careful about my manner of dress.. T F 
8. My table manners at home are as good as when I eat out in a restaurant. . T F 
9. If I could get into a movie without paying nnd be sure I was not seen I would 
probably do it. . T F 
l 0. On a few occasions, I have given up doing something because I thought too little 
of my ability. T F 
11. I like to gossip at times. . T F 
12. There have been times when I felt like rebelling against people in authority even 
though I knew they were right. . T F 
13. No matter who I'm talking to. rm always n good listener. . T F 
14. I can remember "playing sick" to get out of something. . T F 
15. There have been occasions when I took advantage of someone. . T F 
16. I'm always willing to admit it when I make a mistake.. T F 
17. I always try to practice what [preach. . T F 
18. I don't find it particularly difficult to get along with loud mouthed, obnoxious 
people.. T F 
19. I sometimes try to get even rather than forgive and forget.. T F 
20. When I don't know something I don't at all mind admitting it. . T F 
21. I am always courteous, even to people who are disagreeable. . T F 
22. At times I have really insisted on having things my own way. . T F 
23. There have been occasions when I felt like smashing things. . T F 
24. I would never think of letting someone else be punished for my wrongdoings .. 
T F 
25. I never resent being asked to return a favour . T F 
26. I have never been irked when people expressed ideas very different from my own. 
T F 
27. I never make a long trip without checking the safety of my car. . T F 
28. There have been times when I was quite jealous of the good fortune of others .. 
T F 
29. I have almost never felt the urge to tell someone off. . T F 
30. I am sometimes irritated by people who ask favours of me. . T F 
3 J. I have never felt thnl l was punished without cause. . T F 
32. I sometimes think when people have a misfortune they only got whut they 
deserved. • T F 
33. I have never deliberately said something that hurt someone's feelings. T F 
A TIITUDES QUESTlONNAIRE 
Listed below are a number of statements concerning personal attitudes and traits. Reatl 
each item and decide whether the statement is true or false as it pertains to you 
personnlly. Circle responses at end of each statement. 
l. Before voting J thoroughly investigate the qualifications of all the candidates. 
T F . 
2. I never hesitate to go out of my way to help someone in trouble . . T F 
3. It is sometimes hard for me to go on with my work if I am not encouraged T 
F 
4. I have never intensely disliked anyone. . T F 
5. On occasion I have had doubts about my ability to succeed in life. . T F 
6. I sometimes feel resenlf ul when I don't get my way. . T F 
7. I am always careful about my manner of dress. . T F 
8. My table manners at home are as good as when I eat out in a restaurant. . T F 
9. If I could get into a movie without paying nnd be sure I was not seen 1 would 
probably do it. . T F 
I 0. On a few occasions, I have given up doing something because I thought too little 
of my ability. T F 
11. I like to gossip at times. . T F 
12. There have been times when I felt like rebelling against people in authority even 
though I knew they were right. . T F 
13. No matter who I'm talking to, rm always n good listener.. T F 
14. I can remember "playing sick" to get out of something.. T F 
15. There have been occasions when I took advantage of someone.. T F 
16. I'm always willing to admit it when I make a mistake. . T F 
17. I always try to practice what r preach. . T F 
J 8. I don't find it particularly difficult to get along wilh loud mouthed, obnoxious 
people.. T F 
19. I sometimes try to get even rather than forgive and forget.. T F 
20. When I don't know something I don't at all mind admitting it. . T F 
21. I am always courteous, even to people who are disagreeable. . T F 
22. At times I have really insisted on having things my own way. . T F 
23. There have been occasions when I felt like smashing things. . T F 
24. I would never think of letting someone else be punished for my wrongdoings . . 
T F 
25. I never resent being asked to return a favour . T F 
26. I have never been irked when people expressed ideas very different from my own. 
T F 
27. I never make a long trip without checking the safety of my car. . T F 
28. There have been times when I was quite jealous of the good fortune of others .. 
T F 
29. I have almost never felt the urge to tell someone off. . T F 
30. I am sometimes irritated by people who ask favours of me. . T F 
3 1. I have never felt thal l was punished without cause. . T F 
32. I sometimes think when people have a misfortune tbey only got what they 
deserved. . T F 
33. I have never deliberately said something that hurt someone's feelings. T F 
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NECK DJSAlllLlTY JNDBX 
CODE ............. D/\ TE .................... . 
This questionnaire has been designed to give the doctor information as to how your neck pain 
has affected your ability 10 manage in everyday life. Please answer every ~cclion and mark only 
th l;onc box in each section that applies Co you We realise you may cnnsi<ler that two of the 
statements in any one section relate to you but please just mark the box which most closely 
describes your problem. 
Section I Pain Intensity 
0 I have no pain at the momenl 
0 The pain is very mild at the moment 
0 The pain is moderate at the moment 
0 The pain is fairly severe at the moment 
0 The pain is very severe ~t the moment 
0 The pain is the worst imaginable al the 
moment 
Section 2 Personal Care (Washing Dressing 
etc) 
D J can look after myself normally 
without causing extra pain. 
0 I can look after myself nor·mally but it 
causes extra pain 
0 It is painful tu look aflcr myself and I 
am slow and careful 
0 l need some help bu! manage most of 
my personal care 
0 I need help every day in most aspects 
or self care 
0 I <lo not get dressed, I wash with 
difficulty and slay in bed 
Section 3 Lifting 
0 1 can lift heavy" eights without extra 
pain 
0 I can lift heavy weights but it gives 
extra pain 
0 Pain prevents me from lifting heavy 
weights off the floor, l>ul r can manage if 
they are conveniently positioned, for 
example on a table 
0 Pain prevents me from lifting heavy 
weights but 1 can manage light to medium 
weights if they are conveniently positioned 
0 l can lift very light weights 
0 I cannot lift or carry anything at all 
Section 4 Reading/walching TV 
0 I cau read/watch TV as much as I want 
to with no pain my 11~:ck 
0 1 can read/watch rv as much as I want 
to with slight pain my necK: 
0 I can read/watch TV as much as I want 
with moderate pain in my neck 
0 I can't read/watch TV as much as I 
want because of moderate pain in my neck 
0 1 can hardly rcalliwalch TV at all 
because of severe pain in my neck 
0 [cannot read/watch TV at all 
Section 5 Headaches 
0 I have no headaches al all 
0 I have slight headaches which come 
in-frequently 
0 I have mo<.lcrate headaches which come 
in-frequenl ly 
0 I have moderale headaches which come 
frequently 
0 I have severe headaches which come 
frequently 
0 I have headaches almost all the time 
Section 6 Concentration 
0 l can concontrate Cully when l wanl to 
wjth no difficulty 
D I can concentrate fully when I wa.nt to 
wi th slight difficulty 
0 I have a fair degree of difficulty in 
concentrating when I want to 
0 I have a lot of difficulty in 
concentrating when I want to 
0 l have great deal of dilTiculty in 
concentrating when l want lo. 
0 1 cannot concentrate at all 
Section 7 Work 
0 
0 I can du as much work as 1 want to 
0 I can only do my usual work but no 
more 
0 I can do most of my usual work but no 
more 
0 I cannot do my usual work 
0 l can hardly do any work at all 
0 I can' t <lo any work at all 
Section 8 Driving 
0 I can drive my car without any neck 
pain 
O l can drive my c:-ir as long as 1 want 
with slight pain in n1y neck. 
0 I can drive my c:ar as long as I want 
with moderate pain in my neck. 
0 I can l drive my car as long as 1 want 
because of moderate pain in my neck 
0 l can hardly drive at all because or 
severe pain in my nct:k. 
0 l can't drive my car at all 
Section 9 Sleeping 
0 ·I have no tr~)ubk sleeping. 
O {Vly sleep is slightly clisturbc<l (Less 
than l hr sleepless). 
0 My sleep is mildly <listurbec.J ( 1-2 hrs 
sleepless). 
0 My sleep is moderately <.lislurbed (2-3 
hrs sleepless) 
0 My sleep is greatly <listurf?cd (3-5 hrs 
s leepless) 
0 My sleep is completely disturbed (5~ 7 
hrs sleepless) 
Section I 0 Recreation 
0 I am able to engage in all my recreation 
activities with no neck pain at all. 
0 I am able to engage in all my recreation 
activities with some pain in my neck 
0 . ( am able to engage in most but not aH 
of my usual recreation activities because of 
pain in my neck. 
0 I am only able to engage in a few of my 
usual recreation activ ities because of pain 
my neck. 
0 I can hardly do any rccrculion activilics 
because of pain in my neck 
· 0 I can't do any recreation activities at all 
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MONTI-IL Y QUESTIONNAIRE 
DATE ............... ....... CODE NO 
Please circle the correct answer to the questions below. 
I. Has your employment status changed 
No No 
Still at work still off work 
Yes Yes 
Ceased working returned to work 
lf currently employed answer questions 
2,3, a11d 7 thro11gb to comple/Um 
/f c11rrently ... not.employed an.~IJel: 
questions 4 thro11glt.Jo..co.mpletii 
2. During the past four weeks have you 
taken sick leave from your work 
because of neck pain? 
0 
/fes No 
Circle approximately how many 
days? 
1-13 14-20 21-28 
3. During the past month have you had 
to perform reduced duties in your job 
because of neck pain? 
No 
Circle approximately how many days? 
0 1- 13 14-20 21-28 
4. During the last 4 weeks were there 
any days when your pain prevented 
you performing any of your normal 
duties? 
Yes No 
Circle approximately how many days? 
0 1-13 14-20 21-28 
5. During the last 4 weeks were there 
any days when your pain restricted 




Circle approximately how many days? 
0 1-13 14-20 21-28 
6. Are you currently looking for a job? 
Yes No 
7. During the last 4 weeks have you 
returned to this clinic or attended any 
other health service provider because 
~in?(Do 
not respond yes if you have sought 
only preventative treatment) 
Yes No 
8. Are you on, or applying for workers 
compensation for your neck pain? 
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Test retest reliability on questionnaire evaluating therapists attitudes in a double-blind 
randomised controlled trial 
1) How would you rate the treatment therapist's attitude during your exercise sessions on 
theMedX? 
Very enthusiastic and supportive 









Seemingly opposed to the treatment 
Appendix 11 Groups By Blinded Classification 
ID BLCL (Strength) 
82 st 5 star 
96 st 5 star 
37 st 4 star 
84 st 4 star 
27 st 4 star 75 st 3 star 
83 st 4 star 94 st 2 star 
1 st 4 star 66 st 2 star 
9 st 4 star 35 st 2 star 
IO I st 4 star 52 st I star 
57 st 3 star 34 missing 
87 st 3 star 29 missing 
73 st 3 star 88 missing 
49 st 3 star 20 missing 
74 st 3 star 81 failure 
63 st 3 star 97 failure 
80 st 3 star 98 failure 
23 st 3 star 42 failure 
60 st 3 star 62 et/? 
95 st 3 star 21 et 4 star 
89 st 3 star 18 et 4 star 
53 st 2 star/fail 69 et 4 star 
68 st 2 star/fail 39 et 3star 
30 st 2 star 50 et 3 star 
11 st 2 star 7 et 3 star 
14 st 2 star 22 et 3 star 
56 st 2 star 47 et 3 star 
45 st 2 star 79 et 3 star 
61 st 2 star 90 et 3 star 
86 st 2 star 65 et 3 star 
19 st 2 star 58 et 3 star 
99 st 2 star 24 et 3 star 
43 st 2 star 16 et 2 star 
12 st 2 star 4 et 2 star 
76 st 1 star/failure 40 et 2 star 
41 st 1 star/fail 59 et 2 star 
51 st 1 star/fail 67 et 2 star 
71 st 1 star 48 et 2 star 
100 missing 46 et 2 star 
26 missing 78 et 2 star 
64 missing 15 et 2 star 
38 missing 8 et 2 star 
10 missing 33 et 2 star 
36 missing 13 et 2 star 
2 failure 85 et 2 star 
70 failure 25 et I star/ fail 
5 fail 54 et lstar 
3 et/failure 93 et 1 star 
192 et 3 stru: 6 et 1 star 
44 et 2 star 55 et 1 star 
31 et 2 star 17 et 1 star 
28 et lstar/fail 72 et 1 star 
77 et 3 star 
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Appendix 12 Strength Group by Points Based Ranked Adherence and Total 
Weight 
ID Rank Blind Cl 
57 59.5 st 3 star 
37 45.0 st 4 star 
84 42.0 st 4 star 
27 40.0 st 4 star 
83 38.0 st 4 star 
l 37.5 st 4 star 
9 35.0 st 4 star 
82 32.0 st 5 star 
87 28.0 st 3 star 
73 27.5 st 3 star 
49 27.0 st 3 star 
74 26.0 st 3 star 
96 23.0 st 5 star 
30 19.5 st 2 star 
101 19.0 st 4 star 
63 19.0 st 3 star 
80 19.0 st 3 star 
11 11.0 st 2 star 
23 7.5 st 3 star 
89 4.0 st 3 star 
53 2.0 st 2 star/fail 
14 1.0 st 2 star 
100 .0 missing 
26 .0 missing 
64 .0 missing 
38 .0 missing 
5 .0 fail 
10 .0 missing 
36 .0 missing 
60 -2.0 st 3 star 
56 -3.0 st 2 star 
45 -4.0 st 2 star 
61 -5.0 st 2 star 
86 -5.0 st 2 star 
19 -5.5 st 2 star 
99 -10.0 st 2 star 
43 -12.0 st 2 star 
3 -14.0 et/failure 
41 -14.0 st 1 star/fail 
95 -15.0 st 3 star 
68 -19 .0 st 2 star/fail 
76 -20.0 st 1 star/failure 
12 -20.0 st 2 star 
2 -23.0 failure 
70 -34.0 failure 
44 -43.0 et 2 star 
71 -45.0 st 1 star 
Q2 -4&.0 et.3 star 
51 -49.0 st 1 star/fail 
28 -62.0 et l star/fail 
31 -76.0 et 2 star 
ID TOTWT BLCL 
82 802.00 st 5 star 
57 646.00 st 3 star 
101 642.00 st 4 star 
27 570.00 st 4 star 
1 566.00 st 4 star 
37 562.00 st 4 star 
84 552.00 st 4 star 
80 544.00 st 3 star 
73 514.00 st 3 star 
96 512.00 st 5 star 
53 504.00 st 2 star/fail 
49 496.00 st 3 star 
83 494.00 st 4 star 
23 494.00 st 3 star 
63 492.00 st 3 star 
9 488.00 st 4 star 
87 466.00 st 3 star 
30 444.00 st 2 star 
86 440.00 st 2 star 
19 436.00 st 2 star 
11 428.00 st 2 star 
60 420.00 st 3 star 
45 416.00 st 2 star 
74 398.00 st 3 star 
56 374.00 st 2 star 
68 362.00 st 2 star/fai l 
31 330.00 et 2 star 
51 320.00 st 1 star/fail 
95 318.00 st 3 star 
28 306.00 et lstar/fail 
14 306.00 st 2 star 
89 306.00 st 3 star 
12 296.00 st 2 star 
61 290.00 st 2 star 
43 262.00 st 2 star 
76 250.00 st l star/failure 
99 250.00 st 2 star 
71 238.00 st 1 star 
22 232.00 et ~star 
44 220.00 et 2 star 
70 180.00 failure 
41 134.00 st 1 star/fail 
2 120.00 failure 
3 80.00 et/failure 
100 . missing 
26 . missing 
64 . missing 
38 . missing 
5 . fail 
10 . missing 
36 . missing 
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Appendix 13 Endurance Group By Points based Ranked list and Total 
Repetitions 
ID Rank Blind Cl 
ID TOTRPS BLCL 
50 80.0 et 3 star 
77 71.5 et 3 star 21 710.00 et 4 star 
7 69.5 et 3 star 50 710.00 et 3 star 
4 68.5 et 2 star 18 684.00 et 4 star 
40 66.0 et 2 star 77 681.00 et 3 star 
22 65.0 et 3 star 79 679.00 et 3 star 
21 63.5 et 4 star 90 650.00 et 3 star 
47 62.5 et 3 star 48 648.00 et 2 star 
18 62.0 ct 4 star 40 646.00 et 2 star 
79 61.0 et 3 star 67 645.00 et 2 star 
59 60.5 ct 2 star 22 642.00 et 3 star 
67 59.5 et 2 star 47 635.00 et 3 star 
90 59.5 et 3 star 7 628.00 et 3 star 
48 58.5 et 2 star 46 620.00 et 2 star 
46 56.5 et 2 star 65 616.00 et 3 star 
69 56.5 et 4 star 69 614.00 et 4 star 
65 56.0 et 3 star 4 600.00 et 2 star 
78 55.0 et 2 star 13 582.00 et 2 star 
39 46.5 et 3star 78 580.00 et 2 star 
16 45.5 et 2 star 24 566.00 et 3 star 
58 44.5 et 3 star 59 560.00 et 2 star 
54 42.0 et !star 58 550.00 et 3 star 
93 40.5 et I star 75 537.00 st 3 star 
15 39.5 et 2 star 33 534.00 et 2 star 
8 39.0 et 2 star 16 533.00 et 2 star 
24 39.0 et 3 star 54 522.00 et lstar 
33 38.0 et 2 star 15 512.00 et 2 star 
6 33.5 et l star 39 512.00 et 3star 
55 23.0 et l star 103 510.p.o stJstar 
13 17.5 et 2 star 8 490.00 et 2 _!!ar 
75 15.0 st 3 star 32 437.00 st 5 star 
17 14.0 et 1 star 93 433.00 et l star 
85 14.0 et 2 star 6 364.00 et 1 star 
25 11.0 et lstar/fail 85 354.00 et 2 star 
lfil 7.0 st 5 star. 55 344.00 et I s tar 
81 2.0 failure ~ 02 30£~00,:St_4 star 
97 .0 failure 35 278.00 st 2 star 
20 .0 17 278.00 et 1 star 
34 .0 missing 52 277.00 st 1 star 
29 .0 missing [9.1~§'.1~00~~3.-st9.r1!an1 Ii ~:: ~1 
88 .0 missing 25 232.00 et !star/fail 
102 -2.5 st 4 star 94 208.00 st 2 star 
98 -4.o failure 66 178.00 st 2 star 
72 -4.0 et 1 star 72 167.00 et l star 
94 -7.5 st 2 star 62 75.00 et/? 
66 -12.0 st 2 star 42 53.00 failure 
42 -13.0 failure 81 52.00 failure 
~9JGts.o ~t 3 star7fail ~ 98 48.00 failure 
62 -18.0 et/? 97 8.00 failure 
132 -28.0 st 5 star 20 . 
52 -29.0 st 1 star 34 . missing 
35 -31.0 st 2 star 29 . missing 
88 . missing 
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Appendix 14 Different Versions oflncrement Size for Endurance 
Trainingrncrement size 10 
ID Rank Blind Cl 
50 160.0 et 3 star 
77 143.0 et 3 star 
7 139.0 et 3 star 
4 137.0 et 2 star 
40 132.0 et 2 star 
22 130.0 et 3 star 
21 127.0 et 4 star 
47 125.0 ct 3 star 
18 124.0 et 4 star 
79 122.0 et 3 star 
59 12 l.O et 2 star 
90 119.0 et 3 star 
67 119.0 et 2 star 
48 117.0 et 2 star 
46 113.0 et 2 star 
69 113.0 et 4 star 
65 I 12.0 et 3 star 
16 112.0 st 5 star 
78 110.0 et 2 star 
39 93.0 et 3star 
58 89.0 et 3 star 
8 85.0 et 2 star 
54 84.0 et lstar 
93 81.0 et l star 
15 79.0 et 2 star 
24 78.0 et 3 star 
33 76.0 et 2 star 
6 67.0 et l star 
13 56.0 et 2 star 
55 53.0 et 1 star 
75 47.5 st 3 star 
25 29.0 et !star/fail 
85 28.0 et 2 star 
17 28.0 et 1 star 
103 16.0 st 5 star 
81 4.0 failure 
102 2.0 st 4 star 
97 .0 failure 
20 .0 
34 .0 missing 
29 .0 missing 
88 .0 missing 
94 -8.0 st 2 star 
72 -8.0 et l star 
98 -8.0 failure 
42 -19.0 failure 
62 -22.0 et/? 
66 -24.0 st 2 star 
91 -38.0 st 3 star/fail 
32 -41.5 st 5 star 
52 -50.0 st l star 
35 -62.0 st 2 star 
fncrement Size 7 
ID Rank Blind Cl 
50 80.0 et 3 star 
77 71.5 et 3 star 
7 69.5 et 3 star 
4 68.5 et 2 star 
40 66.0 et 2 star 
22 65.0 et 3 star 
21 63.5 et 4 star 
47 62.5 et 3 star 
18 62.0 et4 star 
79 61.0 et 3 star 
59 60.5 et 2 star 
67 59.5 et 2 star 
90 59.5 et 3 star 
48 58.5 et 2 star 
46 56.5 et 2 star 
69 56.5 et 4 star 
65 56.0 et 3 star 
78 55.0 et 2 star 
39 46.5 et 3star 
16 45.5 st 5 star 
58 44.5 et 3 star 
54 42.0 et lstar 
93 40.5 et 1 star 
15 39.5 et 2 star 
8 39.0 et 2 star 
24 39.0 et 3 star 
33 38.0 et 2 star 
6 33.5 et l star 
55 23.0 et 1 star 
13 l 7.5 et 2 star 
75 15.0 st 3 star 
17 14.0 et l star 
85 14.0 et 2 star 
25 11.0 et l star/fail 
103 7.0 st 5 star 
81 2.0 failure 
97 .0 failure 
20 .0 
34 .0 missing 
29 .0 missing 
88 .0 missing 
102 -2.5 st 4 star 
98 -4.0 failure 
72 -4.0 et l star 
94 -7.5 st 2 star 
66 -12.0 st 2 star 
42 -13.0 failure 
91 -18.0 st 3 star/fail 
62 -18.0 et/? 
32 -28.0 st 5 star 
52 -29.0 st l star 
35 -31.0 st 2 star 
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Appendix 15 ANOV A repeated Measures of combined medication intake 
Descriptive Statistics 
GROUP Mean Std. Deviation N 
IUIUK 1=naurance 5.0256 5.2540 39 
Strength 4.4857 5.7375 35 
Total 4.7703 5.4567 74 
PTIOTDR Endurance 6.4359 9.9625 39 
Strength 4.9143 4.9192 35 
Total 5.7162 7.9700 74 
Tests of Within-Subjects Effects 
Measure: MEASURE 1 
Type Ill Sum 
Source of Squares df Mean Square F Sig. 
XILL ::;pnenc1ty Assumea 31.186 1 31.186 .910· .34 
Greenhouse-Geisser 31.186 1.000 31.186 .910 .34 
Huynh-Feldt 31.186 1.000 31.186 .910 .34 
Lower-bound 31.186 1.000 31.186 .910 .34 
XTLZ *GROUP Sphericity Assumed 8.888 1 8.888 .259 .61 
Greenhouse-Geisser 8.888 1.000 8.888 .259 .61 
Huynh-Feldt 8.888 1.000 8.888 .259 .61 
Lower-bound 8.888 1.000 8.888 .259 .61 
Error(XTLZ) Sphericity Assumed 2467.254 72 34.267 
Greenhouse-Geisser 2467.254 72.000 34.267 
Huynh-Feldt 2467.254 72.000 34.267 
Lower-bound 2467.254 72.000 34.267 
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Appendix 16 Pre treatment measures for Simple Analgesics, Weak and Strong 
Opiods, Anti-Inflammatories, Anti- Neuretics and Anti-Depressants 
Group Statistics 
Std. Error 
GROUP N Mean Std. Deviation Mean 
::IA ::>trength 51 1.882 3.536 .495 
Endurance 52 2.212 4.170 .578 
WO Strength 51 .157 1.120 .157 
Endurance 52 .212 .825 .114 
so Strength 51 1.216 3.070 .430·-
Endurance 52 .519 1.894 .263 
XINF Strength 51 .451 1.487 .208 
Endurance 52 .423 1.109 .154 
XN Strength 51 .196 1.000 .140 
Endurance 52 .269 1.050 .146 
XDE Strength 51 .118 .621 8.698E-02 
Endurance 52 .231 .942 .131 
UNK Strength 51 3.92E-02 .20 2.75E-02 
Endurance 52 .31 1.39 .19 
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Independent Samples Test 
Levene's Test for 
Eaualitv of Variances t-test for Eaualitv of M 
Mean 
F Sia. t df Sia. (2-tailed) Difference 
~A t::.quarvanances 
.784 .378 -.432 101 .667 -.329 assumed 
Equal variances 
-.432 98.951 .666 -.329 not assumed 
WO Equal variances 
.211 .647 -.282 101 .778 -5.468E-02 assumed 
Equal variances 
-.282 91 .833 .779 -5.468E-02 
not assumed 
so Equal variances 
5.866 .017 1.389 101 .168 .696 
assumed 
Equal variances 
1.383 82.973 .171 .696 
not assumed 
XINF Equal variances 
.295 .588 .108 101 .914 2.790E-02 assumed 
Equal variances 
.108 92.430 .914 2.790E-02 
not assumed 
XN Equal variances 
.436 .510 -.362 101 .718 -7.315E-02 
assumed 
Equal variances 
-.362 100.916 .718 -7.315E-02 
not assumed 
XDE Equal variances 
2.178 .143 -.718 101 .474 -.113 assumed 
Equal variances 
-.721 88.518 .473 -.113 
not assumed 
UNK Equal variances 
7.954 .006 -1.362 101 .176 -.27 assumed 
Equal variances 
-1.375 53.056 .175 -.27 
not assumed 
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Appendix 17 Change over.time in Medication Intake 
Group Stat istics 
Std. Error 
GROUP N Mean Std. Deviation Mean 
SALJlrr strength 35 1.3143 4.4243 .7479 
Endurance 39 1.5128 4.7786 .7652 
WODIFF Strength 35 -.4571 1.5405 .2604 
Endurance 39 -.8974 3.5303 .5653 
SODIFF Strength 35 -.5143 2.6857 .4540 
Endurance 39 -1.8718 8.3483 1.3368 
XINIF Strength 35 -.3429 2.0856 .3525 
Endurance 39 .1026 1.8609 .2980 
XNDIF Strength 35 -8.57E-02 .9194 .1554 
Endurance 39 .3590 1.2028 .1926 
XDEDIF Strength 35 -.1143 1.3671 .2311 
Endurance 39 .1538 .9608 .1538 
UNKDIF Strength 35 -.2286 1.7165 .2901 
Endurance 39 -.7692 3.9833 .6378 
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Independent Samples Test 
Levene's Test for 
Eaualitv of Variances t-test for Eaualitv o 
Mean 
F SiQ. t df SiQ. (2-tailed) Differenc 
~AU11-r- t:qua1vanances 
.788 .378 -.185 72 .854 -.198 assumed 
Equal variances 
-.186 71.923 .853 -.198 
not assumed 
WODIFF Equal variances 
3.846 .054 .682 72 .498 .440 assumed 
Equal variances 
.707 53.161 .482 .440 not assumed 
SODIFF Equal variances 
2.225 .140 .920 72 .361 1.357 assumed 
Equal variances 
.962 46.578 .341 1.357 not assumed 
XINIF Equal variances 
.104 .748 -.971 72 .335 -.445 assumed 
Equal variances 
-.965 68.606 .338 -.445 
not assumed 
XNDIF Equal variances 
2.022 .159 -1 .771 72 .081 -.444 assumed 
Equal variances 
-1.797 70.290 .077 -.444 
not assumed 
XDEDIF Equal variances 
.402 .528 -.984 72 .328 -.268 assumed 
Equal variances 
-.966 60.233 .338 -.268 not assumed 
UNKDIF Equal variances 
2.360 .129 .743 72 .460 .540 assumed 
Equal variances 
.772 52.824 .444 .540 not assumed 
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Appendix 18 Top Adheres Medication Intake by Drug Category 
Group Statistics 
Std. Error 
GROUP N Mean Std. Deviation Mean 
SADIFr Strength 11 1.6364 4.8015 1.4477 
Endurance 14 1.0000 3.3968 .9078 
WODIFF Strength 11 .0000 .0000 .0000 
Endurance 14 -.5714 2.9798 .7964 
SOD I FF Strength 11 .5000 1.5652 .4719 
Endurance 14 -4.2143 13.3485 3.5675 
XINIF Strength 11 -.3636 1.2060 .3636 
Endurance 14 .4286 1.1579 .3095 
XNDIF Strength 11 .0000 .0000 .0000 
Endurance 14 .8571 1.8752 .5012 
XDEDIF Strength 11 .3636 1.2060 .3636 
Endurance 14 .2857 1.0690 .2857 
UNKDIF Strength 11 9.091E-02 .3015 9.091E-02 
Endurance 14 7.143E-02 .6157 .1646 
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Independent Samples Test 
Levene's Test for 
Equality of Variances t-test for Equality o 
Mean 
F Sig. t df Sig. (2-tailed) Differenc 
SADIFF t:qual variances 
.008 .931 .388 23 .701 .636 assumed 
Equal variances 
.372 17.348 .714 .636 not assumed 
WOO I FF Equal variances 
4.169 .053 .633 23 .533 .571 assumed 
Equal variances 
.718 13.000 .486 .571 
not assumed 
SOD I FF Equal variances 
3.128 .090 1.160 23 .258 4.714 
assumed 
Equal variances 1.310 13.454 .212 4.714 not assumed 
XINIF Equal variances 
.039 .845 -1.668 23 .109 -.792 
assumed 
Equal variances 
-1.659 21 .183 .112 -.792 not assumed 
XNDIF Equal variances 
12.653 .002 -1.509 23 .145 . -.857 assumed 
Equal variances 
-1 .710 13.000 .111 -.857 
not assumed 
XDEDIF Equal variances 
.117 .736 .171 23 .866 7.792E-O assumed 
Equal variances 
.168 20.228 .868 7.792E-O 
not assumed 
UNKDIF Equal variances 
.385 .541 .096 23 .924 1.948E-O 
assumed 
Equal variances 
.104 19.754 .919 1.948E-O 
not assumed 
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Appendix 19 Fatigue Response Test on MedX Equipment 
The fatigue response test is used to measure the endurance characteristics of spe~ific 
muscle groups. It involves three stages 
The Pre Fatigue Response Test 
The patient performs a series of maximal effort isometric contractions at several joint 
angles through their range of movement. 
Dynamic Exercise to Volitional Fatigue 
The patient then performs dynamic controlled repetitions, with a weight of 80% of their 
measured isometric strength, to volitional fatigue. The concentric phase of the repetition 
should last for 2 seconds, with a 1 second pause at full contraction then the eccentric phase 
over a 4 second period ( total 7 seconds per repetition) 
The Post Fatigue Response Test 
The patient then performs a second series of maximal effort isometric contractions at the 
same joint angles as in the first test. 
The difference between the Pre and post fatigue response tests represents the fatiguing 
affect of dynamic exercise. 
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Appendix 20 Distributions for the Mental Health and Role-Emotional Scales 
164 
GROUP 
Case Processing Summary 
Cases 
Valid Missina Total 
GROUP N Percent N Percent N Percent 
vHt::MOI t:naurance 39 76.5% 12 23.5% 51 100.0% 
Strength 40 78.4% 11 21.6% 51 100.0% 
Descriptives 
GROUP Statistic Std. Error 
\...Mt:MUI t:naurance Mean 
-9.4015 6.8123 
95% Confidence Lower Bound -23.1924 
Interval for Mean Upper Bound 4.3893 














Strength Mean 7.5000 6.4811 
95% Confidence Lower Bound -5.6093 
Interval for Mean Upper Bound 20.6093 
5% Trimmed Mean 8.3333 
Median .0000 
Variance 1680.199 




Interquartile Range 33.3333 
Skewness -.105 .374 
Kurtosis .541 .733 
Page 1 
Extreme Values 
GROUP Case Number Value 
vMt:MUI t.nourance Highest 1 75 66.67 
2 24 66.67 
3 79 66.67 
4 69 33.34 
5 78 a 
Lowest 1 33 -100.00 
2 93 -100.00 
3 67 -100.00 
4 29 -66.67 
5 39 b 
Strength Highest 1 57 100.00 
2 86 66.67 
3 45 66.67 
4 80 66.67 
5 83 c 
Lowest 1 10 -100.00 
2 44 -66.67 
3 43 -66.67 
4 23 -33.33 
5 41 d 
a. Only a partial list of cases with the value 33 are shown in the table of upper extremes. 
b. Only a partial list of cases with the value -67 are shown in the table of lower extremes. 
c. Only a partial list of cases with the value 67 are shown in the table of upper extremes. 
d. Only a partial list of cases with the value -33 are shown in the table of lower extremes. 
Tests of Normality 
KolmoQorov-Smirnov" Shapiro-Wilk 





**.This is an upper bound of the true significance. 
a. Lilliefors Significance Correction 
CHEM OT 
Histograms 
SiQ. Statistic df 
39 .000 .886 39 














For GROUP= Endurance 
10 
Std. Dev = 42.54 
Mean = -9.4 
O N = 39.00 
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For GROUP= Strength 
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Std. Dev= 40.99 
Mean = 7.5 
N = 40.00 
Normal Q-Q Plots 
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Normal Q-Q Plot of CHEMOT 
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Detrended Normal Q-Q Plot of CHEMOT 
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GROUP 
Case Processing Summary 
Cases 
Valid Missina Total 
GROUP N Percent N Percent N Percent 
(.;HMH t::nourance 40 78.4% 11 21 .6% 51 100.0% 
Strength 42 82.4% 9 17.6% 51 100.0% 
Pages 
Descriptives 
GROUP Statistic Std. Error 
C,,;HMH t::naurance Mean .6750 2.3461 
95% Confidence Lower Bound -4.0705 
Interval for Mean Upper Bound 5.4205 
5% Trimmed Mean 1.0833 
Median 1.0000 
Variance 220.174 




Interquartile Range 20.0000 
Skewness -.378 .374 
Kurtosis -.117 .733 
Strength Mean 2.5952 1.9658 
95% Confidence Lower Bound -1.3747 
Interval for Mean Upper Bound 6.5652 
5% Trimmed Mean 2.7672 
Median .0000 
Variance 162.296 




Interquartile Range 18.0000 
Skewness -.106 .365 
Kurtosis -.176 .717 
Extreme Values 
GROUP Case Number Value 
C,,;HMH l::naurance H1gnest 1 65 28.00 
2 21 24.00 
3 79 24.00 
4 20 20.00 
5 75 20.00 
Lowest 1 4 -36.00 
2 17 -28.00 
3 8 -24.00 
4 33 -20.00 
5 93 -20.00 
Strength Highest 1 57 28.00 
2 83 24.00 
3 49 24.00 
4 31 20.00 
5 89 20.00 
Lowest 1 30 -28.00 
2 19 -20.00 
3 36 -20.00 
4 76 -16.00 
5 84 -12.00 
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Tests of Normal ity 
KolmoQorov-Smirnov" 
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Detrended Normal Q-Q Plot of CHMH 
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